10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2019

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 000-23486

NN, Inc.

(Exact name of registrant as specified in its charter)

Delaware	62-1096725
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification Number)

6210 Ardrey Kell Road

Charlotte, North Carolina 28277

(Address of principal executive offices, including zip code)

(980) 264-4300

(Registrant’s telephone number, including area code) 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☒
Non-accelerated filer	☐ (Do not check if a smaller reporting company)	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act   ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No  ☒

As of May 3, 2019, there were 42,366,961 shares of the registrant’s common stock, par value $0.01 per share, outstanding.

Securities registered pursuant to Section 12(b) of the Act:
Title of each class	Trading symbol	Name of each exchange on which registered
Common Stock, par value $0.01 per share	NNBR	The Nasdaq Stock Market, LLC

1

NN, Inc.

INDEX

PART I. FINANCIAL INFORMATION		3
Item 1.	Financial Statements	3
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	22
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	28
Item 4.	Controls and Procedures	28
PART II. OTHER INFORMATION		30
Item 1.	Legal Proceedings	30
Item 1A.	Risk Factors	30
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	30
Item 3.	Defaults upon Senior Securities	30
Item 4.	Mine Safety Disclosures	31
Item 5.	Other Information	31
Item 6.	Exhibits	32
SIGNATURES		33

2

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

NN, Inc.

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)

(Unaudited)

Amounts in thousands, except per share data

	Three Months Ended March 31,
	2019			2018
Net sales	$	213,256		$	169,148
Cost of sales (exclusive of depreciation and amortization shown separately below)	161,269			126,444
Selling, general and administrative expense	28,125			22,177
Acquisition related costs excluded from selling, general and administrative expense	—			1,776
Depreciation and amortization	23,425			14,281
Restructuring and integration expense	(12		)	755
Other operating (income) expense, net	(152		)	22
Income from operations	601			3,693
Interest expense	13,801			11,996
Loss on extinguishment of debt and write-off of debt issuance costs	2,699			—
Other (income) expense, net	729			(313		)
Loss before (provision) benefit for income taxes and share of net income from joint venture	(16,628		)	(7,990		)
(Provision) benefit for income taxes	(2,241		)	1,176
Share of net income from joint venture	269			831
Net loss	$	(18,600	)	$	(5,983	)
Other comprehensive income (loss):
Change in fair value of interest rate swap, net of tax	(3,856		)	—
Foreign currency translation gain	1,262			5,465
Other comprehensive income (loss)	$	(2,594	)	$	5,465
Comprehensive loss	$	(21,194	)	$	(518	)
Basic net loss per share
Net loss per share	$	(0.44	)	$	(0.22	)
Weighted average shares outstanding	41,972			27,597
Diluted net loss per share
Net loss per share	$	(0.44	)	$	(0.22	)
Weighted average shares outstanding	41,972			27,597

The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.

3

NN, Inc.

Condensed Consolidated Balance Sheets

(Unaudited)

Amounts in thousands

	March 31, 2019			December 31, 2018
Assets
Current assets:
Cash and cash equivalents	$	20,269		$	17,988
Accounts receivable, net	147,131			133,421
Inventories	128,922			122,615
Income tax receivable	653			946
Other current assets	17,475			21,901
Total current assets	314,450			296,871
Property, plant and equipment, net	352,923			361,028
Finance lease right-of-use assets	12,886			—
Operating lease right-of-use assets	68,458			—
Goodwill	440,169			439,452
Intangible assets, net	363,608			376,248
Investment in joint venture	21,087			20,364
Other non-current assets	7,412			7,607
Total assets	$	1,580,993		$	1,501,570
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable	$	74,348		$	65,694
Accrued salaries, wages and benefits	27,990			24,636
Current maturities of long-term debt	33,444			31,280
Current portion of operating lease liability	7,630			—
Other current liabilities	21,700			23,420
Total current liabilities	165,112			145,030
Deferred tax liabilities	87,993			93,482
Non-current income tax payable	3,875			3,875
Long-term debt, net of current portion	826,274			811,471
Operating lease liability, net of current portion	66,975			—
Other non-current liabilities	35,855			29,417
Total liabilities	1,186,084			1,083,275
Commitments and contingencies (Note 12)
Stockholders’ equity:
Common stock - $0.01 par value, authorized 45,000 shares, 42,367 and 42,104 shares issued and outstanding at March 31, 2019 and December 31, 2018, respectively	424			421
Additional paid-in capital	512,274			511,545
Retained deficit	(83,570		)	(62,046		)
Accumulated other comprehensive loss	(34,219		)	(31,625		)
Total stockholders’ equity	394,909			418,295
Total liabilities and stockholders’ equity	$	1,580,993		$	1,501,570

The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.

4

NN, Inc.

Condensed Consolidated Statement of Changes in Stockholders’ Equity

(Unaudited)

Amounts in thousands

	Common Stock
	Number of shares		Par value		Additional paid in capital			Retained deficit			Accumulated other comprehensive loss			Total
Balance, December 31, 2018	42,104		$	421	$	511,545		$	(62,046	)	$	(31,625	)	$	418,295
Net loss	—		—		—			(18,600		)	—			(18,600		)
Cash dividends declared	—		—		—			(2,942		)	—			(2,942		)
Share-based compensation expense	281		3		870			—			—			873
Restricted shares forgiven for taxes and forfeited	(18	)	—		(141		)	—			—			(141		)
Change in fair value of interest rate swap, net of tax of $1,104	—		—		—			—			(3,856		)	(3,856		)
Foreign currency translation gain	—		—		—			—			1,262			1,262
Adoption of new accounting standard (Note 1)	—		—		—			18			—			18
Balance, March 31, 2019	42,367		$	424	$	512,274		$	(83,570	)	$	(34,219	)	$	394,909

	Common Stock
	Number of shares		Par value		Additional paid in capital			Retained earnings			Accumulated other comprehensive loss			Total
Balance, December 31, 2017	27,572		$	275	$	292,494		$	211,080		$	(17,745	)	$	486,104
Net loss	—		—		—			(5,983		)	—			(5,983		)
Cash dividends declared	—		—		—			(1,955		)	—			(1,955		)
Share-based compensation expense	87		1		1,255			—			—			1,256
Shares issued for option exercises	23		—		242			—			—			242
Restricted shares and performance shares forgiven for taxes and forfeited	(16	)	—		(287		)	—			—			(287		)
Foreign currency translation gain	—		—		—			—			5,465			5,465
Adoption of new accounting standard	—		—		—			17			—			17
Balance, March 31, 2018	27,666		$	276	$	293,704		$	203,159		$	(12,280	)	$	484,859

The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.

5

NN, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

Amounts in thousands

	Three Months Ended March 31,
	2019			2018
Cash flows from operating activities
Net loss	$	(18,600	)	$	(5,983	)
Adjustments to reconcile net loss to net cash provided by (used by) operating activities:
Depreciation and amortization	23,425			14,281
Amortization of debt issuance costs	1,191			1,088
Loss on extinguishment of debt and write-off of debt issuance costs	2,699			—
Share of net income from joint venture, net of cash dividends received	(269		)	(831		)
Compensation expense from issuance of share-based awards	873			1,256
Deferred income taxes	(4,373		)	—
Other	182			347
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	(13,963		)	(9,433		)
Inventories	(6,302		)	(7,791		)
Accounts payable	7,236			(296		)
Income taxes receivable and payable, net	248			(613		)
Other	4,941			7,001
Net cash used by operating activities	(2,712		)	(974		)
Cash flows from investing activities
Acquisition of property, plant and equipment	(14,073		)	(11,860		)
Proceeds from liquidation of short-term investment	8,000			—
Cash paid to acquire businesses, net of cash received	—			(14,676		)
Cash paid for earnest money for Paragon Medical acquisition	—			(6,000		)
Other	2,394			(282		)
Net cash used by investing activities	(3,679		)	(32,818		)
Cash flows from financing activities
Cash paid for debt issuance or prepayment costs	(738		)	—
Dividends paid	(2,947		)	(1,931		)
Proceeds from long-term debt	19,025			10,000
Repayment of long-term debt	(7,522		)	(13,000		)
Proceeds from (repayments of) short-term debt, net	1,982			(52		)
Other	(924		)	(1,278		)
Net cash provided by (used by) financing activities	8,876			(6,261		)
Effect of exchange rate changes on cash flows	(204		)	562
Net change in cash and cash equivalents	2,281			(39,491		)
Cash and cash equivalents at beginning of period	17,988			224,446
Cash and cash equivalents at end of period	$	20,269		$	184,955
Supplemental schedule of non-cash operating, investing and financing activities
Non-cash additions to property, plant and equipment	$	4,071		$	2,992

The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.

6

NN, Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2019

(Unaudited)

Amounts in thousands, except per share data

Note 1. Interim Financial Statements

Nature of Business

NN, Inc., is a global diversified industrial company that combines advanced engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision components and assemblies for the medical, aerospace and defense, electrical, automotive, and general industrial markets. As used in this Quarterly Report on Form 10-Q, the terms “NN,” the “Company,” “we,” “our,” or “us” refer to NN, Inc., and its subsidiaries. As of March 31, 2019, we had 51 facilities in North America, Europe, South America, and China.

Basis of Presentation

The accompanying condensed consolidated financial statements have not been audited, except that the Condensed Consolidated Balance Sheet as of December 31, 2018, was derived from the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2018 (the “2018 Annual Report”), which we filed with the U.S. Securities and Exchange Commission (the “SEC”), on March 18, 2019. In management’s opinion, the accompanying unaudited condensed consolidated financial statements reflect all adjustments necessary to fairly state our results of operations for the three months ended March 31, 2019 and 2018; financial position as of March 31, 2019, and December 31, 2018; and cash flows for the three months ended March 31, 2019 and 2018, on a basis consistent with our audited consolidated financial statements other than the adoption of new accounting standards, such as the new lease standard (see Note 10). These adjustments are of a normal recurring nature and are, in the opinion of management, necessary to state fairly the Company’s financial position and operating results for the interim periods.

Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) have been condensed or omitted from the interim financial statements presented in this Quarterly Report on Form 10-Q. These unaudited condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and accompanying notes included in the 2018 Annual Report. The results for the three months ended March 31, 2019, are not necessarily indicative of results for the year ending December 31, 2019, or any other future periods.

Except for per share data or as otherwise indicated, all U.S. dollar amounts presented in the tables in these Notes to Condensed Consolidated Financial Statements are in thousands.

Accounting Standards Recently Adopted

Leases. On January 1, 2019, we adopted Accounting Standards Codification (“ASC”) 842, Leases, which superseded ASC 840, Leases. We adopted ASC 842 utilizing the modified retrospective transition approach, therefore, historical financial information and disclosures do not reflect the new standard and will continue to be presented under the previous lease accounting guidance. Under the modified retrospective transition method, we recognized the cumulative effect of the initial adoption adjustment to the opening balance of retained deficit as of January 1, 2019. The adoption adjustment to retained deficit was less than $0.1 million. As part of the adoption of ASC 842, we elected the package of practical expedients, the short-term lease exemption, and the practical expedient to not separate lease and non-lease components. We recorded lease-related assets and liabilities to our balance sheet for leases with terms greater than twelve months that were classified as operating leases and not previously recorded on our balance sheet. See Note 10 for the required disclosures related to ASC 842.

Derivatives and Hedging. In August 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities, (“ASU 2017-12”). ASU 2017-12 provides new rules that expand the hedging strategies that qualify for hedge accounting. The new rules also allow additional time to complete hedge effectiveness testing and allow qualitative assessments subsequent to initial quantitative tests if there is supportable expectation that the hedge will remain highly effective. We adopted the guidance on January 1, 2019. We have applied the new rules to 2019 hedging activities as disclosed in Note 16 to these condensed consolidated financial statements. The new guidance has no effect on our historical financial statements.

Effects of Tax Reform in Other Comprehensive Income. In February 2018, the FASB issued guidance related to the impacts of the U.S. Tax Cuts and Jobs Act of 2017 (“Tax Act”). Under existing U.S. GAAP, the effects of changes in tax rates and laws on deferred tax balances are recorded as a component of income tax expense in the period in which the law was enacted. When deferred tax balances related to items originally recorded in accumulated other comprehensive income (“AOCI”) are adjusted, certain tax effects become stranded in AOCI. The FASB issued ASU 2018-2, Income Statement – Reporting Comprehensive

7

Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income, that permits reclassification of certain income tax effects of the Tax Act from AOCI to retained earnings. The guidance also requires certain disclosures about stranded tax effects. The new guidance was effective for us on January 1, 2019. We adopted the new guidance at the beginning of the period of adoption. The new guidance had no effect on our financial statements.

Accounting Standards Not Yet Adopted

Fair Value Disclosures. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement, that modifies fair value disclosure requirements. The new guidance could impact us by streamlining disclosures of Level 3 fair value measurements. The modified disclosures are effective for NN beginning in the first quarter of 2020, with early adoption allowed. ASU 2018-13 changes only disclosures and does not impact our financial condition, results of operations, or cash flows. We are in the process of evaluating the effects of this guidance on our fair value disclosures.

Internal-Use Software. In August 2018, the FASB issued ASU 2018-15, Intangibles - Goodwill and Other - Internal-Use Software: Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (a consensus of the FASB Emerging Issues Task Force), that provides guidance on a customer’s accounting for implementation, set-up, and other upfront costs incurred in a cloud computing arrangement that is hosted by the vendor. Under the new guidance, customers will apply the same criteria for capitalizing implementation costs as they would for an arrangement that has a software license. ASU 2018-15 is effective for us on January 1, 2020, using either a prospective or retrospective approach and with early adoption permitted. We are in the process of evaluating the effects of this guidance on our financial statements.

Note 2. Acquisitions

Paragon Medical, Inc.

On May 7, 2018, we acquired 100% of the stock of PMG Intermediate Holding Corporation, the parent company of Paragon Medical, Inc. (“Paragon Medical”). For accounting purposes, Paragon Medical meets the definition of a business and has been accounted for as a business combination. Paragon Medical is a medical device manufacturer which focuses on the orthopedic, case and tray, implant, and instrument markets. This acquisition continues our strategic focus to expand our Life Sciences portfolio as well as create a balanced business by diversifying our products and finished device offerings. We have performed an assessment of the opening balance sheet which is subject to completion of our internal review procedures over fair value estimates. Opening balance sheet deferred taxes have been recorded based on estimates made as of the acquisition date as well as information currently available to management. As estimates are refined and additional information is received throughout the measurement period, adjustments to opening deferred taxes may be recorded with an offsetting adjustment to goodwill.

Beginning May 7, 2018, our consolidated results of operations include the results of Paragon Medical.

The unaudited pro forma financial results shown in the table below for the three months ended March 31, 2018, combine the consolidated results of NN and Paragon Medical giving effect to the Paragon Medical acquisition as if it had been completed on January 1, 2017. The unaudited pro forma financial results do not give effect to any of our other acquisitions that occurred after January 1, 2017, and do not include any anticipated synergies or other assumed benefits of the Paragon Medical acquisition. This unaudited pro forma financial information is presented for informational purposes only and is not indicative of future operations or results had the Paragon Medical acquisition been completed as of January 1, 2017.

The unaudited pro forma financial results include certain adjustments for debt service costs and additional depreciation and amortization expense based upon the fair value step-up and estimated useful lives of Paragon Medical depreciable fixed assets and definite-life amortizable assets acquired. The provision for income taxes has also been adjusted for all periods, based upon the foregoing adjustments to historical results.

	Three Months Ended March 31, 2018
Pro forma net sales	$	209,830
Pro forma net loss	$	(8,077	)
Basic net loss per share	$	(0.29	)
Diluted net loss per share	$	(0.29	)

8

Other Acquisitions

Bridgemedica, LLC. On February 22, 2018, we completed the acquisition of 100% of the assets of Bridgemedica, LLC (“Bridgemedica”). For accounting purposes, Bridgemedica meets the definition of a business and has been accounted for as a business combination. Bridgemedica is a medical device company that provides concept to supply solutions through design, development engineering, and manufacturing. Operating results of Bridgemedica are reported in our Life Sciences group after the acquisition date. We have finalized the purchase price allocation with no material changes to the initial allocation.

Southern California Technical Arts, Inc. On August 9, 2018, we completed the acquisition of 100% of the capital stock of Southern California Technical Arts, Inc. (“Technical Arts”). For accounting purposes, Technical Arts meets the definition of a business and has been accounted for as a business combination. Technical Arts is an industrial machining company that manufactures tight tolerance metal components and assemblies. The acquisition of Technical Arts expands our presence in the aerospace and defense end market. Operating results of Technical Arts are reported in our Power Solutions group after the acquisition date. We have completed a preliminary purchase price allocation and are in the process of finalizing the fair value of assets acquired and liabilities assumed.

Note 3. Segment Information

We determined our reportable segments under the provisions of U.S. GAAP related to disclosures about segments of an enterprise. Management has concluded that Mobile Solutions, Power Solutions, and Life Sciences each constitutes an operating segment as each engages in business activities for which it earns revenues and incurs expenses for which separate financial information is available, and this is the level at which the Chief Operating Decision Maker (“CODM”) reviews discrete financial information for purposes of allocating resources and assessing performance.

Mobile Solutions

Mobile Solutions is focused on growth in the general industrial and automotive end markets. We have developed an expertise in manufacturing highly complex, system critical components for fuel systems, engines and transmissions, power steering systems, and electromechanical motors on a high-volume basis. This expertise has been gained through investment in technical capabilities, processes and systems, and skilled program management and product launch capabilities.

Power Solutions

Power Solutions is focused on growth in the electrical and aerospace and defense end markets. Within this group we combine materials science expertise with advanced engineering and production capabilities to design and manufacture a broad range of high-precision metal and plastic components, assemblies, and finished devices used in applications ranging from power control to flight control and for military devices.

We manufacture a variety of products including electrical contacts, connectors, contact assemblies, and precision stampings for the electrical end market and high precision products for the aerospace and defense end markets utilizing our extensive process technologies for optical grade plastics, thermally conductive plastics, titanium, Inconel, magnesium, and electroplating.

Life Sciences

Life Sciences is focused on growth in the medical end market. Within this group we combine advanced engineering and production capabilities to design and manufacture a broad range of high-precision metal and plastic components, assemblies, and finished devices.

We manufacture a variety of components, assemblies, and instruments, such as surgical knives, bioresorbable implants, surgical staples, cases and trays, orthopedic implants and tools, laparoscopic devices, and drug delivery devices for the medical and life sciences end market.

9

Segment Results

The following table presents results of operations for each reportable segment.

	Mobile Solutions		Power Solutions		Life Sciences		Corporate and Consolidations				Total
Three Months Ended March 31, 2019
Net sales	$	78,075	$	49,657	$	86,008	$	(484	)	(a)	$	213,256
Income (loss) from operations	$	4,107	$	3,824	$	3,846	$	(11,176	)		$	601
Interest expense											(13,801		)
Other											(3,428		)
Loss before provision for income taxes and share of net income from joint venture											$	(16,628	)
Three Months Ended March 31, 2018
Net sales	$	89,794	$	48,682	$	31,200	$	(528	)	(a)	$	169,148
Income (loss) from operations	$	9,785	$	5,233	$	4,204	$	(15,529	)		$	3,693
Interest expense											(11,996		)
Other											313
Loss before benefit for income taxes and share of net income from joint venture											$	(7,990	)

_______________________________

(a) Includes elimination of intersegment transactions occurring during the ordinary course of business.

	Total Assets as of
	March 31, 2019		December 31, 2018
Mobile Solutions	$	392,100	$	356,387
Power Solutions	311,771		297,947
Life Sciences	824,891		802,770
Corporate and Consolidations	52,231		44,466
Total	$	1,580,993	$	1,501,570

Note 4. Inventories

Inventories are comprised of the following amounts:

	March 31, 2019		December 31, 2018
Raw materials	$	55,286	$	52,930
Work in process	47,372		42,578
Finished goods	26,264		27,107
Total inventories	$	128,922	$	122,615

Note 5. Goodwill

The following table shows changes in the carrying amount of goodwill.

	Mobile Solutions		Power Solutions		Life Sciences		Total
Balance as of December 31, 2018	$	—	$	94,505	$	344,947	$	439,452
Currency impacts	—		198		519		717
Balance as of March 31, 2019	$	—	$	94,703	$	345,466	$	440,169

Based on the closing price of a share of our common stock as of March 31, 2019, our market capitalization had declined to a level that is less than the net book value of our stockholders’ equity. A prolonged or significant decline in market capitalization could be an indicator of additional goodwill impairment. We will continue to monitor our market capitalization to determine if an indicator of impairment exists in subsequent periods.

10

During 2018, as a result of our annual goodwill impairment analysis performed during the fourth quarter of 2018, we recorded an impairment of $109.1 million in our Power Solutions group. After the impairment, Power Solutions reported a goodwill balance of $94.5 million at December 31, 2018. Given the carrying value of the Power Solutions reporting unit was equal to its fair value at December 31, 2018 as a result of the 2018 goodwill impairment, if actual performance of the Power Solutions reporting unit falls short of expected results, additional material impairment charges may be required. During the first quarter of 2019, we reassessed the relevant facts and circumstances and concluded there was no impairment during the period. We will continue to monitor and assess Power Solutions during 2019.

Note 6. Intangible Assets, Net

The following table shows changes in the carrying amount of intangible assets, net.

	Mobile Solutions			Power Solutions			Life Sciences			Total
Balance as of December 31, 2018	$	35,892		$	95,991		$	244,365		$	376,248
Amortization	(885		)	(2,748		)	(9,017		)	(12,650		)
Other	2			—			8			10
Balance as of March 31, 2019	$	35,009		$	93,243		$	235,356		$	363,608

Note 7. Investment in Joint Venture

We own a 49% investment in Wuxi Weifu Autocam Precision Machinery Company, Ltd. (the “JV”), a joint venture located in Wuxi, China. The JV is jointly controlled and managed, and we account for it under the equity method.

The following table summarizes activity related to our investment in the JV.

Balance as of December 31, 2018	$	20,364
Share of earnings	269
Foreign currency translation gain	454
Balance as of March 31, 2019	$	21,087

During the fourth quarter of 2018, as a result of changing market conditions, the fair value of the JV was assessed and we recorded an impairment charge of $16.6 million against our investment in the JV. The fair value assessment was most significantly affected by changes in our assessment of future growth rates. It is reasonably possible that material deviation of future performance from the estimates used in the 2018 valuation could result in further impairment to our investment in the JV in subsequent periods. There was no impairment of our investment in the JV during the three months ended March 31, 2019.

We recognized sales to the JV of less than $0.1 million and $0.1 million during the three months ended March 31, 2019 and 2018, respectively.

Note 8. Income Taxes

Our effective tax rate was (13.5)% for the three months ended March 31, 2019, and 14.7% for the three months ended March 31, 2018. Our 2019 effective tax rate differs from the U.S. federal statutory tax rate of 21% principally due to a discrete tax charge of $6.0 million related to final tax regulations published by the Department of the Treasury and Internal Revenue Service on February 4, 2019. The 2019 effective tax rate was also impacted by the minimum tax on global intangible low-tax income (“GILTI”) and earnings outside the United States, which are taxed at different rates than the U.S. federal statutory tax rate of 21%.

Our 2018 effective tax rate differed from the U.S. federal statutory tax rate of 21% due to permanent differences including GILTI and earnings outside the United States, which were taxed at different rates than the U.S. federal statutory rate of 21%.

11

Note 9. Debt

Collectively, our credit facility is comprised of a term loan with a face amount of $545.0 million, maturing on October 19, 2022 (the “Senior Secured Term Loan”); a term loan with a face amount of $300.0 million, maturing on April 3, 2021 (the Incremental Term Loan”); and a revolving line of credit with a face amount of $143.0 million, maturing on October 19, 2020 (the “Senior Secured Revolver”). The credit facility is collateralized by all of our assets.

The following table presents debt balances as of March 31, 2019, and December 31, 2018.

	March 31, 2019		December 31, 2018
Senior Secured Term Loan	$	530,625	$	532,063
Incremental Term Loan	276,000		279,000
Senior Secured Revolver	56,184		38,720
International lines of credit and other loans	10,601		9,810
Total principal	873,410		859,593
Less—current maturities of long-term debt	33,444		31,280
Principal, net of current portion	839,966		828,313
Less—unamortized debt issuance costs	13,692		16,842
Long-term debt, net of current portion	$	826,274	$	811,471

We capitalized interest costs amounting to $0.6 million and $0.2 million in the three months ended March 31, 2019 and 2018, respectively, related to construction in progress.

Senior Secured Term Loan

Outstanding borrowings under the Senior Secured Term Loan bear interest at the greater of 0.75% or one-month London Interbank Offered Rate (“LIBOR”) plus an applicable margin of 3.75%. At March 31, 2019, the Senior Secured Term Loan bore interest at 6.24%.

Incremental Term Loan

Outstanding borrowings under the Incremental Term Loan bear interest at one-month LIBOR plus an applicable margin of 3.25%. At March 31, 2019, the Incremental Term Loan bore interest of 5.74%.

Senior Secured Revolver

Outstanding borrowings under the Senior Secured Revolver bear interest at one-month LIBOR plus an applicable margin of 3.50%. At March 31, 2019, the Senior Secured Revolver bore interest of 5.99%. We pay an annual commitment fee of 0.50% for unused capacity under the Senior Secured Revolver on a quarterly basis.

Total available capacity under the Senior Secured Revolver was $125.0 million as of March 31, 2019. Our credit facility is subject to certain financial covenants based on a consolidated net leverage ratio, as defined in the credit facility agreement. The financial covenants are effective when we have outstanding borrowings under our Senior Secured Revolver on the last day of any fiscal quarter, become more restrictive over time, and are dependent upon our operational and financial performance. If our operational or financial performance is below our expectations, we may be required to take actions to reduce expenditures and decrease our net indebtedness to maintain compliance in future periods. We had $56.2 million outstanding under the Senior Secured Revolver at March 31, 2019, and we were in compliance with all covenants under our credit facility.

On March 15, 2019, we amended our existing credit facility (the “March 2019 amendment”) to amend the defined terms within the credit facility. We paid $0.8 million of debt issuance costs related to the March 2019 amendment which was recorded as a direct reduction to the carrying amount of the associated long-term debt. We also wrote-off $2.7 million of unamortized debt issuance costs related to the modification of the credit facility.

Derivative Instruments and Hedging Activities

In February 2019, we entered into a $700.0 million amortizing notional amount fixed-rate interest rate swap agreement to manage the interest rate risk associated with our long-term variable-rate debt until 2022. The fixed-rate interest rate swap agreement calls for us to receive interest monthly at a variable rate equal to one-month LIBOR and to pay interest monthly at a fixed rate of 2.4575%. Refer to Note 16 for further discussion of the interest rate swap agreement.

Note 10. Leases

We adopted ASC 842 on January 1, 2019, and elected the modified retrospective approach in which the new standard is applied to all leases existing at the date of adoption through a cumulative-effect adjustment of less than $0.1 million to retained deficit.

12

Consequently, financial information is not updated, and the disclosures required under the new standard are not provided for periods prior to January 1, 2019.  As part of the adoption, we elected the package of practical expedients, the short-term lease exemption, and the practical expedient to not separate lease and non-lease components permitted within ASC 842. Accordingly, we accounted for our existing operating leases as operating leases under the new standard, without reassessing (a) whether the contracts contain a lease under ASC 842, (b) whether classification of the operating leases would be different in accordance with ASC 842, or (c) whether any unamortized initial direct costs would have met the definition of initial direct costs in ASC 842 at lease commencement.

We determine whether an arrangement is a lease at inception. Right-of-use (“ROU”) lease assets represent our right to use an underlying asset for the lease term, and lease obligations represent our obligation to make lease payments arising from the lease. ROU lease assets and obligations are recognized at the lease commencement date based on the present value of lease payments over the lease term. When the implicit rate is not readily determinable, we use the estimated incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. The lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Amortization of ROU lease assets is recognized in expense on a straight-line basis over the lease term.

Short-term leases are leases having a term of twelve months or less. We recognize short-term leases on a straight-line basis and do not record a related lease asset or liability for such leases. Finance lease ROU assets consist of equipment used in the manufacturing process with terms between thirteen months and five years. Operating lease ROU assets consist of the following:

• Equipment used in the manufacturing process as well as office equipment with terms between thirteen months and five years.

• Manufacturing plants and office facilities with terms between thirteen months and 25 years.

The following table presents components of lease expense for the three months ended March 31, 2019:

	Financial Statement Line Item	Three Months Ended March 31, 2019
Lease cost:
Finance lease cost
Amortization of right-of-use assets	Depreciation and amortization	$	322
Interest expense	Interest expense	53
Operating lease cost	Cost of sales and selling, general and administrative expense	3,434
Short-term lease cost (1)	Cost of sales and selling, general and administrative expense	107
Total lease cost		$	3,916

_______________________________

(1) Excludes expenses related to leases with a lease term of one month or less.

13

The following table presents the lease-related assets and liabilities recorded on the balance sheet as of March 31, 2019:

	Financial Statement Line Item	March 31, 2019
Lease assets and liabilities:
Assets
Operating lease assets	Operating lease right-of-use assets	$	68,458
Finance lease asset	Finance lease right-of-use assets	12,886
Total lease assets		$	81,344
Liabilities
Current liabilities
Operating lease liabilities	Current portion of operating lease liability	$	7,630
Finance lease liabilities	Other current liabilities	2,401
Non-current liabilities
Operating lease liabilities	Operating lease liability, net of current portion	66,975
Finance lease liabilities	Other non-current liabilities	6,150
Total lease liabilities		$	83,156

The following table contains supplemental information related to leases for the three months ended March 31, 2019:

Supplemental Cash Flows Information	Three Months Ended March 31, 2019
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from finance leases	$	53
Operating cash flows from operating leases	5,288
Financing cash flows from finance leases	792
Right-of-use assets obtained in exchange for new operating lease liabilities	$	2,836

As of March 31, 2019, the weighted average remaining lease term and weighted-average discount rate for finance and operating leases was as follows:

	Weighted-Average Remaining Lease Term (years)	Weighted-Average Discount Rate
Finance leases	4.1	2.4	%
Operating leases	10.5	8.5	%

The future minimum lease obligations with noncancelable terms in excess of twelve months as of March 31, 2019, is as follows:

	Operating Leases		Finance Leases
2019 (1)	$	10,104	$	2,190
2020	11,979		2,033
2021	11,118		2,020
2022	10,812		1,853
2023	9,264		962
Thereafter	59,946		17
Total future minimum lease payments	113,223		9,075
Less: imputed interest	38,618		524
Total lease liabilities	$	74,605	$	8,551

(1) For the period from April 1, 2019 to December 31, 2019.

14

As of March 31, 2019, we have an additional operating lease commitment that has not yet commenced that would require us to pay a total of approximately $21.9 million base rent payments over the lease term of 15 years. This lease is expected to commence during the fourth quarter of 2019.

The following table summarizes the future minimum lease payments under operating leases with initial or non-cancelable lease terms in excess of one year prior to adoption of ASC 842 as reported in our Annual Report on Form 10-K for the year ended December 31, 2018.

Year Ending December 31,
2019	$	13,337
2020	11,515
2021	10,557
2022	10,293
2023	8,752
Thereafter	53,945
Total minimum payments	$	108,399

During the three months ended March 31, 2018, we recognized rent expense of $2.1 million.

Note 11. Restructuring and Integration

The following table summarizes restructuring and integration charges incurred for the three months ended March 31, 2019 and 2018.

	Three Months Ended March 31, 2019
	Mobile Solutions			Power Solutions		Life Sciences		Corporate and Consolidations		Total
Severance and other employee costs	$	—		$	—	$	—	$	—	$	—
Site closure and other associated costs	(12		)	—		—		—		(12		)
Total	$	(12	)	$	—	$	—	$	—	$	(12	)
	Three Months Ended March 31, 2018
	Mobile Solutions			Power Solutions		Life Sciences		Corporate and Consolidations		Total
Severance and other employee costs	$	—		$	—	$	—	$	728	$	728
Site closure and other associated costs	27			—		—		—		27
Total	$	27		$	—	$	—	$	728	$	755

The following table summarizes restructuring and integration reserve activity for the three months ended March 31, 2019.

	Reserve Balance as of December 31, 2018		Charges			Non-cash Adjustments		Cash Reductions			Reserve Balance as of March 31, 2019
Severance and other employee costs	$	1,122	$	—		$	—	$	(274	)	$	848
Site closure and other associated costs	24		(12		)	—		(12		)	—
Total	$	1,146	$	(12	)	$	—	$	(286	)	$	848

The amount accrued for restructuring and integration costs represents what we expect to pay over the next 1.9 years. We expect to pay $0.5 million within the next twelve months.

Note 12. Commitments and Contingencies

Brazil ICMS Tax Matter

Prior to the acquisition of Autocam Corporation in 2014 (“Autocam”), Autocam’s Brazilian subsidiary (“Autocam Brazil”) received notification from the Brazilian tax authority regarding ICMS (state value added tax or “VAT”) tax credits claimed on intermediary materials (e.g., tooling and perishable items) used in the manufacturing process. The Brazilian tax authority notification disallowed state ICMS tax credits claimed on intermediary materials based on the argument that these items are not

15

intrinsically related to the manufacturing processes. Autocam Brazil filed an administrative defense with the Brazilian tax authority arguing, among other matters, that it should qualify for an ICMS tax credit, contending that the intermediary materials are directly related to the manufacturing process.

We believe that we have substantial legal and factual defenses, and we plan to defend our interests in this matter vigorously. The matter encompasses several lawsuits filed with the Brazilian courts requesting declaratory actions that no tax is due or seeking a stay of execution on the collection of the tax. In 2018, we obtained a favorable decision in one of the declaratory actions for which the period for appeal has expired. We have filed actions in each court requesting dismissal of the matter based on the earlier court action. Although we anticipate a favorable resolution to all matters, we can provide no assurances that we will be successful in achieving dismissal of all pending cases. While we believe a loss is not probable, we estimate the range of possible losses related to this assessment is from $0 to $6.0 million. Noamount was accrued at March 31, 2019, for this matter.

We are entitled to indemnification from the former shareholders of Autocam, subject to the limitations and procedures set forth in the agreement and plan of merger relating to the Autocam acquisition. Management believes the indemnification would include amounts owed for the tax, interest, and penalties related to this matter.

All Other Legal Matters

All other legal proceedings are of an ordinary and routine nature and are incidental to our operations. Management believes that such proceedings should not, individually or in the aggregate, have a material adverse effect on our business, financial condition, results of operations, or cash flows. In making that determination, we analyze the facts and circumstances of each case at least quarterly in consultation with our attorneys and determine a range of reasonably possible outcomes.

Note 13. Revenue from Contracts with Customers

Revenue is recognized when control of the good or service is transferred to the customer either at a point in time or, in limited circumstances, as our services are rendered over time. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or services. Sales, value add, and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. Incidental items that are immaterial in the context of the contract are recognized as expense.

The following tables summarize sales to external customers by major source.

	Three Months Ended March 31, 2019
	Mobile Solutions		Power Solutions		Life Sciences		Intersegment Sales Eliminations			Total
United States	$	44,457	$	41,115	$	68,343	$	(484	)	$	153,431
China	9,153		1,838		1,692		—			12,683
Mexico	5,378		2,709		127		—			8,214
Brazil	8,382		69		—		—			8,451
Germany	1,406		16		8,885		—			10,307
Switzerland	1,359		16		3,265		—			4,640
Poland	1,913		4		6		—			1,923
Italy	1,856		63		421		—			2,340
Czech Republic	1,509		188		—		—			1,697
France	44		—		1,225		—			1,269
Africa	—		1,156		—		—			1,156
Other	2,618		2,483		2,044		—			7,145
Total net sales	$	78,075	$	49,657	$	86,008	$	(484	)	$	213,256

16

	Three Months Ended March 31, 2018
	Mobile Solutions		Power Solutions		Life Sciences		Intersegment Sales Eliminations			Total
United States	$	49,655	$	40,128	$	30,553	$	(528	)	$	119,808
China	11,581		1,485		126		—			13,192
Mexico	7,236		3,197		172		—			10,605
Brazil	9,885		50		—		—			9,935
Poland	2,052		14		—		—			2,066
Czech Republic	1,810		—		—		—			1,810
Italy	1,577		98		—		—			1,675
Germany	1,534		7		1		—			1,542
Switzerland	1,406		—		—		—			1,406
Netherlands	—		974		—		—			974
Other	3,058		2,729		348		—			6,135
Total net sales	$	89,794	$	48,682	$	31,200	$	(528	)	$	169,148

Deferred Revenue

The following table provides information about contract liabilities from contracts with customers.

	Deferred Revenue
Balance at January 1, 2019	$	2,974
Balance at March 31, 2019	$	2,890

Revenue recognized during the three months ended March 31, 2019, from amounts included in deferred revenue at the beginning of the period for performance obligations satisfied or partially satisfied during the period, was approximately $0.6 million.

Transaction Price Allocated to Future Performance Obligations

We are required to disclose the aggregate amount of transaction price that is allocated to performance obligations that have not yet been satisfied as of March 31, 2019, unless our contracts meet one of the practical expedients. Our contracts met the following practical expedient provided by the guidance:

• The performance obligation is part of a contract that has an original expected duration of one year or less.

Sales Concentration

During the three months ended March 31, 2019, we recognized sales from a single customer of $23.3 million, or 10.9% of consolidated net sales. Revenues from this customer are in our Life Sciences and Power Solutions groups. No customers represented more than 10% of our net sales during the three months ended March 31, 2018.

Note 14. Shared-Based Compensation

The following table lists the components of share-based compensation expense by type of award.

	Three Months Ended March 31,
	2019		2018
Stock options	$	192	$	205
Restricted stock	459		460
Performance share units	222		591
Share-based compensation expense	$	873	$	1,256

Stock Options

17

During the three months ended March 31, 2019, we granted options to purchase 210,400 shares to certain key employees. The weighted average grant date fair value of the options granted during the three months ended March 31, 2019, was $2.77 per share. The fair value of our options cannot be determined by market value because they are not traded in an open market. Accordingly, we utilized the Black Scholes financial pricing model to estimate the fair value. 

The following table shows the weighted average assumptions relevant to determining the fair value of stock options granted in 2019.

	2019
Expected term	6 years
Risk free interest rate	2.47	%
Dividend yield	3.53	%
Expected volatility	49.53	%
Expected forfeiture rate	4.00	%

The expected term is derived from using the simplified method of determining stock option terms as described under the Staff Accounting Bulletin Topic 14, Share-based payment. The simplified method was used because sufficient historical stock option exercise experience was not available, primarily due to the transformation of the management structure over the past several years.

The average risk-free interest rate is derived from United States Department of Treasury published interest rates of daily yield curves for the same time period as the expected term.

The expected dividend yield is derived by a mathematical formula which uses the expected annual dividends over the expected term divided by the fair market value of our common stock at the grant date.

The expected volatility rate is derived from our actual common stock historical volatility over the same time period as the expected term. The volatility rate is derived by mathematical formula utilizing daily closing price data.

The forfeiture rate is determined from examining the historical pre-vesting forfeiture patterns of past option issuances to key employees. While the forfeiture rate is not an input of the Black Scholes model for determining the fair value of the options, it is an important determinant of stock option compensation expense to be recorded.

The following table summarizes stock option activity for the three months ended March 31, 2019.

	Number of Options (in thousands)		Weighted- Average Exercise Price (per share)		Weighted- Average Remaining Contractual Term (years)	Aggregate Intrinsic Value
Outstanding at January 1, 2019	771		$	15.17
Granted	210		7.93
Exercised	—					$	—
Forfeited or expired	(3	)	24.41
Outstanding at March 31, 2019	978		$	13.58	6.3	$	—	(1)
Exercisable at March 31, 2019	701		$	14.27	5.0	$	—	(1)

_______________________________

(1) The aggregate intrinsic value is the sum of intrinsic values for each exercisable individual option grant. The intrinsic value is the amount by which the closing market price of our stock at March 31, 2019, was greater than the exercise price of any individual option grant.

Restricted Stock

During the three months ended March 31, 2019, we granted 281,065 restricted stock awards to non-executive directors, officers and certain other key employees. The shares of restricted stock granted during the three months ended March 31, 2019, vest pro-rata over three years for officers and certain other key employees and over one year for non-executive directors. We determined the fair value of the shares awarded by using the closing price of our common stock as of the date of grant. The weighted average grant date value of restricted stock granted in the three months ended March 31, 2019, was $7.93 per share. Total grant-date fair value of restricted stock that vested in the three months ended March 31, 2019, was $1.5 million.

18

The following table summarizes the status of unvested restricted stock awards as of March 31, 2019, and changes during the three months then ended.

	Nonvested Restricted Shares (in thousands)		Weighted Average Grant-Date Fair Value (per share)
Nonvested at January 1, 2019	146		$	22.07
Granted	281		$	7.93
Vested	(70	)	$	20.92
Forfeited	(18	)	$	18.98
Nonvested at March 31, 2019	339		$	10.74

Performance Share Units

Performance Share Units (“PSUs”) are a form of long-term incentive compensation awarded to executive officers and certain other key employees designed to directly align the interests of employees to the interests of our stockholders, and to create long-term stockholder value. PSU awards granted in 2019 were made pursuant to the NN, Inc. 2016 Omnibus Incentive Plan and a Performance Share Unit Agreement (the “2016 Omnibus Agreement”). Some PSUs are based on total shareholder return (“TSR Awards”), and other PSUs are based on return on invested capital (“ROIC Awards”).

The TSR Awards vest, if at all, upon our achieving a specified relative total shareholder return, which will be measured against the total shareholder return of the S&P SmallCap 600 Index during specified performance periods as defined in the 2016 Omnibus Agreement. The ROIC Awards vest, if at all, upon our achieving a specified average return on invested capital during the performance periods. Each performance period generally begins on January 1 of the year of grant and ends 36 months later on December 31.

We recognize compensation expense over the performance period in which the performance and market conditions are measured. If the PSUs do not vest at the end of the performance periods, then the PSUs will expire automatically. Upon vesting, the PSUs will be settled by the issuance of shares of our common stock, subject to the executive officer’s continued employment. The actual number of shares of common stock to be issued to each award recipient at the end of the performance periods will be interpolated between a threshold and maximum payout amount based on actual performance results. No dividends will be paid on outstanding PSUs during the performance period; however, dividend equivalents will be paid based on the number of shares of common stock that are ultimately earned at the end of the performance periods.

With respect to the TSR Awards, a participant will earn 50% of the target number of PSUs for “Threshold Performance,” 100% of the target number of PSUs for “Target Performance,” and 150% of the target number of PSUs for “Maximum Performance.” With respect to the ROIC Awards, a participant will earn 35% of the target number of PSUs for “Threshold Performance,” 100% of the target number of PSUs for “Target Performance,” and 150% of the target number of PSUs for “Maximum Performance. For performance levels falling between the values shown below, the percentages will be determined by interpolation.

The following table presents the goals with respect to TSR Awards and ROIC Awards granted in 2019.

TSR Awards:	Threshold Performance (50% of Shares)		Target Performance (100% of Shares)		Maximum Performance (150% of Shares)
2019 grants	35th Percentile		50th Percentile		75th Percentile
ROIC Awards:	Threshold Performance (35% of Shares)		Target Performance (100% of Shares)		Maximum Performance (150% of Shares)
2019 grants (1)	4.7	%	5.8	%	7.0	%

(1) For the ROIC Awards granted in 2019, the denominator of the calculation is different than in prior years, and therefore the target percentages are not comparable to historical target percentages.

We estimate the grant date fair value of TSR Awards using the Monte Carlo simulation model, as the total shareholder return metric is considered a market condition under ASC Topic 718, Compensation – stock compensation. The grant date fair value of ROIC Awards is based on the closing price of a share of our common stock on the date of grant.

The following table presents the number of awards granted and the grant date fair value of each award in the period presented.

19

	TSR Awards			ROIC Awards
Award Year	Shares (in thousands)	Grant Date Fair Value (per share)		Shares (in thousands)	Grant Date Fair Value (per share)
2019	136	$	9.28	174	$	7.93

We recognize expense for ROIC Awards based on the probable outcome of the associated performance condition. We generally recognize an expense for ROIC Awards based on the Target Performance threshold of 100% because, at the date of grant, the Target Performance is the probable level of performance achievement.

The following table summarizes the status of unvested PSUs as of March 31, 2019, and changes during the three months then ended.

	Nonvested TSR Awards			Nonvested ROIC Awards
	Shares (in thousands)	Weighted Average Grant-Date Fair Value (per share)		Shares (in thousands)	Weighted  Average Grant-Date Fair Value (per share)
Nonvested at January 1, 2019	94	$	26.84	100	$	24.39
Granted	136	$	9.28	174	$	7.93
Forfeited	—	$	—	—	$	—
Nonvested at March 31, 2019	230	$	16.47	274	$	13.93

Note 15. Net Income (Loss) Per Share

	Three Months Ended March 31,
	2019			2018
Numerator:
Net loss	$	(18,600	)	$	(5,983	)
Denominator:
Weighted average shares outstanding	41,972			27,597
Effect of dilutive stock options	—			—
Diluted shares outstanding	41,972			27,597
Per common share net loss:
Basic net loss per share	$	(0.44	)	$	(0.22	)
Diluted net loss per share	$	(0.44	)	$	(0.22	)
Cash dividends declared per share	$	0.07		$	0.07

The calculation of diluted net loss per share for the three months ended March 31, 2019 and 2018, excludes 0.7 million and 0.5 million potentially dilutive stock options, which had the effect of being anti-dilutive. Given the net loss for the three months ended March 31, 2019 and 2018, all options are considered anti-dilutive and were excluded from the calculation of diluted net loss per share.

Note 16. Fair Value Measurements

Fair value is an exit price representing the expected amount that an entity would receive to sell an asset or pay to transfer a liability in an orderly transaction with market participants at the measurement date. We followed consistent methods and assumptions to estimate fair values as more fully described in the 2018 Annual Report.

Our financial instruments that are subject to fair value disclosure consist of cash and cash equivalents, accounts receivable, accounts payable, derivatives, and long-term debt. As of March 31, 2019, the carrying values of these financial instruments approximated fair value. The fair value of floating-rate debt approximates the carrying amount because the interest rates paid are based on short-term maturities. As of March 31, 2019, we had $10.6 million fixed-rate debt outstanding included in the “International lines of credit and other loans” line item within Note 9 to these Notes to Condensed Consolidated

20

Financial Statements. These fair values represent Level 2 under the three-tier hierarchy described above. Due to the nature of these loans, fair value approximates book value.

Recurring Fair Value Measurements

Fair value principles prioritize valuation inputs across three broad levels. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument. Level 3 inputs are unobservable inputs based on the assumptions used to measure assets and liabilities at fair value. An asset or liability’s classification within the various levels is determined based on the lowest level input that is significant to the fair value measurement.

We manage our exposure to fluctuations in interest rates using a mix of fixed and variable rate debt. On February 8, 2019, we entered into a $700.0 million fixed-rate interest rate swap agreement that changed the LIBOR-based portion of the interest rate on a portion of our variable rate debt to a fixed rate of 2.4575% (the “interest rate swap”). The term of the interest rate swap is from the effective date of February 12, 2019, through the termination date of October 19, 2022 (the “interest rate swap term”). The interest rate swap effectively mitigates our exposures to the risks and variability of changes in LIBOR.

The notional amount of the interest rate swap will decrease over the interest rate swap term as follows:

	Notional Amount
February 12, 2019 - December 30, 2020	$	700,000
December 31, 2020 - December 30, 2021	466,667
December 31, 2021 - October 19, 2022	233,333

The objective of the interest rate swap is to eliminate the variability of cash flows in interest payments on the first $700.0 million of variable rate debt attributable to changes in benchmark one-month LIBOR interest rates. The hedged risk is the interest rate risk exposure to changes in interest payments, attributable to changes in benchmark one-month LIBOR interest rates over the interest rate swap term. If one-month LIBOR is greater than the minimum percentage under the Senior Secured Term Loan, the changes in cash flows of the interest rate swap are expected to exactly offset changes in cash flows of the variable rate debt. The interest rate swap is designated as a cash flow hedge.

As of March 31, 2019, we reported $3.9 millionloss , net of tax, in accumulated other comprehensive income related to the interest rate swap.

The following shows the liabilities measured at fair value on a recurring basis for the interest rate swap as of March 31, 2019.

	Fair Value Measurements as of March 31, 2019
Description	Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Derivative liability - other current liabilities	$	—	$	543	$	—
Derivative liability - other non-current liabilities	—		4,417		—
Total	$	—	$	4,960	$	—

The inputs for determining fair value of the interest rate swap are classified as Level 2 inputs. Level 2 fair value is based on estimates using standard pricing models. These standard pricing models use inputs which are derived from or corroborated by observable market data such as interest rate yield curves, index forward curves, discount curves, and volatility surfaces. Counterparty to this derivative contracts is a highly rated financial institution which we believe carries only a minimal risk of nonperformance.

As of December 31, 2018, we had no interest rate swap agreements outstanding.

21

Note 17. Subsequent Event

Tennessee Shared Service Center Closure

On April 18, 2019, we announced the closure of our shared service center in Johnson City, Tennessee, effective at the end of June 2019. Closure of the Tennessee shared service center aligns with our focus on operating excellence and efficiency and is not expected to have a material impact on our financial statements.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Overview

NN, Inc., is a global diversified industrial company that combines advanced engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision components and assemblies for the medical, aerospace and defense, electrical, automotive, and general industrial markets. As used in this Quarterly Report on Form 10-Q, the terms “NN,” the “Company,” “we,” “our,” or “us” refer to NN, Inc., and its subsidiaries. As of March 31, 2019, we had 51 facilities in North America, Europe, South America, and China.

Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements may discuss goals, intentions and expectations as to future trends, plans, events, results of operations or financial condition, or state other information relating to NN, Inc., based on current beliefs of management as well as assumptions made by, and information currently available to, management. Forward-looking statements generally will be accompanied by words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “forecast,” “guidance,” “intend,” “may,” “possible,” “potential,” “predict,” “project” or other similar words, phrases or expressions. Forward-looking statements involve a number of risks and uncertainties that are outside of management’s control and that may cause actual results to be materially different from such forward-looking statements. Such factors include, among others, general economic conditions and economic conditions in the industrial sector, competitive influences, risks that current customers will commence or increase captive production, risks of capacity underutilization, quality issues, availability of raw materials, currency and other risks associated with international trade, our dependence on certain major customers, the impact of acquisitions and divestitures, unanticipated difficulties integrating acquisitions, new laws and governmental regulations, and other risk factors and cautionary statements listed from time-to-time in our periodic reports filed with the Securities and Exchange Commission. We disclaim any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements included herein or therein to reflect future events or developments.

For additional information concerning such risk factors and cautionary statements, please see the section titled “Item 1A. Risk Factors” in our 2018 Annual Report on Form 10-K for the fiscal year ended December 31, 2018, which we filed with the SEC on March 18, 2019 (the “2018 Annual Report”).

Results of Operations

Factors That May Influence Results of Operations

The following paragraphs describe factors that have influenced results of operations for the three months ended March 31, 2019, that management believes are important to provide an understanding of the business and results of operations, or that may influence operations in the future.

Management Structure

In 2018, we implemented a new enterprise and management structure designed to accelerate growth and further balance our portfolio by aligning our strategic assets and businesses. Our businesses were reorganized into the Mobile Solutions, Power Solutions, and Life Sciences groups and are based principally on the end markets they serve. Mobile Solutions is focused on growth in the general industrial and automotive end markets. Power Solutions is focused on growth in the electrical and aerospace and defense end markets. Life Sciences is focused on growth in the medical end market.

Acquisitions

In February 2018, we acquired 100% of the assets of Bridgemedica, LLC (“Bridgemedica”). Bridgemedica is a medical device company that provides concept to supply solutions through design, development engineering, and manufacturing. Operating results of Bridgemedica are reported in our Life Sciences group.

22

In May 2018, we acquired 100% of the stock of PMG Intermediate Holding Corporation, the parent company of Paragon Medical, Inc. (“Paragon Medical”). Paragon Medical is a medical device manufacturer which focuses on the orthopedic, case and tray, implant, and instrument markets. Operating results of Paragon Medical are reported in our Life Sciences group.

In August 2018, we acquired 100% of the capital stock of Southern California Technical Arts, Inc. (“Technical Arts”). Technical Arts is an industrial machining company that manufactures tight tolerance metal components and assemblies. The acquisition of Technical Arts expands our presence in the aerospace and defense end market. Operating results of Technical Arts are reported in our Power Solutions group.

Three Months Ended March 31, 2019, compared to the Three Months Ended March 31, 2018

	Three Months Ended March 31,
	2019			2018			$ Change
Net sales	$	213,256		$	169,148		$	44,108
Acquisitions										$	55,224
Volume										(7,999		)
Foreign exchange effects										(2,820		)
Price/mix/inflation/other										(297		)
Cost of sales (exclusive of depreciation and amortization shown separately below)	161,269			126,444			34,825
Acquisitions										$	37,862
Volume										(4,300		)
Foreign exchange effects										(2,346		)
Cost reduction projects										(3,008		)
Inflation										1,691
Mix/other										4,926
Selling, general and administrative expense	28,125			22,177			5,948
Acquisition related costs excluded from selling, general and administrative expense	—			1,776			(1,776		)
Depreciation and amortization	23,425			14,281			9,144
Other operating (income) expense, net	(152		)	22			(174		)
Restructuring and integration expense	(12		)	755			(767		)
Income from operations	601			3,693			(3,092		)
Interest expense	13,801			11,996			1,805
Loss on extinguishment of debt and write-off of debt issuance costs	2,699			—			2,699
Other (income) expense, net	729			(313		)	1,042
Loss before (provision) benefit for income taxes and share of net income from joint venture	(16,628		)	(7,990		)	(8,638		)
(Provision) benefit for income taxes	(2,241		)	1,176			(3,417		)
Share of net income from joint venture	269			831			(562		)
Net loss	$	(18,600	)	$	(5,983	)	$	(12,617	)

Net Sales. Net sales increased by $44.1 million, or 26%, in the three months ended March 31, 2019 compared to the three months ended March 31, 2018, primarily due to $55.2 million of net sales attributable to the 2018 business acquisitions. The increase in sales was partially offset by a decrease in volume of $8.0 million, primarily as a result of lower demand within the automotive end market as well as unfavorable foreign exchange effects of $2.8 million, primarily in Brazil.

Cost of Sales. Cost of sales increased by $34.8 million, or 28%, in the three months ended March 31, 2019 compared to the three months ended March 31, 2018, primarily due to $37.9 million in cost of sales attributable to the 2018 business acquisitions. The increase in cost of sales was partially offset by lower volume of $4.3 million, consistent with the decrease in sales demand. The increase in cost of sales was also partially offset by favorable foreign exchange effects of $2.3 million and $3.0 million in cost savings from production process improvement projects. Inflation and wage increases contributed $1.7 million to the increase in cost of sales.

Selling, General and Administrative Expense. Selling, general and administrative expense increased by $5.9 million during the three months ended March 31, 2019, compared to the three months ended March 31, 2018, primarily due to the 2018 business

23

acquisitions which collectively contributed $5.0 million to selling, general and administrative expense during the three months ended March 31, 2019. Infrastructure and staffing costs incurred related to our strategic initiatives, including integration of recent acquisitions and a global implementation of an enterprise resource planning (“ERP”) system, also contributed to the increase. These increases were partially offset by lower costs for professional services as a result of our strategic initiatives.

Acquisition Related Costs Excluded from Selling, General and Administrative Expense. Acquisition related costs decreased during the three months ended March 31, 2019, compared to the three months ended March 31, 2018, as there was no business acquisition activity during the three months ended March 31, 2019. The three months ended March 31, 2018, included professional service costs incurred in connection with the 2018 business acquisitions.

Depreciation and Amortization. Depreciation and amortization increased during the three months ended March 31, 2019, compared to the three months ended March 31, 2018, consistent with additions to intangible assets and property, plant and equipment, including $8.9 million from the 2018 business acquisitions. The increase in depreciation and amortization includes the effects of related fair value adjustments to certain property, plant and equipment and the addition of intangible assets, principally for customer relationships and trade names.

Other Operating (Income) Expense, Net. Other operating income, net, decreased during the three months ended March 31, 2019, compared to the three months ended March 31, 2018, primarily due to a $0.2 million net gain on the sale of property, plant and equipment.

Restructuring and Integration Expense. Restructuring and integration expense decreased during the three months ended March 31, 2019, compared to the three months ended March 31, 2018, primarily due to employee severance costs incurred in connection with implementing our new enterprise and management structure in 2018. Note 11 in the Notes to Condensed Consolidated Financial Statements provides more information regarding the effects of restructuring and integration on our operating results.

Interest Expense. Interest expense increased by $1.8 million during the three months ended March 31, 2019, compared to the three months ended March 31, 2018, primarily due to an increased balance in our Senior Secured Revolver as well as a higher variable interest rate. The increase was partially offset by the fixed-rate interest rate swap entered into in February 2019, which reduced the variability in the interest expense.

	Three Months Ended March 31,
	2019			2018
Interest on debt	$	13,119		$	10,802
Amortization of debt issuance costs	1,191			1,088
Capitalized interest	(553		)	(205		)
Other	44			311
Total interest expense	$	13,801		$	11,996

Loss on Extinguishment of Debt and Write-off of Unamortized Debt Issuance Costs. Loss on extinguishment of debt and write-off of unamortized debt issuance costs increased during the three months ended March 31, 2019, compared to the three months ended March 31, 2018, due to costs written off due to the March 2019 amendment to the credit facility.

Provision/Benefit for Income Taxes. Our effective tax rate was (13.5)% for the three months ended March 31, 2019, compared to 14.7% for the three months ended March 31, 2018. Note 8 in the Notes to Condensed Consolidated Financial Statements describes the components of income taxes for each period presented.

Share of Net Income from Joint Venture. Our share of net income from a Chinese joint venture in our Mobile Solutions group decreased by $0.6 million primarily due to price and volume decreases resulting from reduced demand in the Chinese automotive market.

24

Results by Segment

MOBILE SOLUTIONS

	Three Months Ended March 31,
	2019		2018		$ Change
Net sales	$	78,075	$	89,794	$	(11,719	)
Volume								$	(9,529	)
Foreign exchange effects								(2,642		)
Price/mix/inflation/other								452
Income from operations	$	4,107	$	9,785	$	(5,678	)

Net sales decreased during the during the three months ended March 31, 2019, compared to the three months ended March 31, 2018, primarily due to reduced demand within the North American and Chinese automotive markets, unfavorable foreign exchange effects, and the impact of reduced demand for components associated with programs nearing the end of life.

Income from operations decreased by $5.7 million compared to prior year due to lost variable margin on the above-referenced sales volume decline and costs associated with the launch of new fuel systems business within our European operations. These unfavorable impacts were partially offset by fixed cost reduction actions taken in response to the decline in sales volume.

POWER SOLUTIONS

	Three Months Ended March 31,
	2019		2018		$ Change
Net sales	$	49,657	$	48,682	$	975
Acquisitions								$	1,612
Volume								359
Foreign exchange effects								(178		)
Price/mix/inflation/other								(818		)
Income from operations	$	3,824	$	5,233	$	(1,409	)

Net sales increased during the during the three months ended March 31, 2019, compared to the three months ended March 31, 2018, primarily due to growth in sales to customers in the electrical products end market. Sales from the Technical Arts business, acquired in August 2018, contributed $1.6 million to the current quarter.

Income from operations decreased by $1.4 million compared to prior year primarily due to higher selling, general and administrative expenses associated with the 2018 business group resegmentation.

LIFE SCIENCES

	Three Months Ended March 31,
	2019		2018		$ Change
Net sales	$	86,008	$	31,200	$	54,808
Acquisitions								$	53,612
Volume								1,171
Price/mix/inflation/other								25
Income from operations	$	3,846	$	4,204	$	(358	)

Net sales increased during the three months ended March 31, 2019, compared to the three months ended March 31, 2018, primarily due to $53.6 million of net sales attributable to the Paragon Medical and Bridgemedica acquisitions as well as a $1.2 millionincrease in core volume.

Income from operations decreased by $0.4 million compared to prior year primarily due to higher costs associated with the integration and transfer of production between legacy and acquired businesses, higher compensation-related expenses for personnel additions associated with management establishing a platform for future growth within the Life Sciences group, and higher selling, general and administrative expenses associated with the 2018 business group resegmentation. The decrease was partially offset by $3.8 million of income from operations attributable to the Paragon Medical and Bridgemedica acquisitions.

25

Changes in Financial Condition from December 31, 2018, to March 31, 2019

From December 31, 2018, to March 31, 2019, total assets increased by $79.4 million primarily due to the initial recognition of operating lease assets as of January 1, 2019, pursuant to ASC 842. Overall, accounts receivable increased consistently with sales growth. Inventories increased as our plants prepare for second quarter sales. Days inventory outstanding decreased by approximately two days as our businesses met expected customer demand on a timely basis and due to managing procurement based on market price projections.

From December 31, 2018, to March 31, 2019, total liabilities increased by $102.8 million, primarily due to the initial recognition of operating lease liabilities as of January 1, 2019, pursuant to ASC 842, an increased balance in our Senior Secured Revolver used to fund operations, and recognition of the fair value of the interest rate swap.

Working capital, which consists principally of cash, accounts receivable, inventories, and other current assets offset by accounts payable, accrued payroll costs, income taxes payable, current maturities of long-term debt, current portion of lease liabilities, and other current liabilities, was $149.3 million as of March 31, 2019, compared to $151.8 million as of December 31, 2018. The decrease in working capital was due primarily to the increase in accounts receivable and inventories consistent with our sales growth offset by an increase in accounts payable due to inventory growth, and the initial recognition of operating lease liabilities.

Cash used by operations was $2.7 million for the three months ended March 31, 2019, compared with cash used by operations of $1.0 million for the three months ended March 31, 2018. The difference was primarily due to higher interest payments during the three months ended March 31, 2019 compared to the three months ended March 31, 2018.

Cash used by investing activities was $3.7 million for the three months ended March 31, 2019, compared with cash used by investing activities of $32.8 million for the three months ended March 31, 2018. The decrease was primarily due to cash received from the liquidation of the short-term investment during 2019 and cash paid in 2018 for the 2018 business acquisitions. These decreases were partially offset by an increase in investment in property, plant and equipment during the three months ended March 31, 2019.

Cash provided by financing activities was $8.9 million for the three months ended March 31, 2019, compared with cash used by financing activities of $6.3 million for the three months ended March 31, 2018. The difference was primarily due to an increase in net borrowings under our credit facility for the three months ended March 31, 2019.

During 2018, as a result of our annual goodwill impairment analysis performed during the fourth quarter of 2018, we recorded an impairment of $109.1 million in our Power Solutions group. After the impairment, Power Solutions reported a goodwill balance of $94.5 million at December 31, 2018. Given the carrying value of the Power Solutions reporting unit was equal to its fair value at December 31, 2018 as a result of the 2018 goodwill impairment, if actual performance of the Power Solutions reporting unit falls short of expected results, additional material impairment charges may be required. During the first quarter of 2019, we reassessed the relevant facts and circumstances and concluded there was no impairment during the period. We will continue to monitor and assess Power Solutions during 2019.

Based on the closing price of a share of our common stock as of March 31, 2019, our market capitalization had declined to a level that is less than the net book value of our stockholders’ equity. A prolonged or significant decline in market capitalization could be an indicator of additional goodwill impairment. Given the increase in our market capitalization subsequent to March 31, 2019, and factoring in a reasonable control premium, we concluded that our market capitalization was not an indication of additional goodwill impairment. We will continue to monitor our market capitalization to determine if an indicator of impairment exists in subsequent periods.

Liquidity and Capital Resources

Overview

As of March 31, 2019, we had $20.3 million of cash and $56.7 million of unused borrowing capacity under our Senior Secured Revolver. We believe that these sources of cash and funds generated from our consolidated operations will provide sufficient cash flow to service the required debt and interest payments under our existing credit facility and to fund our operating activities, capital expenditure requirements, and dividend payments.

Our arrangements with customers typically provide that payments are due within 30 to 60 days following the date of shipment. We invoice and receive payment from many of our customers in euros as well as other currencies. Additionally, we are party to various third party and intercompany loans, payables, and receivables denominated in currencies other than the U.S. dollar. As a result of these sales, loans, payables, and receivables, our foreign exchange transaction and translation risk is elevated. Various strategies to manage this risk are available to management, including producing and selling in local currencies and hedging programs. As of March 31, 2019, no currency derivatives were in place. In addition, a strengthening of the U.S. dollar

26

and/or euro against foreign currencies could impair our ability to compete with international competitors for foreign as well as domestic sales.

For the next twelve months, we expect the sum of capital expenditures and assets procured under finance leases to remain relatively consistent with 2018 spending levels, the majority of which relate to new or expanded business or continuous improvement programs. We believe that funds generated from continuing operations and borrowings from the Senior Secured Revolver will be sufficient to finance capital expenditures and working capital needs through this period. We base these assertions on current unused borrowing capacity under our Senior Secured Revolver of $56.7 million and forecasted positive cash flow from operations for the next twelve months.

In June 2016, voters in the United Kingdom approved an advisory referendum to withdraw from the European Union, commonly referred to as “Brexit.” The uncertainty surrounding the terms of the United Kingdom’s withdrawal and the timing (deadline to leave was extended to October 31, 2019), could adversely impact consumer and investor confidence, and the level of consumer purchases of discretionary items and retail products, including our products. Any of these effects, among others, could materially adversely affect our business, results of operations, and financial condition. We will continue to monitor and evaluate the potential effect Brexit has on our business, results of operations, and financial condition.

On February 8, 2019, we entered into a $700.0 million fixed-rate interest rate swap agreement (the “interest rate swap”) that changed the LIBOR-based portion of the interest rate on a portion of our variable rate debt to a fixed rate of 2.4575%. The term of the interest rate swap is from the effective date of February 12, 2019, through the termination date of October 19, 2022, with a declining notional amount over the term of the interest rate swap. Refer to Note 16 in the Notes to Condensed Consolidated Financial Statements for further discussion about the interest rate swap.

Credit Facility

Aggregate principal amounts outstanding under our Senior Secured Term Loan, Incremental Term Loan, and Senior Secured Revolver as of March 31, 2019, were $862.8 million (without regard to unamortized debt issuance costs). As of March 31, 2019, we had unused borrowing capacity of $56.7 million under the Senior Secured Revolver, subject to certain limitations. This amount of borrowing capacity is net of $12.1 million of outstanding letters of credit at March 31, 2019, which are considered as usage of the Senior Secured Revolver.

Collectively, our Senior Secured Term Loan, Incremental Term Loan, and Senior Secured Revolver comprise our credit facility. Total available capacity under the Senior Secured Revolver was $125.0 million as of March 31, 2019. The Senior Secured Revolver matures on October 19, 2020.

The Senior Secured Term Loan requires quarterly principal payments of $1.4 million through October 19, 2022, with the remaining principal amount due on the maturity date. If one-month LIBOR is less than 0.75%, then we pay 4.50% per annum in interest. If one-month LIBOR exceeds 0.75%, then we pay the variable one-month LIBOR plus an applicable margin of 3.75%. Based on the outstanding balance and interest rate in effect at March 31, 2019, annual interest payments would have been $33.1 million.

The Incremental Term Loan requires quarterly principal payments of $3.0 million through April 3, 2021, with the remaining principal amount due on the maturity date. The Incremental Term Loan bears interest at the variable one-month LIBOR plus an applicable margin of 3.25%. Based on the outstanding balance and interest rate in effect at March 31, 2019, annual interest payments would have been $15.9 million.

The Senior Secured Revolver bears interest at the variable one-month LIBOR plus an applicable margin of 3.50%. Based on the outstanding balance and interest rate in effect at March 31, 2019, annual interest payments would have been $3.4 million. We pay a quarterly commitment fee at an annual rate of 0.50% on the Senior Secured Revolver for unused borrowing capacity.

Covenants

Our credit facility is subject to certain financial covenants based on a consolidated net leverage ratio, as defined in the credit facility agreement. The financial covenants are effective when we have outstanding borrowings under our Senior Secured Revolver on the last day of any fiscal quarter, become more restrictive over time, and are dependent upon our operational and financial performance. If our operational or financial performance is below our expectations, we may be required to take actions to reduce expenditures and decrease our net indebtedness to maintain compliance in future periods. We had $56.2 million outstanding under the Senior Secured Revolver at March 31, 2019, and we were in compliance with all covenants under our credit facility.

Seasonality and Fluctuation in Quarterly Results

General economic conditions impact our business and financial results, and certain businesses experience seasonal and other trends related to the industries and end markets that they serve. For example, European sales are often weaker in the summer months as customers slow production, medical device sales are often stronger in the fourth calendar quarter, and sales to

27

original equipment manufacturers are often stronger immediately preceding and following the launch of new products. However, as a whole, we are not materially impacted by seasonality.

Off-Balance Sheet Arrangements

We are not a party to any off-balance sheet arrangements that have, or are reasonably likely to have, a material current or future effect on our financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources.

Critical Accounting Policies

Our critical accounting policies, including the assumptions and judgments underlying them, are disclosed in the 2018 Annual Report, including those policies as discussed in Note 1 to the Notes to Consolidated Financial Statements included in the 2018 Annual Report. There have been no changes to these policies during the three months ended March 31, 2019, except as discussed in Note 1 to the Notes to Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q.    

Recent Accounting Pronouncements

See Note 1 in the Notes to Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are exposed to changes in financial market conditions in the normal course of business due to use of certain financial instruments as well as transacting business in various foreign currencies. To mitigate the exposure to these market risks, we have established policies, procedures, and internal processes governing the management of financial market risks. We are exposed to changes in interest rates primarily as a result of borrowing activities.

Interest Rate Risk

Variable Rate Debt

At March 31, 2019, we had $530.6 million of principal outstanding under the variable rate Senior Secured Term Loan, without regard to debt issuance costs. At March 31, 2019, a one-percent increase in the interest rate charged on outstanding variable rate borrowings under the Senior Secured Term Loan would result in interest expense increasing annually by approximately $5.3 million.

At March 31, 2019, we had $276.0 million of principal outstanding under the Incremental Term Loan, without regard to debt issuance costs. At March 31, 2019, a one-percent increase in the interest rate charged on outstanding variable rate borrowings under the Incremental Term Loan would result in interest expense increasing annually by approximately $2.8 million.

At March 31, 2019, we had $56.2 million of principal outstanding under the Senior Secured Revolver, without regard to debt issuance costs. At March 31, 2019, a one-percent increase in the interest rate charged on outstanding variable rate borrowings under the Senior Secured Revolver would result in interest expense increasing annually by approximately $0.6 million.

Interest Rate Swaps and Hedging Activities

Our policy is to manage interest expense using a mix of fixed and variable rate debt. In February 2019, we entered into a $700.0 million fixed-rate interest rate swap agreement changed the LIBOR-based portion of the interest rate on a portion of our variable rate debt to a fixed rate of 2.4575%. The term of the interest rate swap is from the effective date of February 12, 2019, through the termination date of October 19, 2022, with a declining notional amount over the term of the interest rate swap. Refer to Note 16 in the Notes to Condensed Consolidated Financial Statements for further discussion about the interest rate swap. The nature and amount of borrowings may vary as a result of future business requirements, market conditions, and other factors.

Foreign Currency Risk

Translation of our operating cash flows denominated in foreign currencies is impacted by changes in foreign exchange rates. We participate in various third party and intercompany loans, payables, and receivables denominated in currencies other than the U.S. dollar. To help reduce exposure to foreign currency fluctuation, we have incurred debt in euros in the past. From time to time, we may use foreign currency derivatives to hedge currency exposures when these exposures meet certain discretionary levels. We did not hold a position in any foreign currency derivatives as of March 31, 2019.

Item 4. Controls and Procedures

28

Disclosure Controls and Procedures

Under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer, we evaluated the effectiveness of disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Based upon that evaluation, as a result of the material weakness in internal control over financial reporting described below, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of March 31, 2019, to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure.

Previously Identified Material Weakness in Internal Control Over Financial Reporting

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements would not be prevented or detected on a timely basis.

We did not maintain an effective control environment due to a lack of a sufficient complement of personnel with an appropriate level of knowledge, experience, and training commensurate with our financial reporting requirements. This material weakness resulted in immaterial errors to other current assets; property, plant and equipment, net; goodwill; investment in joint venture; other non-current assets; accounts payable; accrued salaries, wages and benefits; other current liabilities; deferred tax liabilities; accumulated other comprehensive income; selling, general and administrative expense; depreciation and amortization; other operating expense/income; write-off of unamortized debt issuance costs; provision/benefit for income taxes; comprehensive income/loss; and cash flows in our consolidated financial statements for the years ended December 31, 2017, 2016, and 2015. These immaterial errors also resulted in a revision to previously issued financial statements for the periods December 31, 2017 and December 31, 2016. Additionally, this material weakness could result in a misstatement of substantially all account balances or disclosures that would result in a material misstatement to the annual or interim consolidated financial statements that would not be prevented or detected.    

Notwithstanding the material weakness, our Chief Executive Officer and Chief Financial Officer have concluded that our condensed consolidated financial statements in this Quarterly Report on Form 10-Q present fairly, and in all material respects, our financial position, results of operations, and cash flows for the periods presented in conformity with accounting principles generally accepted in the United States.

Status of Remediation Efforts for the Unremediated Material Weakness

To ensure we have a sufficient complement of resources within our finance department, in 2018 we hired qualified personnel for critical finance roles. After we integrate these professionals into our control environment, we expect that the remediation of this material weakness will be completed.

Changes in Internal Control Over Financial Reporting

During the fiscal quarter ended March 31, 2019, we implemented technology, processes, and controls related to the recording of right-of-use assets and liabilities in connection with the adoption of ASC 842, Leases, as described in Note 1 and Note 10 in the Notes to Condensed Consolidated Financial Statements. Otherwise, there were no other changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting during the fiscal quarter ended March 31, 2019.

29

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

Brazil ICMS Tax Matter

Prior to the acquisition of Autocam Corporation in 2014 (“Autocam”), Autocam’s Brazilian subsidiary (“Autocam Brazil”) received notification from the Brazilian tax authority regarding ICMS (state value added tax or “VAT”) tax credits claimed on intermediary materials (e.g., tooling and perishable items) used in the manufacturing process. The Brazilian tax authority notification disallowed state ICMS tax credits claimed on intermediary materials based on the argument that these items are not intrinsically related to the manufacturing processes. Autocam Brazil filed an administrative defense with the Brazilian tax authority arguing, among other matters, that it should qualify for an ICMS tax credit, contending that the intermediary materials are directly related to the manufacturing process.

We believe that we have substantial legal and factual defenses, and we plan to defend our interests in this matter vigorously. The matter encompasses several lawsuits filed with the Brazilian courts requesting declaratory actions that no tax is due or seeking a stay of execution on the collection of the tax. In 2018, we obtained a favorable decision in one of the declaratory actions for which the period for appeal has expired. We have filed actions in each court requesting dismissal of the matter based on the earlier court action. Although we anticipate a favorable resolution to all matters, we can provide no assurances that we will be successful in achieving dismissal of all pending cases. While we believe a loss is not probable, we estimate the range of possible losses related to this assessment is from $0 to $6.0 million. Noamount was accrued at March 31, 2019, for this matter.

We are entitled to indemnification from the former shareholders of Autocam, subject to the limitations and procedures set forth in the agreement and plan of merger relating to the Autocam acquisition. Management believes the indemnification would include amounts owed for the tax, interest, and penalties related to this matter.

All Other Legal Matters

All other legal proceedings are of an ordinary and routine nature and are incidental to our operations. Management believes that such proceedings should not, individually or in the aggregate, have a material adverse effect on our business, financial condition, results of operations, or cash flows. In making that determination, we analyze the facts and circumstances of each case at least quarterly in consultation with our attorneys and determine a range of reasonably possible outcomes.

Item 1A. Risk Factors

There have been no material changes to the risk factors disclosed in our 2018 Annual Report on Form 10-K for the fiscal year ended December 31, 2018, which was filed with the SEC on March 18, 2019, under Item 1A. “Risk Factors.”

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Period	Total Number of Shares Purchased (1)	Average Price Paid Per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (1)	Maximum Number (or Approximate Dollar Value) of Shares That May Yet Be Purchased Under the Plan or Programs (1)
January 2019	—	$	—	—	—
February 2019	—	—		—	—
March 2019	18,311	7.71		—	—
Total	18,311	$	7.71	—	—

_______________________________

(1) Shares were withheld to pay for tax obligations due upon the vesting of restricted stock held by certain employees granted under the NN, Inc. 2016 Omnibus Incentive Plan (the “Plan”). The Plan provides for the withholding of shares to satisfy tax obligations. It does not specify a maximum number of shares that can be withheld for this purpose. These shares may be deemed to be “issuer purchases” of shares that are required to be disclosed pursuant to this Item.

Item 3. Defaults upon Senior Securities

None. 

30

Item 4. Mine Safety Disclosures

Not applicable. 

Item 5. Other Information

None.

31

Item 6. Exhibits

Exhibit     No.	Description
10.1*	Separation Agreement, dated as of April 1, 2017, by and between NN, Inc. and D. Gail Nixon.
10.2*	Separation Agreement, dated as of April 1, 2017, by and between NN, Inc. and J. Robbie Atkinson.
31.1	Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as amended.
31.2	Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as amended.
32.1	Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2	Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Service
101.CAL	Taxonomy Calculation Linkbase
101.LAB	XBRL Taxonomy Label Linkbase
101.PRE	XBRL Presentation Linkbase Document
101.DEF	XBRL Definition Linkbase Document

* Management contract or compensatory plan or arrangement.

32

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	NN, Inc.
	(Registrant)
Date: May 10, 2019	/s/ Richard D. Holder
	Richard D. Holder
	President, Chief Executive Officer and Director
	(Principal Executive Officer)
	(Duly Authorized Officer)
Date: May 10, 2019	/s/ Thomas C. Burwell, Jr.
	Thomas C. Burwell, Jr.
	Senior Vice President—Chief Financial Officer
	(Principal Financial Officer)
	(Duly Authorized Officer)
Date: May 10, 2019	/s/ Michael C. Felcher
	Michael C. Felcher
	Vice President—Chief Accounting Officer
	(Principal Accounting Officer)

33

EX-10.1

Exhibit 10.1

SEPARATION AGREEMENT

THIS SEPERATION AGREEMENT (this “Agreement”)is made as of this 1st day of April, 2017, (the “Effective Date”) by and between NN, Inc., a Delaware Corporation with its principal place of business in Johnson City, Tennessee (the “Company”), and D. Gail Nixon (the “Executive”).

WITNESSETH:

WHEREAS, the Company will employ the Executive for the success of the Company and recognizes that the Executive will perform key functions for the Company; and

WHEREAS, the Company has determined that it is in the best interests of the Company to institute a formalized separation arrangement with the Executive in the event of a separation of employment; and

WHEREAS, the Executive desires to enter into this Agreement with the Company;

NOW, THEREFORE, in consideration of the foregoing and of the promises, covenants and mutual agreements set forth below, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:

1. Compensation and Benefits in the Event of Separation from Service. In the event of the Executive’s Separation from Service, compensation and benefits shall be paid as set forth below.

(a) Qualifying Termination Prior To A Change In Control. If the Executive has a Qualifying Termination after the Effective Date and prior to a Change in Control, then upon such Qualifying Termination the Executive shall be entitled to receive the following:

(i) The Executive’s annual salary through the effective date of Separation from Service, at the annual rate in effect at the time the Notice of Termination is given (or death occurs), to the extent unpaid prior to such Separation from Service.

(ii) In consideration of Executive’s prior service to the Company an amount equal to 18 months of his annual base salary in effect on the date of his Separation from Service. These amounts shall be payable in accordance with the Company’s regular payroll procedures over the 18 month period following the Executive’s Separation from Service.

(iii) Any vested rights of Executive in accordance with the Company’s plans, programs or policies. A payment equal to the target annual bonus to which the Executive would have been entitled but for the Qualifying Termination, prorated for the portion of the year during which the Executive was employed by the Company (which bonus will be determined in accordance with the Company’s corporate guidelines and distributed after completion of the Company’s fiscal year end audit).

(iv) Prompt reimbursement for any and all reimbursable business expenses (to the extent not already reimbursed) upon Executive’s properly accounting for the same.

1

Exhibit 10.1

(v) $12,000.00 payable in a single lump sum to assist with the Executive’s transition from employment.

Payments under (ii) and (v) above shall commence or shall be paid within 60 days following the Executive’s Separation from Service; provided, however, that the Executive is in full compliance with the covenants under paragraphs 2, 3, 4, and 6 of this Agreement.

(b) Termination By The Company For Cause Or By The Executive Without Good Reason. In the event Executive’s Separation from Service is terminated (A) by action of the Company for Cause; (B) by action of the Executive without Good Reason; or (C) by reason of the Executive’s death, Disability or retirement, the following compensation and benefits shall be paid and provided the Executive (or his beneficiary):

(i) The Executive’s annual salary provided through the effective date of Separation from Service, at the annual rate in effect at the time the Notice of Termination is given (or death occurs), to the extent unpaid prior to such Separation from Service.

(ii) Any vested rights of Executive in accordance with the Company’s plans, programs or policies.

(iii) Prompt reimbursement for any and all reimbursable business expenses (to the extent not already reimbursed) upon Executive’s properly accounting for the same.

(c)    Qualifying Termination Following a Change in Control.

(i)    In the event that Executive has a Qualifying Termination within 24 months following a Change in Control, Executive shall receive the following, subject to paragraph 1(c)(ii):

(1) The annual salary due to the Executive through the date of his Separation from Service.

(2) A lump sum payment equal to an amount set forth on Schedule Ato this Agreement (the “Severance Payment”). The Severance Payment shall be made by wire transfer or immediately available funds to an account designated by Executive following the date of the Separation from Service.

(3) A payment equal to the target annual bonus to which Executive would have been entitled but for Executive’s Separation from Service, for the year of Executive’s termination; pro-rated for the portion of the year during which he was employed by the Company (“Pro-rated Bonus”).

(4) Any vested rights of Executive in accordance with the Company’s plans, programs or policies.

(5) Prompt reimbursement for any and all reimbursable business expenses (to the extent not already reimbursed) upon Executive’s properly accounting for the same.

2

Exhibit 10.1

(6) $12,000.00 payable in a single lump sum to assist with the Executive’s transition from employment.

Payments under (2), (3) and (6) above shall be paid in full in a lump sum within 60 days following the Executive’s Separation from Service; provided, however, that the Executive is in full compliance with the covenants under paragraphs 2, 3, 4, and 6 of this Agreement.

(ii)    Excise Tax.

(1) If it is determined that any payment or distribution in the nature of compensation (within the meaning of Section 280G(b)(2) of the Code) to or for the benefit of the Executive, whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise (the “Change in Control Payment”), would constitute an “excess parachute payment” within the meaning of Section 280G of the Code, then the Company shall pay to the Executive whichever of the following gives the Executive the highest net after-tax amount (after taking into account all applicable federal, state, local and social security taxes): (i) the Change in Control Payment, or (ii) the amount that would not result in the imposition of excise tax on the Executive under Section 4999 of the Code. Any required reduction in the Change in Control Payment pursuant to the foregoing shall be accomplished solely by reducing the amount of severance payment payable pursuant to paragraph 1(c)(i)(1) of this Agreement and then, to the extent necessary, paragraph 1(c)(i)(2) of this Agreement.

(2) All determinations to be made under this paragraph 1(c)(ii) shall be made by an independent public accounting firm selected by the Company immediately prior to the Change in Control (the “Accounting Firm”), which shall provide its determinations and any supporting calculations both to the Company and the Executive within ten (10) days of the Change in Control. Any such determination by the Accounting Firm shall be binding upon the Company and the Executive. All of the fees and expenses of the Accounting Firm in performing the determinations referred to in this paragraph 1(c)(iii) shall be borne solely by the Company.

(d) Continuation of Benefits. Following Executive’s Separation from Service, the Executive shall have the right to continue in the Company’s group health insurance plan or other Company benefit program, at his or her own cost and without any contribution by the Company, as may be required by COBRA or any other federal or state law or regulation.

(e) Limit on Company Liability. Except as expressly set forth in this paragraph 1, the Company shall have no obligation to Executive under this Agreement following Executive’s Separation from Service. Without limiting the generality of the provision of the foregoing sentence, the Company shall not, following Executive’s Separation from Service, have any obligation to provide any further benefit to Executive under this Agreement or make any further

3

Exhibit 10.1

contribution for Executive’s benefit under this Agreement except as provided in this paragraph 1.

2. Disclosure of Confidential Information. The Company has developed confidential information, strategies and programs, which include customer lists, prospects, lists, expansion and acquisition plans, market research, sales systems, marketing programs, computer systems and programs, product development strategies, manufacturing strategies and techniques, budgets, pricing strategies, identity and requirements of national accounts, customer lists, methods of operating, service systems, training programs and methods, other trade secrets and information about the business in which the Company is engaged that is not known to the public and gives the Company an opportunity to obtain an advantage over competitors who do not know of such information (collectively, “Confidential Information”), provided that the term “Confidential Information” shall not include (i) any such information that, prior to its use or disclosure by Executive, can be shown to have been in the public domain or generally known or available to customers, suppliers or competitors of the Company through no breach of the provisions of this Agreement or other non-disclosure covenants; (ii) any such information that, prior to its disclosure by the Executive, was rightfully in the receiving third party’s possession, without violation of the provisions of this Agreement or other non-disclosure covenants; and (iii) any such information that, prior to its disclosure by the Executive, was independently developed by the receiving third party without violation of the provisions of this Agreement or other non-disclosure covenants. In performing duties for the Company, Executive regularly will be exposed to and work with Confidential Information of the Company. Executive may also be exposed to and work with Confidential Information of the Company’s affiliates and subsidiaries. Executive acknowledges that Confidential Information of the Company and its affiliates and subsidiaries is critical to the Company’s success and that the Company and its affiliates and subsidiaries have invested substantial sums of money in developing the Confidential Information. While Executive is employed by the Company and after such employment ends for any reason, Executive will never reproduce, publish, disclose, use, reveal, show or otherwise communicate to any person or entity any Confidential Information of Company, its affiliates, and/or its subsidiaries unless specifically directed by the Company to do so in writing, provided that nothing herein shall prohibit the Executive from disclosing Confidential Information as required by law or pursuant to legal process. Executive agrees that whenever Executive’s employment with the Company ends for any reason, all documents containing or referring to Confidential Information of the Company, its affiliates, and/or its subsidiaries that may be in Executive’s possession or control will be delivered by Executive to the Company promptly upon the Company’s request.

3. Non-Interference with Personnel Relations. At any time while Executive is employed by the Company and at any time during the Restrictive Period after such employment ends for any reason, Executive acting either directly or indirectly, or through any other person, firm, or corporation, will not then, at such time, hire, contract with or employ any then employee of the Company, and/or any then employee of an affiliate or subsidiary of the Company with which Executive interacted or about which Executive gained Confidential Information during his employment with Company (“Restricted Employees”). Further, Executive will not induce or attempt to induce or influence any of the Restricted Employees to terminate employment with the Company, affiliate, and/or subsidiary.

4

Exhibit 10.1

However, this provision shall not apply to Executive in the case of the solicitation of his immediate family members.

4. Non-Competition. While Executive is employed by the Company and for the Restrictive Period after such employment ends, Executive will not, directly or indirectly, or through any other person, firm or corporation (i) be employed by, consult for, have any ownership interest in or engage in any activity on behalf of any company that engages in a Competing Business, as defined below, or (ii) call on, solicit or communicate with any of the Company’s customers or suppliers for any purpose related to a Competing Business, as defined below. A “Competing Business” is one that engages in the production, sale, or marketing of a product or service that is substantially similar to, or serves the same purpose as, any product or service produced, sold or marketed by the Company or any parent, subsidiary or affiliate of the Company with which Executive interacted or about which Executive gained Confidential Information during his employment with the Company. The term “customer” or “supplier” means any customer or supplier (whether actual or potential) with whom Executive or any other employee of the Company or any parent, subsidiary or affiliate of the Company had business contact during the eighteen (18) months immediately before Executive’s employment with the Company ended. Notwithstanding the foregoing, this paragraph shall not be construed to prohibit Executive from owning less than five percent (5%) of the outstanding securities of a corporation which is publicly traded on a securities exchange or over-the-counter.

5. Notification to Subsequent Employers. Executive grants the Company the right to notify any future employer or prospective employer of Executive concerning the existence of and terms of this Agreement and grants the Company the right to provide a copy of this Agreement to any such subsequent employer or prospective employer.

6. Company Proprietary Rights.

(a) Company to Retain Rights. Executive agrees that all right, title and interest of every kind and nature whatsoever in and to copyrights, patents, ideas, business or strategic plans and concepts, studies, presentations, creations, inventions, writings, properties, discoveries and all other intellectual property conceived by Executive during the term of this Agreement and pertaining to or useful in or to (directly or indirectly) the activities of the Company and/or any parent, subsidiary or affiliate of the Company (collectively, “Company Intellectual Property”) shall become and remain the exclusive property of the Company and/or such parent, subsidiary or affiliate, and Executive shall have no interest therein.

(b) Further Assurances. At the request of the Company, Executive shall, at the Company’s expense but without additional consideration, execute such documents and perform such other acts as the Company may deem necessary or appropriate to vest in the Company or its designee such title as Executive may have to all Company Intellectual Property in which Executive may be able to claim any rights by virtue of his employment under this Agreement.

5

Exhibit 10.1

(c) Return of Material. Upon the termination of the Executive’s employment under this Agreement at the Company’s written request, the Executive will promptly return to the Company all copies of information protected by paragraph 6(a) hereof which are in his possession, custody or control, whether prepared by him or others, and the Executive agrees that he shall not retain any of same.

7. Withholding. Any provision of this Agreement to the contrary notwithstanding, all payments made by the Company hereunder to the Executive or his estate or beneficiaries shall be subject to the withholding of such amounts, if any, relating to tax and other payroll deductions as the Company may reasonably determine should be withheld pursuant to any applicable law or regulation. In lieu of withholding such amounts, the Company may accept other provisions, provided that it has sufficient funds to pay all taxes required by law to be withheld in respect of any or all such payments.

8. Mitigation. The Company’s obligation to make the payments provided for in this Agreement and otherwise to perform its obligations hereunder shall not be subject to set off for any reason and shall not be affected by any set-off, counterclaim, recoupment, defense or other claim, right or action which the Company may have against Executive or others. In no event shall Executive be obligated to seek other employment or take any other action by way of mitigation of the amounts payable to Executive under any of the provisions of this agreement and such amounts shall not be reduced whether or not Executive obtains other employment.

9. Notices. All notices, requests, demands and other communications provided for by this Agreement shall be in writing and shall be sufficiently given if and when mailed in the continental United States by registered or certified mail, or personally delivered to the party entitled thereto, at the address stated below or to such changed address as the addressee may have given by a similar notice:

To the Company:    NN, Inc.

Attn: General Counsel

207 Mockingbird Lane Johnson City, TN 37604

To the Executive:    D. Gail Nixon

806 Glen Oaks Court

Johnson City, TN 37615

10. Successors: Binding Agreement. The Company shall require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or assets of the Company, by agreement in the form and substance satisfactory to the Executive, to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place. Failure of the Company to obtain such agreement prior to the effectiveness of any such succession shall be a breach of this Agreement. For purposes of this Agreement, “Company” shall include any successor

6

Exhibit 10.1

to its business and/or assets as aforesaid which executes and delivers the agreement provided for in this paragraph or which otherwise becomes bound by all the terms and provisions of this Agreement by operation of law.

This Agreement shall inure to the benefit of and be enforceable by the Executive’s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees. If the Executive should die while any amount would still be payable to him hereunder if he had continued to live, all such amounts, except to the extent otherwise provided under this Agreement, shall be paid in accordance with the terms of this Agreement to his devisee, legatee or other designee, or if there be no such designee, to the Executive’s estate.

11. Modification, Waiver or Discharge. No provision of this Agreement may be modified or discharged unless such modification or discharge is authorized by the Board of Directors of the Company and is agreed to in writing, signed by the Executive and by an officer of the Company duly authorized by the Board. However, the Company may unilaterally revise the provisions of this Agreement governed by the provisions of Section 409A of the Code in order to make the Agreement compliant therewith, and as necessary under any provision of the Code or any other federal or state statute or regulation to prevent the imposition of any federal or state fine, tax, or penalty upon Company or Executive that would result from the performance of any provisions of this Agreement. No waiver by either party hereto of any breach by the other party hereto of any condition or provision of this Agreement to be performed by such other party will be deemed a waiver of similar or dissimilar provisions or conditions at the time or at any time or at any prior or subsequent time.

12. Entire Agreement. This Agreement constitutes the entire understanding of the parties hereto with respect to its subject matter and supersedes all prior agreements between the parties hereto with respect to its subject matter, including, but not limited to, all employment agreements, change of control agreements, non-competition agreements or any other agreement related to Executive’s employment with the Company; provided, however, nothing herein shall affect the terms of any indemnification agreement by and between the Company and Executive or any general indemnification policy in favor of Executive, which shall continue and remain in full force and effect.

13. Governing Law. The validity, interpretation, construction and performance of this Agreement shall be governed by the laws of the State of Tennessee, without regard to its conflict of laws principles, to the extent federal law does not apply.

14. Resolution of Disputes. Any dispute or claim arising out of or relating to this Agreement shall be settled by final and binding arbitration in Johnson City, Tennessee in accordance with the Commercial Arbitration rules of the American Arbitration Association, and judgment upon the award rendered by the arbitrators may be entered in any court having jurisdiction thereof. The fees and expenses of the arbitration panel shall be equally borne by the Company and Executive. Each party shall be liable for its own costs and expenses as a result of any dispute related to this Agreement.

7

Exhibit 10.1

15. Validity. The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of the other provisions of this Agreement, which latter provisions shall remain in full force and effect.

16. Compliance with Section 409A.

(a) General. It is intended that the Agreement will comply with Section 409A of the Code and the regulations and other guidance thereunder (“Section 409A”), and the Agreement shall be interpreted consistent with such intent. As permitted by Section 409A, each installment or other payment made or benefit provided hereunder shall be treated as “separate payment” for purposes of Section 409A and the available exemptions under Section 409A shall be stacked to the maximum extent possible. This Agreement may be amended in any respect deemed necessary (including retroactively) by the Company in order to pursue compliance with Section 409A. The foregoing shall not be construed as a guarantee of any particular tax effect for benefits under this Agreement. The Executive or any beneficiary, as applicable, is solely responsible and liable for the satisfaction of all taxes, interest and penalties that may be imposed on the Executive or any beneficiary in connection with any payments to the Executive or beneficiary under the Agreement, including any taxes, interest and penalties under Section 409A, and neither the Company nor any director, officer or affiliate shall have any obligation to indemnify or otherwise hold the Executive or a beneficiary harmless from any and all of such taxes, interest and penalties. To the extent Executive is entitled to be paid or reimbursed for any taxable expenses under this Agreement, and such payments or reimbursements are includible in Executive’s federal gross taxable income, the amount of such expenses reimbursable in any one calendar year shall not affect the amount reimbursable in any other calendar year, and the reimbursement of an eligible expense shall be made no later than December 31 of the year after the year in which the expense was incurred. Executive’s right to reimbursement of expenses under this Agreement shall not be subject to liquidation or exchange for another benefit.

(b) Six Month Delay for Specified Employees. Notwithstanding anything in the Agreement to the contrary, if the Executive is determined to be a “specified employee” (as defined in Section 409A) for the year in which the Executive incurs a Separation from Service, any payment due under the Agreement that is not permitted to be paid on the date of such separation without the imposition of additional taxes, interest and penalties under Section 409A shall be paid on the first business day following the six-month anniversary of the Executive's date of separation or, if earlier, the Executive's death.

17. No Adequate Remedy At Law. The Company and the Executive recognize that each party may have no adequate remedy at law for breach by the other of any of the agreements contained herein, and particularly a breach of paragraphs 2, 3, 4, and 6, and, in the event of any such breach, the Company and the Executive hereby agree and consent that the other shall be entitled to injunctive relief or other appropriate remedy to enforce performance of such agreements.

18. Non-Assignability. This Agreement, and the rights and obligations of the parties hereunder, are personal and neither this Agreement, nor any right, benefit or obligation of either party hereto, shall

8

Exhibit 10.1

be subject to voluntary or involuntary assignment, alienation or transfer, whether by operation of law or otherwise, without the prior written consent of the other party; provided, however, that the Company may assign this Agreement in connection with a merger or consolidation involving the Company or a sale of substantially all of its assets to the surviving corporation or purchaser, as the case may be, so long as such assignee assumes the Company’s obligations hereunder.

19. Headings. The section headings contained in this Agreement are for convenience of reference only and will not be deemed to control or affect the meaning or construction of any provision of this Agreement. Reference to paragraphs are to paragraphs in this Agreement.

20. Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original, but of which together will constitute one and the same instrument.

21. Definitions. For purposes of this Agreement, the following terms shall have the following meanings:

(a)    “Cause” means any of the following:

(i) the failure of the Executive to perform the Executive’s duties under this Agreement (other than as a result of physical or mental illness or injury), which failure, if correctable, and provided it does not constitute willful misconduct or gross negligence, remains uncorrected for 10 days following written notice to Executive by the Chief Executive Officer or the Board of Directors of the Company of such breach;

(ii) willful misconduct or gross negligence by the Executive in either case that results in material damage to the business or reputation of the Company;

(iii) a material breach by Executive of this Agreement which, if correctable, remains uncorrected for 10 days following written notice to Executive by the Chief Executive Officer or the Board of Directors of the Company of such breach; or

(iv) the Executive is convicted of a felony or any other crime (other than traffic violations) involving moral turpitude (whether or not in connection with the performance by Executive of his duties under this Agreement).

(b)    “Change in Control” means, and shall occur on the date that any of the following occurs:

(i) A person, corporation, entity or group (1) makes a tender or exchange offer for the issued and outstanding voting stock of NN, Inc., (“NN”) and beneficially owns fifty percent (50%) or more of the issued and outstanding voting stock of NN after such tender or exchange offer, or (2) acquires (or has acquired during the 12-month period ending on the date of the most recent acquisition by such person, corporation, entity or group), directly or indirectly, the beneficial ownership of fifty percent (50%) or

9

Exhibit 10.1

more of the issued and outstanding voting stock of NN in a single transaction or a series of transactions (other than any person, corporation, entity or group for which a Schedule 13G is on file with the Securities and Exchange Commission, so long as such person, corporation, entity or group has beneficial ownership of less than fifty percent (50%) of the issued and outstanding voting stock of NN); or

(ii) NN is a party to a merger, consolidation or similar transaction and following such transaction, fifty percent (50%) or more of the issued and outstanding voting stock of the resulting entity is not beneficially owned by those persons, corporations or entities that constituted the stockholders of NN immediately prior to the transaction;

(iii) NN sells fifty percent (50%) or more of its assets to any other person or persons (other than an affiliate or affiliates of NN); or

(iv) Individuals who, during any 12-month period, constitute the Board (the “Incumbent Board”) cease for any reason to constitute at least seventy-five percent (75%) of the Board of Directors of NN; provided, however, that any individual becoming a director whose election or nomination was approved by a majority of the directors than comprising the Incumbent Board, shall be considered a member of the Incumbent Board, but not including any individual whose initial board membership is a result of an actual or threatened election contest (as that term is used in Rule 14a-11 promulgated under the Securities Act of 1934, as amended) or an actual or threatened solicitation of proxies or consents by or on behalf of a party other than the Board.

It is not intended that a Change in Control, in and of itself, will serve as an event which entitles Executive to any payment hereunder.

(c) “Code” means the Internal Revenue Code of 1986 as amended.

(d) “Disability” means the Executive (i) is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than twelve (12) months; or (ii) is, by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than twelve (12) months, receiving income replacement benefits for a period of not less than three (3) months under an accident and health plan covering employees or directors of the Company. Executive will be deemed Disabled if he is determined to be totally disabled by the Social Security Administration, or if Executive is determined to be disabled in accordance with a disability insurance program maintained by the Company if the definition of “disability” applied under such disability insurance program complies with the requirements of the preceding sentence. Upon the request of the plan administrator, the Executive must submit proof to the plan administrator of the Social Security Administration’s or the provider’s determination.

10

Exhibit 10.1

(e) “Good Reason” means any of the following events if not remedied by the Company within 30 days after receipt of notice thereof from the Executive: (i) assignment to the Executive of any duties inconsistent with Executive’s position duties, responsibilities, office, or any other action by the Company that results in a material diminution in the Executive’s position, authority, duties or responsibilities; (ii) any material failure by the Company to comply with this Agreement; (iii) any material adverse change in Executive’s annual compensation and other benefits; or (iv) a requirement to relocate Executive’s place of employment in excess of fifty (50) miles from the current principal office of the Company as of the date hereof.

Notwithstanding anything in this definition to the contrary, an alleged act by the Company shall not constitute a “Good Reason” event for purposes of this Agreement unless Executive gives written notice of the same to the Company within 60 days of the initial existence of such act. Further, for avoidance of doubt, nothing in this Agreement shall preclude the Company from reducing Executive’s annual base salary and/or incentive opportunity as part of an across-the-board compensation adjustment to other employees at Executive’s level of employment.

(f) “Notice of Termination” means a written notice which shall include the specific termination provision under this Agreement relied upon, and shall set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Executive’s employment. Any purported termination of the Executive’s employment hereunder by action of either party shall be communicated by delivery of a Notice of Termination to the other party. Any termination by Executive of his employment without Good Reason shall be made on not less than 14 days’ notice.

(g) “Qualifying Termination” means a Separation from Service by action of the Company that is not for Cause, or a Separation from Service by action of the Executive that is for Good Reason.

(h) “Restrictive Period” means (i) a number of months following Executive’s termination of employment pursuant to paragraph 1(a) or 1(c) above which is equal to the number of months for which the Executive is entitled to receive his base salary under paragraph 1(a) or 1(c) above, or a period of 12 months following Executive’s termination of employment pursuant to paragraph 1(b) above.

(i) “Separation from Service” means Executive’s “separation from service” as defined in Treasury Regulation Section 1.409A-1(h).

11

Exhibit 10.1

IN WITNESS WHEREOF, the Executive and the Company (by action of its duly authorized officers) have executed this Agreement as of the date first above written.

NN, INC.

By:/s/ Richard D. Holder
Name: Richard D. Holder
Title: President and Chief Executive Officer

EXECUTIVE:

/s/ D. Gail Nixon
Name: D. Gail Nixon

12

Exhibit 10.1

SCHEDULE A

Executive’s Severance Payment subsequent to a Change in Control as provided in paragraph 1(c)(i) shall be a lump sum payment equal to:

1. 2.0 times Executive’s base salary (as of the date of Executive’s termination); plus

2. 1.0 times Executive’s target bonus.

22543288.2

13

EX-10.2

Exhibit 10.2

SEPARATION AGREEMENT

THIS SEPERATION AGREEMENT (this “Agreement”)is made as of this 1st day of April, 2017, (the “Effective Date”) by and between NN, Inc., a Delaware Corporation with its principal place of business in Johnson City, Tennessee (the “Company”), and J. Robbie Atkinson (the “Executive”).

WITNESSETH:

WHEREAS, the Company will employ the Executive for the success of the Company and recognizes that the Executive will perform key functions for the Company; and

WHEREAS, the Company has determined that it is in the best interests of the Company to institute a formalized separation arrangement with the Executive in the event of a separation of employment; and

WHEREAS, the Executive desires to enter into this Agreement with the Company;

NOW, THEREFORE, in consideration of the foregoing and of the promises, covenants and mutual agreements set forth below, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:

1. Compensation and Benefits in the Event of Separation from Service. In the event of the Executive’s Separation from Service, compensation and benefits shall be paid as set forth below.

(a) Qualifying Termination Prior To A Change In Control. If the Executive has a Qualifying Termination after the Effective Date and prior to a Change in Control, then upon such Qualifying Termination the Executive shall be entitled to receive the following:

(i) The Executive’s annual salary through the effective date of Separation from Service, at the annual rate in effect at the time the Notice of Termination is given (or death occurs), to the extent unpaid prior to such Separation from Service.

(ii) In consideration of Executive’s prior service to the Company an amount equal to 18 months of his annual base salary in effect on the date of his Separation from Service. These amounts shall be payable in accordance with the Company’s regular payroll procedures over the 18 month period following the Executive’s Separation from Service.

(iii) Any vested rights of Executive in accordance with the Company’s plans, programs or policies. A payment equal to the target annual bonus to which the Executive would have been entitled but for the Qualifying Termination, prorated for the portion of the year during which the Executive was employed by the Company (which bonus will be determined in accordance with the Company’s corporate guidelines and distributed after completion of the Company’s fiscal year end audit).

(iv) Prompt reimbursement for any and all reimbursable business expenses (to the extent not already reimbursed) upon Executive’s properly accounting for the same.

1

Exhibit 10.2

(v) $12,000.00 payable in a single lump sum to assist with the Executive’s transition from employment.

Payments under (ii) and (v) above shall commence or shall be paid within 60 days following the Executive’s Separation from Service; provided, however, that the Executive is in full compliance with the covenants under paragraphs 2, 3, 4, and 6 of this Agreement.

(b) Termination By The Company For Cause Or By The Executive Without Good Reason. In the event Executive’s Separation from Service is terminated (A) by action of the Company for Cause; (B) by action of the Executive without Good Reason; or (C) by reason of the Executive’s death, Disability or retirement, the following compensation and benefits shall be paid and provided the Executive (or his beneficiary):

(i) The Executive’s annual salary provided through the effective date of Separation from Service, at the annual rate in effect at the time the Notice of Termination is given (or death occurs), to the extent unpaid prior to such Separation from Service.

(ii) Any vested rights of Executive in accordance with the Company’s plans, programs or policies.

(iii) Prompt reimbursement for any and all reimbursable business expenses (to the extent not already reimbursed) upon Executive’s properly accounting for the same.

(c)    Qualifying Termination Following a Change in Control.

(i)    In the event that Executive has a Qualifying Termination within 24 months following a Change in Control, Executive shall receive the following, subject to paragraph 1(c)(ii):

(1) The annual salary due to the Executive through the date of his Separation from Service.

(2) A lump sum payment equal to an amount set forth on Schedule Ato this Agreement (the “Severance Payment”). The Severance Payment shall be made by wire transfer or immediately available funds to an account designated by Executive following the date of the Separation from Service.

(3) A payment equal to the target annual bonus to which Executive would have been entitled but for Executive’s Separation from Service, for the year of Executive’s termination; pro-rated for the portion of the year during which he was employed by the Company (“Pro-rated Bonus”).

(4) Any vested rights of Executive in accordance with the Company’s plans, programs or policies.

(5) Prompt reimbursement for any and all reimbursable business expenses (to the extent not already reimbursed) upon Executive’s properly accounting for the same.

2

Exhibit 10.2

(6) $12,000.00 payable in a single lump sum to assist with the Executive’s transition from employment.

Payments under (2), (3) and (6) above shall be paid in full in a lump sum within 60 days following the Executive’s Separation from Service; provided, however, that the Executive is in full compliance with the covenants under paragraphs 2, 3, 4, and 6 of this Agreement.

(ii)    Excise Tax.

(1) If it is determined that any payment or distribution in the nature of compensation (within the meaning of Section 280G(b)(2) of the Code) to or for the benefit of the Executive, whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise (the “Change in Control Payment”), would constitute an “excess parachute payment” within the meaning of Section 280G of the Code, then the Company shall pay to the Executive whichever of the following gives the Executive the highest net after-tax amount (after taking into account all applicable federal, state, local and social security taxes): (i) the Change in Control Payment, or (ii) the amount that would not result in the imposition of excise tax on the Executive under Section 4999 of the Code. Any required reduction in the Change in Control Payment pursuant to the foregoing shall be accomplished solely by reducing the amount of severance payment payable pursuant to paragraph 1(c)(i)(1) of this Agreement and then, to the extent necessary, paragraph 1(c)(i)(2) of this Agreement.

(2) All determinations to be made under this paragraph 1(c)(ii) shall be made by an independent public accounting firm selected by the Company immediately prior to the Change in Control (the “Accounting Firm”), which shall provide its determinations and any supporting calculations both to the Company and the Executive within ten (10) days of the Change in Control. Any such determination by the Accounting Firm shall be binding upon the Company and the Executive. All of the fees and expenses of the Accounting Firm in performing the determinations referred to in this paragraph 1(c)(iii) shall be borne solely by the Company.

(d) Continuation of Benefits. Following Executive’s Separation from Service, the Executive shall have the right to continue in the Company’s group health insurance plan or other Company benefit program, at his or her own cost and without any contribution by the Company, as may be required by COBRA or any other federal or state law or regulation.

(e) Limit on Company Liability. Except as expressly set forth in this paragraph 1, the Company shall have no obligation to Executive under this Agreement following Executive’s Separation from Service. Without limiting the generality of the provision of the foregoing sentence, the Company shall not, following Executive’s Separation from Service, have any obligation to provide any further benefit to Executive under this Agreement or make any further

3

Exhibit 10.2

contribution for Executive’s benefit under this Agreement except as provided in this paragraph 1.

2. Disclosure of Confidential Information. The Company has developed confidential information, strategies and programs, which include customer lists, prospects, lists, expansion and acquisition plans, market research, sales systems, marketing programs, computer systems and programs, product development strategies, manufacturing strategies and techniques, budgets, pricing strategies, identity and requirements of national accounts, customer lists, methods of operating, service systems, training programs and methods, other trade secrets and information about the business in which the Company is engaged that is not known to the public and gives the Company an opportunity to obtain an advantage over competitors who do not know of such information (collectively, “Confidential Information”), provided that the term “Confidential Information” shall not include (i) any such information that, prior to its use or disclosure by Executive, can be shown to have been in the public domain or generally known or available to customers, suppliers or competitors of the Company through no breach of the provisions of this Agreement or other non-disclosure covenants; (ii) any such information that, prior to its disclosure by the Executive, was rightfully in the receiving third party’s possession, without violation of the provisions of this Agreement or other non-disclosure covenants; and (iii) any such information that, prior to its disclosure by the Executive, was independently developed by the receiving third party without violation of the provisions of this Agreement or other non-disclosure covenants. In performing duties for the Company, Executive regularly will be exposed to and work with Confidential Information of the Company. Executive may also be exposed to and work with Confidential Information of the Company’s affiliates and subsidiaries. Executive acknowledges that Confidential Information of the Company and its affiliates and subsidiaries is critical to the Company’s success and that the Company and its affiliates and subsidiaries have invested substantial sums of money in developing the Confidential Information. While Executive is employed by the Company and after such employment ends for any reason, Executive will never reproduce, publish, disclose, use, reveal, show or otherwise communicate to any person or entity any Confidential Information of Company, its affiliates, and/or its subsidiaries unless specifically directed by the Company to do so in writing, provided that nothing herein shall prohibit the Executive from disclosing Confidential Information as required by law or pursuant to legal process. Executive agrees that whenever Executive’s employment with the Company ends for any reason, all documents containing or referring to Confidential Information of the Company, its affiliates, and/or its subsidiaries that may be in Executive’s possession or control will be delivered by Executive to the Company promptly upon the Company’s request.

3. Non-Interference with Personnel Relations. At any time while Executive is employed by the Company and at any time during the Restrictive Period after such employment ends for any reason, Executive acting either directly or indirectly, or through any other person, firm, or corporation, will not then, at such time, hire, contract with or employ any then employee of the Company, and/or any then employee of an affiliate or subsidiary of the Company with which Executive interacted or about which Executive gained Confidential Information during his employment with Company (“Restricted Employees”). Further, Executive will not induce or attempt to induce or influence any of the Restricted Employees to terminate employment with the Company, affiliate, and/or subsidiary.

4

Exhibit 10.2

However, this provision shall not apply to Executive in the case of the solicitation of his immediate family members.

4. Non-Competition. While Executive is employed by the Company and for the Restrictive Period after such employment ends, Executive will not, directly or indirectly, or through any other person, firm or corporation (i) be employed by, consult for, have any ownership interest in or engage in any activity on behalf of any company that engages in a Competing Business, as defined below, or (ii) call on, solicit or communicate with any of the Company’s customers or suppliers for any purpose related to a Competing Business, as defined below. A “Competing Business” is one that engages in the production, sale, or marketing of a product or service that is substantially similar to, or serves the same purpose as, any product or service produced, sold or marketed by the Company or any parent, subsidiary or affiliate of the Company with which Executive interacted or about which Executive gained Confidential Information during his employment with the Company. The term “customer” or “supplier” means any customer or supplier (whether actual or potential) with whom Executive or any other employee of the Company or any parent, subsidiary or affiliate of the Company had business contact during the eighteen (18) months immediately before Executive’s employment with the Company ended. Notwithstanding the foregoing, this paragraph shall not be construed to prohibit Executive from owning less than five percent (5%) of the outstanding securities of a corporation which is publicly traded on a securities exchange or over-the-counter.

5. Notification to Subsequent Employers. Executive grants the Company the right to notify any future employer or prospective employer of Executive concerning the existence of and terms of this Agreement and grants the Company the right to provide a copy of this Agreement to any such subsequent employer or prospective employer.

6. Company Proprietary Rights.

(a) Company to Retain Rights. Executive agrees that all right, title and interest of every kind and nature whatsoever in and to copyrights, patents, ideas, business or strategic plans and concepts, studies, presentations, creations, inventions, writings, properties, discoveries and all other intellectual property conceived by Executive during the term of this Agreement and pertaining to or useful in or to (directly or indirectly) the activities of the Company and/or any parent, subsidiary or affiliate of the Company (collectively, “Company Intellectual Property”) shall become and remain the exclusive property of the Company and/or such parent, subsidiary or affiliate, and Executive shall have no interest therein.

(b) Further Assurances. At the request of the Company, Executive shall, at the Company’s expense but without additional consideration, execute such documents and perform such other acts as the Company may deem necessary or appropriate to vest in the Company or its designee such title as Executive may have to all Company Intellectual Property in which Executive may be able to claim any rights by virtue of his employment under this Agreement.

5

Exhibit 10.2

(c) Return of Material. Upon the termination of the Executive’s employment under this Agreement at the Company’s written request, the Executive will promptly return to the Company all copies of information protected by paragraph 6(a) hereof which are in his possession, custody or control, whether prepared by him or others, and the Executive agrees that he shall not retain any of same.

7. Withholding. Any provision of this Agreement to the contrary notwithstanding, all payments made by the Company hereunder to the Executive or his estate or beneficiaries shall be subject to the withholding of such amounts, if any, relating to tax and other payroll deductions as the Company may reasonably determine should be withheld pursuant to any applicable law or regulation. In lieu of withholding such amounts, the Company may accept other provisions, provided that it has sufficient funds to pay all taxes required by law to be withheld in respect of any or all such payments.

8. Mitigation. The Company’s obligation to make the payments provided for in this Agreement and otherwise to perform its obligations hereunder shall not be subject to set off for any reason and shall not be affected by any set-off, counterclaim, recoupment, defense or other claim, right or action which the Company may have against Executive or others. In no event shall Executive be obligated to seek other employment or take any other action by way of mitigation of the amounts payable to Executive under any of the provisions of this agreement and such amounts shall not be reduced whether or not Executive obtains other employment.

9. Notices. All notices, requests, demands and other communications provided for by this Agreement shall be in writing and shall be sufficiently given if and when mailed in the continental United States by registered or certified mail, or personally delivered to the party entitled thereto, at the address stated below or to such changed address as the addressee may have given by a similar notice:

To the Company:    NN, Inc.

Attn: General Counsel

207 Mockingbird Lane Johnson City, TN 37604

To the Executive:    J. Robbie Atkinson

225 Lake Ridge Drive

Jonesborough, TN 37659

10. Successors: Binding Agreement. The Company shall require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or assets of the Company, by agreement in the form and substance satisfactory to the Executive, to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place. Failure of the Company to obtain such agreement prior to the effectiveness of any such succession shall be a breach of this Agreement. For purposes of this Agreement, “Company” shall include any successor

6

Exhibit 10.2

to its business and/or assets as aforesaid which executes and delivers the agreement provided for in this paragraph or which otherwise becomes bound by all the terms and provisions of this Agreement by operation of law.

This Agreement shall inure to the benefit of and be enforceable by the Executive’s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees. If the Executive should die while any amount would still be payable to him hereunder if he had continued to live, all such amounts, except to the extent otherwise provided under this Agreement, shall be paid in accordance with the terms of this Agreement to his devisee, legatee or other designee, or if there be no such designee, to the Executive’s estate.

11. Modification, Waiver or Discharge. No provision of this Agreement may be modified or discharged unless such modification or discharge is authorized by the Board of Directors of the Company and is agreed to in writing, signed by the Executive and by an officer of the Company duly authorized by the Board. However, the Company may unilaterally revise the provisions of this Agreement governed by the provisions of Section 409A of the Code in order to make the Agreement compliant therewith, and as necessary under any provision of the Code or any other federal or state statute or regulation to prevent the imposition of any federal or state fine, tax, or penalty upon Company or Executive that would result from the performance of any provisions of this Agreement. No waiver by either party hereto of any breach by the other party hereto of any condition or provision of this Agreement to be performed by such other party will be deemed a waiver of similar or dissimilar provisions or conditions at the time or at any time or at any prior or subsequent time.

12. Entire Agreement. This Agreement constitutes the entire understanding of the parties hereto with respect to its subject matter and supersedes all prior agreements between the parties hereto with respect to its subject matter, including, but not limited to, all employment agreements, change of control agreements, non-competition agreements or any other agreement related to Executive’s employment with the Company; provided, however, nothing herein shall affect the terms of any indemnification agreement by and between the Company and Executive or any general indemnification policy in favor of Executive, which shall continue and remain in full force and effect.

13. Governing Law. The validity, interpretation, construction and performance of this Agreement shall be governed by the laws of the State of Tennessee, without regard to its conflict of laws principles, to the extent federal law does not apply.

14. Resolution of Disputes. Any dispute or claim arising out of or relating to this Agreement shall be settled by final and binding arbitration in Johnson City, Tennessee in accordance with the Commercial Arbitration rules of the American Arbitration Association, and judgment upon the award rendered by the arbitrators may be entered in any court having jurisdiction thereof. The fees and expenses of the arbitration panel shall be equally borne by the Company and Executive. Each party shall be liable for its own costs and expenses as a result of any dispute related to this Agreement.

7

Exhibit 10.2

15. Validity. The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of the other provisions of this Agreement, which latter provisions shall remain in full force and effect.

16. Compliance with Section 409A.

(a) General. It is intended that the Agreement will comply with Section 409A of the Code and the regulations and other guidance thereunder (“Section 409A”), and the Agreement shall be interpreted consistent with such intent. As permitted by Section 409A, each installment or other payment made or benefit provided hereunder shall be treated as “separate payment” for purposes of Section 409A and the available exemptions under Section 409A shall be stacked to the maximum extent possible. This Agreement may be amended in any respect deemed necessary (including retroactively) by the Company in order to pursue compliance with Section 409A. The foregoing shall not be construed as a guarantee of any particular tax effect for benefits under this Agreement. The Executive or any beneficiary, as applicable, is solely responsible and liable for the satisfaction of all taxes, interest and penalties that may be imposed on the Executive or any beneficiary in connection with any payments to the Executive or beneficiary under the Agreement, including any taxes, interest and penalties under Section 409A, and neither the Company nor any director, officer or affiliate shall have any obligation to indemnify or otherwise hold the Executive or a beneficiary harmless from any and all of such taxes, interest and penalties. To the extent Executive is entitled to be paid or reimbursed for any taxable expenses under this Agreement, and such payments or reimbursements are includible in Executive’s federal gross taxable income, the amount of such expenses reimbursable in any one calendar year shall not affect the amount reimbursable in any other calendar year, and the reimbursement of an eligible expense shall be made no later than December 31 of the year after the year in which the expense was incurred. Executive’s right to reimbursement of expenses under this Agreement shall not be subject to liquidation or exchange for another benefit.

(b) Six Month Delay for Specified Employees. Notwithstanding anything in the Agreement to the contrary, if the Executive is determined to be a “specified employee” (as defined in Section 409A) for the year in which the Executive incurs a Separation from Service, any payment due under the Agreement that is not permitted to be paid on the date of such separation without the imposition of additional taxes, interest and penalties under Section 409A shall be paid on the first business day following the six-month anniversary of the Executive's date of separation or, if earlier, the Executive's death.

17. No Adequate Remedy At Law. The Company and the Executive recognize that each party may have no adequate remedy at law for breach by the other of any of the agreements contained herein, and particularly a breach of paragraphs 2, 3, 4, and 6, and, in the event of any such breach, the Company and the Executive hereby agree and consent that the other shall be entitled to injunctive relief or other appropriate remedy to enforce performance of such agreements.

18. Non-Assignability. This Agreement, and the rights and obligations of the parties hereunder, are personal and neither this Agreement, nor any right, benefit or obligation of either party hereto, shall

8

Exhibit 10.2

be subject to voluntary or involuntary assignment, alienation or transfer, whether by operation of law or otherwise, without the prior written consent of the other party; provided, however, that the Company may assign this Agreement in connection with a merger or consolidation involving the Company or a sale of substantially all of its assets to the surviving corporation or purchaser, as the case may be, so long as such assignee assumes the Company’s obligations hereunder.

19. Headings. The section headings contained in this Agreement are for convenience of reference only and will not be deemed to control or affect the meaning or construction of any provision of this Agreement. Reference to paragraphs are to paragraphs in this Agreement.

20. Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original, but of which together will constitute one and the same instrument.

21. Definitions. For purposes of this Agreement, the following terms shall have the following meanings:

(a)    “Cause” means any of the following:

(i) the failure of the Executive to perform the Executive’s duties under this Agreement (other than as a result of physical or mental illness or injury), which failure, if correctable, and provided it does not constitute willful misconduct or gross negligence, remains uncorrected for 10 days following written notice to Executive by the Chief Executive Officer or the Board of Directors of the Company of such breach;

(ii) willful misconduct or gross negligence by the Executive in either case that results in material damage to the business or reputation of the Company;

(iii) a material breach by Executive of this Agreement which, if correctable, remains uncorrected for 10 days following written notice to Executive by the Chief Executive Officer or the Board of Directors of the Company of such breach; or

(iv) the Executive is convicted of a felony or any other crime (other than traffic violations) involving moral turpitude (whether or not in connection with the performance by Executive of his duties under this Agreement).

(b)    “Change in Control” means, and shall occur on the date that any of the following occurs:

(i) A person, corporation, entity or group (1) makes a tender or exchange offer for the issued and outstanding voting stock of NN, Inc., (“NN”) and beneficially owns fifty percent (50%) or more of the issued and outstanding voting stock of NN after such tender or exchange offer, or (2) acquires (or has acquired during the 12-month period ending on the date of the most recent acquisition by such person, corporation, entity or group), directly or indirectly, the beneficial ownership of fifty percent (50%) or

9

Exhibit 10.2

more of the issued and outstanding voting stock of NN in a single transaction or a series of transactions (other than any person, corporation, entity or group for which a Schedule 13G is on file with the Securities and Exchange Commission, so long as such person, corporation, entity or group has beneficial ownership of less than fifty percent (50%) of the issued and outstanding voting stock of NN); or

(ii) NN is a party to a merger, consolidation or similar transaction and following such transaction, fifty percent (50%) or more of the issued and outstanding voting stock of the resulting entity is not beneficially owned by those persons, corporations or entities that constituted the stockholders of NN immediately prior to the transaction;

(iii) NN sells fifty percent (50%) or more of its assets to any other person or persons (other than an affiliate or affiliates of NN); or

(iv) Individuals who, during any 12-month period, constitute the Board (the “Incumbent Board”) cease for any reason to constitute at least seventy-five percent (75%) of the Board of Directors of NN; provided, however, that any individual becoming a director whose election or nomination was approved by a majority of the directors than comprising the Incumbent Board, shall be considered a member of the Incumbent Board, but not including any individual whose initial board membership is a result of an actual or threatened election contest (as that term is used in Rule 14a-11 promulgated under the Securities Act of 1934, as amended) or an actual or threatened solicitation of proxies or consents by or on behalf of a party other than the Board.

It is not intended that a Change in Control, in and of itself, will serve as an event which entitles Executive to any payment hereunder.

(c) “Code” means the Internal Revenue Code of 1986 as amended.

(d) “Disability” means the Executive (i) is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than twelve (12) months; or (ii) is, by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than twelve (12) months, receiving income replacement benefits for a period of not less than three (3) months under an accident and health plan covering employees or directors of the Company. Executive will be deemed Disabled if he is determined to be totally disabled by the Social Security Administration, or if Executive is determined to be disabled in accordance with a disability insurance program maintained by the Company if the definition of “disability” applied under such disability insurance program complies with the requirements of the preceding sentence. Upon the request of the plan administrator, the Executive must submit proof to the plan administrator of the Social Security Administration’s or the provider’s determination.

10

Exhibit 10.2

(e) “Good Reason” means any of the following events if not remedied by the Company within 30 days after receipt of notice thereof from the Executive: (i) assignment to the Executive of any duties inconsistent with Executive’s position duties, responsibilities, office, or any other action by the Company that results in a material diminution in the Executive’s position, authority, duties or responsibilities; (ii) any material failure by the Company to comply with this Agreement; (iii) any material adverse change in Executive’s annual compensation and other benefits; or (iv) a requirement to relocate Executive’s place of employment in excess of fifty (50) miles from the current principal office of the Company as of the date hereof.

Notwithstanding anything in this definition to the contrary, an alleged act by the Company shall not constitute a “Good Reason” event for purposes of this Agreement unless Executive gives written notice of the same to the Company within 60 days of the initial existence of such act. Further, for avoidance of doubt, nothing in this Agreement shall preclude the Company from reducing Executive’s annual base salary and/or incentive opportunity as part of an across-the-board compensation adjustment to other employees at Executive’s level of employment.

(f) “Notice of Termination” means a written notice which shall include the specific termination provision under this Agreement relied upon, and shall set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Executive’s employment. Any purported termination of the Executive’s employment hereunder by action of either party shall be communicated by delivery of a Notice of Termination to the other party. Any termination by Executive of his employment without Good Reason shall be made on not less than 14 days’ notice.

(g) “Qualifying Termination” means a Separation from Service by action of the Company that is not for Cause, or a Separation from Service by action of the Executive that is for Good Reason.

(h) “Restrictive Period” means (i) a number of months following Executive’s termination of employment pursuant to paragraph 1(a) or 1(c) above which is equal to the number of months for which the Executive is entitled to receive his base salary under paragraph 1(a) or 1(c) above, or a period of 12 months following Executive’s termination of employment pursuant to paragraph 1(b) above.

(i) “Separation from Service” means Executive’s “separation from service” as defined in Treasury Regulation Section 1.409A-1(h).

11

Exhibit 10.2

IN WITNESS WHEREOF, the Executive and the Company (by action of its duly authorized officers) have executed this Agreement as of the date first above written.

NN, INC.

By:Richard D. Holder
Name: Richard D. Holder
Title: President and Chief Executive Officer

EXECUTIVE:

/s/ J. Robbie Atkinson

Name:_J. Robbie Atkinson

12

Exhibit 10.2

SCHEDULE A

Executive’s Severance Payment subsequent to a Change in Control as provided in paragraph 1(c)(i) shall be a lump sum payment equal to:

1. 2.0 times Executive’s base salary (as of the date of Executive’s termination); plus

2. 1.0 times Executive’s target bonus.

22543288.2

13

EX-31.1

Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

I, Richard D. Holder, certify that:

1) I have reviewed this quarterly report on Form 10-Q of NN, Inc.;

2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4) The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of the annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5) The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

May 10, 2019	/s/ Richard D. Holder
	Richard D. Holder
	President, Chief Executive Officer and Director
	(Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

I, Thomas C. Burwell, Jr., certify that:

1) I have reviewed this quarterly report on Form 10-Q of NN, Inc.;

2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4) The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of the annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5) The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

May 10, 2019	/s/ Thomas C. Burwell, Jr.
	Thomas C. Burwell, Jr.
	Senior Vice President – Chief Financial Officer
	(Principal Financial Officer)

EX-32.1

Exhibit 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT

TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of NN, Inc. (the “Company”) on Form 10-Q for the interim period ended March 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacity and date indicated below, hereby certifies pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge: (1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods indicated.

May 10, 2019	/s/ Richard D. Holder
	Richard D. Holder
	President, Chief Executive Officer and Director (Principal Executive Officer)

EX-32.2

Exhibit 32.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT

TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of NN, Inc. (the “Company”) on Form 10-Q for the interim period ended March 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacity and date indicated below, hereby certifies pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge: (1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods indicated.

May 10, 2019	/s/ Thomas C. Burwell, Jr.
	Thomas C. Burwell, Jr.
	Senior Vice President – Chief Financial Officer (Principal Financial Officer)

XML

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2019	May 03, 2019
Document And Entity Information [Abstract]
Entity Registrant Name	NN INC
Entity Central Index Key	0000918541
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Document Type	10-Q
Trading Symbol	NNBR
Document Period End Date	Mar. 31, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Common Stock, Shares Outstanding		42,366,961

XML

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Income Statement [Abstract]
Net sales	$ 213,256	$ 169,148
Cost of sales (exclusive of depreciation and amortization shown separately below)	161,269	126,444
Selling, general and administrative expense	28,125	22,177
Acquisition related costs excluded from selling, general and administrative expense	0	1,776
Depreciation and amortization	23,425	14,281
Restructuring and integration expense	(12)	755
Other operating (income) expense, net	(152)	22
Income from operations	601	3,693
Interest expense	13,801	11,996
Loss on extinguishment of debt and write-off of debt issuance costs	2,699	0
Other (income) expense, net	729	(313)
Loss before (provision) benefit for income taxes and share of net income from joint venture	(16,628)	(7,990)
(Provision) benefit for income taxes	(2,241)	1,176
Share of net income from joint venture	269	831
Net loss	(18,600)	(5,983)
Other comprehensive income (loss):
Change in fair value of interest rate swap, net of tax	(3,856)	0
Foreign currency translation gain	1,262	5,465
Other comprehensive income (loss)	(2,594)	5,465
Comprehensive loss	$ (21,194)	$ (518)
Basic net loss per share
Net loss per share (in dollars per share)	$ (0.44)	$ (0.22)
Weighted average shares outstanding (in shares)	41,972	27,597
Diluted net loss per share
Net loss per share (in dollars per share)	$ (0.44)	$ (0.22)
Weighted average shares outstanding (in shares)	41,972	27,597

XML

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Current assets:
Cash and cash equivalents	$ 20,269	$ 17,988
Accounts receivable, net	147,131	133,421
Inventories	128,922	122,615
Income tax receivable	653	946
Other current assets	17,475	21,901
Total current assets	314,450	296,871
Property, plant and equipment, net	352,923	361,028
Finance lease right-of-use assets	12,886
Operating lease right-of-use assets	68,458
Goodwill	440,169	439,452
Intangible assets, net	363,608	376,248
Investment in joint venture	21,087	20,364
Other non-current assets	7,412	7,607
Total assets	1,580,993	1,501,570
Current liabilities:
Accounts payable	74,348	65,694
Accrued salaries, wages and benefits	27,990	24,636
Current maturities of long-term debt	33,444	31,280
Current portion of operating lease liability	7,630	0
Other current liabilities	21,700	23,420
Total current liabilities	165,112	145,030
Deferred tax liabilities	87,993	93,482
Non-current income tax payable	3,875	3,875
Long-term debt, net of current portion	826,274	811,471
Operating lease liability, net of current portion	66,975
Other non-current liabilities	35,855	29,417
Total liabilities	1,186,084	1,083,275
Commitments and contingencies (Note 12)
Common stock - $0.01 par value, authorized 45,000 shares, 42,367 and 42,104 shares issued and outstanding at March 31, 2019 and December 31, 2018, respectively	424	421
Additional paid-in capital	512,274	511,545
Retained deficit	(83,570)	(62,046)
Accumulated other comprehensive loss	(34,219)	(31,625)
Total stockholders’ equity	394,909	418,295
Total liabilities and stockholders’ equity	$ 1,580,993	$ 1,501,570

XML

Condensed Consolidated Balance Sheets - Parenthetical - $ / shares	Mar. 31, 2019	Dec. 31, 2018
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	45,000,000	45,000,000
Common stock, shares issued (in shares)	42,367,000	42,104,000
Common stock, shares outstanding (in shares)	42,367,000	42,104,000

XML

Condensed Consolidated Statement of Changes in Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	AOCI Attributable to Parent
Beginning balance (in shares) at Dec. 31, 2017		27,572,000
Beginning balance at Dec. 31, 2017	$ 486,104	$ 275	$ 292,494	$ 211,080	$ (17,745)
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]
Net loss	(5,983)			(5,983)
Cash dividends declared	(1,955)			(1,955)
Share-based compensation expense (in shares)		87,000
Share-based compensation expense	1,256	$ 1	1,255
Shares issued for option exercises (in shares)		23,000
Shares issued for option exercises	242		242
Restricted shares and performance shares forgiven for taxes and forfeited (in shares)		(16,000)
Restricted shares and performance shares forgiven for taxes and forfeited	(287)		(287)
Change in fair value of interest rate swap, net of tax of $1,104	0
Foreign currency translation gain	5,465				5,465
Ending balance (in shares) at Mar. 31, 2018		27,666,000
Ending balance at Mar. 31, 2018	484,859	$ 276	293,704	203,159	(12,280)
Beginning balance (in shares) at Dec. 31, 2018		42,104,000
Beginning balance at Dec. 31, 2018	418,295	$ 421	511,545	(62,046)	(31,625)
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]
Net loss	(18,600)			(18,600)
Cash dividends declared	(2,942)			(2,942)
Share-based compensation expense (in shares)		281,000
Share-based compensation expense	$ 873	$ 3	870
Shares issued for option exercises (in shares)	0
Restricted shares and performance shares forgiven for taxes and forfeited (in shares)		(18,000)
Restricted shares and performance shares forgiven for taxes and forfeited	$ (141)		(141)
Change in fair value of interest rate swap, net of tax of $1,104	(3,856)				(3,856)
Foreign currency translation gain	1,262				1,262
Ending balance (in shares) at Mar. 31, 2019		42,367,000
Ending balance at Mar. 31, 2019	$ 394,909	$ 424	$ 512,274	$ (83,570)	$ (34,219)

XML

Condensed Consolidated Statement of Changes in Stockholders' Equity (Parenthetical) $ in Thousands	3 Months Ended
	Mar. 31, 2019 USD ($)
Statement of Stockholders' Equity [Abstract]
Change in fair value interest rate swap, tax	$ 1,104

XML

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash flows from operating activities
Net loss	$ (18,600)	$ (5,983)
Adjustments to reconcile net loss to net cash provided by (used by) operating activities:
Depreciation and amortization	23,425	14,281
Amortization of debt issuance costs	1,191	1,088
Loss on extinguishment of debt and write-off of debt issuance costs	2,699	0
Share of net income from joint venture, net of cash dividends received	(269)	(831)
Compensation expense from issuance of share-based awards	873	1,256
Deferred income taxes	(4,373)	0
Other	182	347
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	(13,963)	(9,433)
Inventories	(6,302)	(7,791)
Accounts payable	7,236	(296)
Income taxes receivable and payable, net	248	(613)
Other	4,941	7,001
Net cash used by operating activities	(2,712)	(974)
Cash flows from investing activities
Acquisition of property, plant and equipment	(14,073)	(11,860)
Proceeds from liquidation of short-term investment	8,000	0
Cash paid to acquire businesses, net of cash received	0	(14,676)
Cash paid for earnest money for Paragon Medical acquisition	0	(6,000)
Other	2,394	(282)
Net cash used by investing activities	(3,679)	(32,818)
Cash flows from financing activities
Cash paid for debt issuance or prepayment costs	(738)	0
Dividends paid	(2,947)	(1,931)
Proceeds from long-term debt	19,025	10,000
Repayment of long-term debt	(7,522)	(13,000)
Proceeds from (repayments of) short-term debt, net	1,982	(52)
Other	(924)	(1,278)
Net cash provided by (used by) financing activities	8,876	(6,261)
Effect of exchange rate changes on cash flows	(204)	562
Net change in cash and cash equivalents	2,281	(39,491)
Cash and cash equivalents at beginning of period	17,988	224,446
Cash and cash equivalents at end of period	20,269	184,955
Supplemental schedule of non-cash operating, investing and financing activities
Non-cash additions to property, plant and equipment	$ 4,071	$ 2,992

XML

Interim Financial Statements

3 Months Ended

Mar. 31, 2019

Quarterly Financial Information Disclosure [Abstract]

Interim Financial Statements

Interim Financial Statements

Nature of Business

NN, Inc., is a global diversified industrial company that combines advanced engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision components and assemblies for the medical, aerospace and defense, electrical, automotive, and general industrial markets. As used in this Quarterly Report on Form 10-Q, the terms “NN,” the “Company,” “we,” “our,” or “us” refer to NN, Inc., and its subsidiaries. As of March 31, 2019, we had 51 facilities in North America, Europe, South America, and China.

Basis of Presentation

The accompanying condensed consolidated financial statements have not been audited, except that the Condensed Consolidated Balance Sheet as of December 31, 2018, was derived from the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2018 (the “2018 Annual Report”), which we filed with the U.S. Securities and Exchange Commission (the “SEC”), on March 18, 2019. In management’s opinion, the accompanying unaudited condensed consolidated financial statements reflect all adjustments necessary to fairly state our results of operations for the three months ended March 31, 2019 and 2018; financial position as of March 31, 2019, and December 31, 2018; and cash flows for the three months ended March 31, 2019 and 2018, on a basis consistent with our audited consolidated financial statements other than the adoption of new accounting standards, such as the new lease standard (see Note 10). These adjustments are of a normal recurring nature and are, in the opinion of management, necessary to state fairly the Company’s financial position and operating results for the interim periods.

Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) have been condensed or omitted from the interim financial statements presented in this Quarterly Report on Form 10-Q. These unaudited condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and accompanying notes included in the 2018 Annual Report. The results for the three months ended March 31, 2019, are not necessarily indicative of results for the year ending December 31, 2019, or any other future periods.

Except for per share data or as otherwise indicated, all U.S. dollar amounts presented in the tables in these Notes to Condensed Consolidated Financial Statements are in thousands.

Accounting Standards Recently Adopted

Leases. On January 1, 2019, we adopted Accounting Standards Codification (“ASC”) 842, Leases, which superseded ASC 840, Leases. We adopted ASC 842 utilizing the modified retrospective transition approach, therefore, historical financial information and disclosures do not reflect the new standard and will continue to be presented under the previous lease accounting guidance. Under the modified retrospective transition method, we recognized the cumulative effect of the initial adoption adjustment to the opening balance of retained deficit as of January 1, 2019. The adoption adjustment to retained deficit was less than $0.1 million. As part of the adoption of ASC 842, we elected the package of practical expedients, the short-term lease exemption, and the practical expedient to not separate lease and non-lease components. We recorded lease-related assets and liabilities to our balance sheet for leases with terms greater than twelve months that were classified as operating leases and not previously recorded on our balance sheet. See Note 10 for the required disclosures related to ASC 842.

Derivatives and Hedging. In August 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities, (“ASU 2017-12”). ASU 2017-12 provides new rules that expand the hedging strategies that qualify for hedge accounting. The new rules also allow additional time to complete hedge effectiveness testing and allow qualitative assessments subsequent to initial quantitative tests if there is supportable expectation that the hedge will remain highly effective. We adopted the guidance on January 1, 2019. We have applied the new rules to 2019 hedging activities as disclosed in Note 16 to these condensed consolidated financial statements. The new guidance has no effect on our historical financial statements.

Effects of Tax Reform in Other Comprehensive Income. In February 2018, the FASB issued guidance related to the impacts of the U.S. Tax Cuts and Jobs Act of 2017 (“Tax Act”). Under existing U.S. GAAP, the effects of changes in tax rates and laws on deferred tax balances are recorded as a component of income tax expense in the period in which the law was enacted. When deferred tax balances related to items originally recorded in accumulated other comprehensive income (“AOCI”) are adjusted, certain tax effects become stranded in AOCI. The FASB issued ASU 2018-2, Income Statement – Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income, that permits reclassification of certain income tax effects of the Tax Act from AOCI to retained earnings. The guidance also requires certain disclosures about stranded tax effects. The new guidance was effective for us on January 1, 2019. We adopted the new guidance at the beginning of the period of adoption. The new guidance had no effect on our financial statements.

Accounting Standards Not Yet Adopted

Fair Value Disclosures. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement, that modifies fair value disclosure requirements. The new guidance could impact us by streamlining disclosures of Level 3 fair value measurements. The modified disclosures are effective for NN beginning in the first quarter of 2020, with early adoption allowed. ASU 2018-13 changes only disclosures and does not impact our financial condition, results of operations, or cash flows. We are in the process of evaluating the effects of this guidance on our fair value disclosures.

Internal-Use Software. In August 2018, the FASB issued ASU 2018-15, Intangibles - Goodwill and Other - Internal-Use Software: Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (a consensus of the FASB Emerging Issues Task Force), that provides guidance on a customer’s accounting for implementation, set-up, and other upfront costs incurred in a cloud computing arrangement that is hosted by the vendor. Under the new guidance, customers will apply the same criteria for capitalizing implementation costs as they would for an arrangement that has a software license. ASU 2018-15 is effective for us on January 1, 2020, using either a prospective or retrospective approach and with early adoption permitted. We are in the process of evaluating the effects of this guidance on our financial statements.

XML

Acquisitions

3 Months Ended

Mar. 31, 2019

Business Combinations [Abstract]

Acquisitions

Acquisitions

Paragon Medical, Inc.

On May 7, 2018, we acquired 100% of the stock of PMG Intermediate Holding Corporation, the parent company of Paragon Medical, Inc. (“Paragon Medical”). For accounting purposes, Paragon Medical meets the definition of a business and has been accounted for as a business combination. Paragon Medical is a medical device manufacturer which focuses on the orthopedic, case and tray, implant, and instrument markets. This acquisition continues our strategic focus to expand our Life Sciences portfolio as well as create a balanced business by diversifying our products and finished device offerings. We have performed an assessment of the opening balance sheet which is subject to completion of our internal review procedures over fair value estimates. Opening balance sheet deferred taxes have been recorded based on estimates made as of the acquisition date as well as information currently available to management. As estimates are refined and additional information is received throughout the measurement period, adjustments to opening deferred taxes may be recorded with an offsetting adjustment to goodwill.

Beginning May 7, 2018, our consolidated results of operations include the results of Paragon Medical.

The unaudited pro forma financial results shown in the table below for the three months ended March 31, 2018, combine the consolidated results of NN and Paragon Medical giving effect to the Paragon Medical acquisition as if it had been completed on January 1, 2017. The unaudited pro forma financial results do not give effect to any of our other acquisitions that occurred after January 1, 2017, and do not include any anticipated synergies or other assumed benefits of the Paragon Medical acquisition. This unaudited pro forma financial information is presented for informational purposes only and is not indicative of future operations or results had the Paragon Medical acquisition been completed as of January 1, 2017.

The unaudited pro forma financial results include certain adjustments for debt service costs and additional depreciation and amortization expense based upon the fair value step-up and estimated useful lives of Paragon Medical depreciable fixed assets and definite-life amortizable assets acquired. The provision for income taxes has also been adjusted for all periods, based upon the foregoing adjustments to historical results.

	Three Months Ended March 31, 2018
Pro forma net sales	$	209,830
Pro forma net loss	$	(8,077	)
Basic net loss per share	$	(0.29	)
Diluted net loss per share	$	(0.29	)

Other Acquisitions

Bridgemedica, LLC. On February 22, 2018, we completed the acquisition of 100% of the assets of Bridgemedica, LLC (“Bridgemedica”). For accounting purposes, Bridgemedica meets the definition of a business and has been accounted for as a business combination. Bridgemedica is a medical device company that provides concept to supply solutions through design, development engineering, and manufacturing. Operating results of Bridgemedica are reported in our Life Sciences group after the acquisition date. We have finalized the purchase price allocation with no material changes to the initial allocation.

Southern California Technical Arts, Inc. On August 9, 2018, we completed the acquisition of 100% of the capital stock of Southern California Technical Arts, Inc. (“Technical Arts”). For accounting purposes, Technical Arts meets the definition of a business and has been accounted for as a business combination. Technical Arts is an industrial machining company that manufactures tight tolerance metal components and assemblies. The acquisition of Technical Arts expands our presence in the aerospace and defense end market. Operating results of Technical Arts are reported in our Power Solutions group after the acquisition date. We have completed a preliminary purchase price allocation and are in the process of finalizing the fair value of assets acquired and liabilities assumed.

XML

Segment Information

3 Months Ended

Mar. 31, 2019

Segment Reporting [Abstract]

Segment Information

Segment Information

We determined our reportable segments under the provisions of U.S. GAAP related to disclosures about segments of an enterprise. Management has concluded that Mobile Solutions, Power Solutions, and Life Sciences each constitutes an operating segment as each engages in business activities for which it earns revenues and incurs expenses for which separate financial information is available, and this is the level at which the Chief Operating Decision Maker (“CODM”) reviews discrete financial information for purposes of allocating resources and assessing performance.

Mobile Solutions

Mobile Solutions is focused on growth in the general industrial and automotive end markets. We have developed an expertise in manufacturing highly complex, system critical components for fuel systems, engines and transmissions, power steering systems, and electromechanical motors on a high-volume basis. This expertise has been gained through investment in technical capabilities, processes and systems, and skilled program management and product launch capabilities.

Power Solutions

Power Solutions is focused on growth in the electrical and aerospace and defense end markets. Within this group we combine materials science expertise with advanced engineering and production capabilities to design and manufacture a broad range of high-precision metal and plastic components, assemblies, and finished devices used in applications ranging from power control to flight control and for military devices.

We manufacture a variety of products including electrical contacts, connectors, contact assemblies, and precision stampings for the electrical end market and high precision products for the aerospace and defense end markets utilizing our extensive process technologies for optical grade plastics, thermally conductive plastics, titanium, Inconel, magnesium, and electroplating.

Life Sciences

Life Sciences is focused on growth in the medical end market. Within this group we combine advanced engineering and production capabilities to design and manufacture a broad range of high-precision metal and plastic components, assemblies, and finished devices.

We manufacture a variety of components, assemblies, and instruments, such as surgical knives, bioresorbable implants, surgical staples, cases and trays, orthopedic implants and tools, laparoscopic devices, and drug delivery devices for the medical and life sciences end market.

Segment Results

The following table presents results of operations for each reportable segment.

	Mobile Solutions		Power Solutions		Life Sciences		Corporate and Consolidations				Total
Three Months Ended March 31, 2019
Net sales	$	78,075	$	49,657	$	86,008	$	(484	)	(a)	$	213,256
Income (loss) from operations	$	4,107	$	3,824	$	3,846	$	(11,176	)		$	601
Interest expense											(13,801		)
Other											(3,428		)
Loss before provision for income taxes and share of net income from joint venture											$	(16,628	)
Three Months Ended March 31, 2018
Net sales	$	89,794	$	48,682	$	31,200	$	(528	)	(a)	$	169,148
Income (loss) from operations	$	9,785	$	5,233	$	4,204	$	(15,529	)		$	3,693
Interest expense											(11,996		)
Other											313
Loss before benefit for income taxes and share of net income from joint venture											$	(7,990	)

_______________________________

(a) Includes elimination of intersegment transactions occurring during the ordinary course of business.

	Total Assets as of
	March 31, 2019		December 31, 2018
Mobile Solutions	$	392,100	$	356,387
Power Solutions	311,771		297,947
Life Sciences	824,891		802,770
Corporate and Consolidations	52,231		44,466
Total	$	1,580,993	$	1,501,570

XML

Inventories

3 Months Ended

Mar. 31, 2019

Inventory Disclosure [Abstract]

Inventories

Inventories

Inventories are comprised of the following amounts:

	March 31, 2019		December 31, 2018
Raw materials	$	55,286	$	52,930
Work in process	47,372		42,578
Finished goods	26,264		27,107
Total inventories	$	128,922	$	122,615

XML

Goodwill

3 Months Ended

Mar. 31, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill

Goodwill

The following table shows changes in the carrying amount of goodwill.

	Mobile Solutions		Power Solutions		Life Sciences		Total
Balance as of December 31, 2018	$	—	$	94,505	$	344,947	$	439,452
Currency impacts	—		198		519		717
Balance as of March 31, 2019	$	—	$	94,703	$	345,466	$	440,169

Based on the closing price of a share of our common stock as of March 31, 2019, our market capitalization had declined to a level that is less than the net book value of our stockholders’ equity. A prolonged or significant decline in market capitalization could be an indicator of additional goodwill impairment. We will continue to monitor our market capitalization to determine if an indicator of impairment exists in subsequent periods.

During 2018, as a result of our annual goodwill impairment analysis performed during the fourth quarter of 2018, we recorded an impairment of $109.1 million in our Power Solutions group. After the impairment, Power Solutions reported a goodwill balance of $94.5 million at December 31, 2018. Given the carrying value of the Power Solutions reporting unit was equal to its fair value at December 31, 2018 as a result of the 2018 goodwill impairment, if actual performance of the Power Solutions reporting unit falls short of expected results, additional material impairment charges may be required. During the first quarter of 2019, we reassessed the relevant facts and circumstances and concluded there was no impairment during the period. We will continue to monitor and assess Power Solutions during 2019.

XML

Intangible Assets, Net

3 Months Ended

Mar. 31, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets

Intangible Assets, Net

The following table shows changes in the carrying amount of intangible assets, net.

	Mobile Solutions			Power Solutions			Life Sciences			Total
Balance as of December 31, 2018	$	35,892		$	95,991		$	244,365		$	376,248
Amortization	(885		)	(2,748		)	(9,017		)	(12,650		)
Other	2			—			8			10
Balance as of March 31, 2019	$	35,009		$	93,243		$	235,356		$	363,608

XML

Investment in Joint Venture

3 Months Ended

Mar. 31, 2019

Equity Method Investments and Joint Ventures [Abstract]

Investment in Joint Venture

Investment in Joint Venture

We own a 49% investment in Wuxi Weifu Autocam Precision Machinery Company, Ltd. (the “JV”), a joint venture located in Wuxi, China. The JV is jointly controlled and managed, and we account for it under the equity method.

The following table summarizes activity related to our investment in the JV.

Balance as of December 31, 2018	$	20,364
Share of earnings	269
Foreign currency translation gain	454
Balance as of March 31, 2019	$	21,087

During the fourth quarter of 2018, as a result of changing market conditions, the fair value of the JV was assessed and we recorded an impairment charge of $16.6 million against our investment in the JV. The fair value assessment was most significantly affected by changes in our assessment of future growth rates. It is reasonably possible that material deviation of future performance from the estimates used in the 2018 valuation could result in further impairment to our investment in the JV in subsequent periods. There was no impairment of our investment in the JV during the three months ended March 31, 2019.

We recognized sales to the JV of less than $0.1 million and $0.1 million during the three months ended March 31, 2019 and 2018, respectively.

XML

Income Taxes

3 Months Ended

Mar. 31, 2019

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

Our effective tax rate was (13.5)% for the three months ended March 31, 2019, and 14.7% for the three months ended March 31, 2018. Our 2019 effective tax rate differs from the U.S. federal statutory tax rate of 21% principally due to a discrete tax charge of $6.0 million related to final tax regulations published by the Department of the Treasury and Internal Revenue Service on February 4, 2019. The 2019 effective tax rate was also impacted by the minimum tax on global intangible low-tax income (“GILTI”) and earnings outside the United States, which are taxed at different rates than the U.S. federal statutory tax rate of 21%.

Our 2018 effective tax rate differed from the U.S. federal statutory tax rate of 21% due to permanent differences including GILTI and earnings outside the United States, which were taxed at different rates than the U.S. federal statutory rate of 21%.

XML

Debt

3 Months Ended

Mar. 31, 2019

Debt Disclosure [Abstract]

Debt

Debt

Collectively, our credit facility is comprised of a term loan with a face amount of $545.0 million, maturing on October 19, 2022 (the “Senior Secured Term Loan”); a term loan with a face amount of $300.0 million, maturing on April 3, 2021 (the Incremental Term Loan”); and a revolving line of credit with a face amount of $143.0 million, maturing on October 19, 2020 (the “Senior Secured Revolver”). The credit facility is collateralized by all of our assets.

The following table presents debt balances as of March 31, 2019, and December 31, 2018.

	March 31, 2019		December 31, 2018
Senior Secured Term Loan	$	530,625	$	532,063
Incremental Term Loan	276,000		279,000
Senior Secured Revolver	56,184		38,720
International lines of credit and other loans	10,601		9,810
Total principal	873,410		859,593
Less—current maturities of long-term debt	33,444		31,280
Principal, net of current portion	839,966		828,313
Less—unamortized debt issuance costs	13,692		16,842
Long-term debt, net of current portion	$	826,274	$	811,471

We capitalized interest costs amounting to $0.6 million and $0.2 million in the three months ended March 31, 2019 and 2018, respectively, related to construction in progress.

Senior Secured Term Loan

Outstanding borrowings under the Senior Secured Term Loan bear interest at the greater of 0.75% or one-month London Interbank Offered Rate (“LIBOR”) plus an applicable margin of 3.75%. At March 31, 2019, the Senior Secured Term Loan bore interest at 6.24%.

Incremental Term Loan

Outstanding borrowings under the Incremental Term Loan bear interest at one-month LIBOR plus an applicable margin of 3.25%. At March 31, 2019, the Incremental Term Loan bore interest of 5.74%.

Senior Secured Revolver

Outstanding borrowings under the Senior Secured Revolver bear interest at one-month LIBOR plus an applicable margin of 3.50%. At March 31, 2019, the Senior Secured Revolver bore interest of 5.99%. We pay an annual commitment fee of 0.50% for unused capacity under the Senior Secured Revolver on a quarterly basis.

Total available capacity under the Senior Secured Revolver was $125.0 million as of March 31, 2019. Our credit facility is subject to certain financial covenants based on a consolidated net leverage ratio, as defined in the credit facility agreement. The financial covenants are effective when we have outstanding borrowings under our Senior Secured Revolver on the last day of any fiscal quarter, become more restrictive over time, and are dependent upon our operational and financial performance. If our operational or financial performance is below our expectations, we may be required to take actions to reduce expenditures and decrease our net indebtedness to maintain compliance in future periods. We had $56.2 million outstanding under the Senior Secured Revolver at March 31, 2019, and we were in compliance with all covenants under our credit facility.

On March 15, 2019, we amended our existing credit facility (the “March 2019 amendment”) to amend the defined terms within the credit facility. We paid $0.8 million of debt issuance costs related to the March 2019 amendment which was recorded as a direct reduction to the carrying amount of the associated long-term debt. We also wrote-off $2.7 million of unamortized debt issuance costs related to the modification of the credit facility.

Derivative Instruments and Hedging Activities

In February 2019, we entered into a $700.0 million amortizing notional amount fixed-rate interest rate swap agreement to manage the interest rate risk associated with our long-term variable-rate debt until 2022. The fixed-rate interest rate swap agreement calls for us to receive interest monthly at a variable rate equal to one-month LIBOR and to pay interest monthly at a fixed rate of 2.4575%. Refer to Note 16 for further discussion of the interest rate swap agreement.

XML

Leases

3 Months Ended

Mar. 31, 2019

Leases [Abstract]

Leases

Leases

We adopted ASC 842 on January 1, 2019, and elected the modified retrospective approach in which the new standard is applied to all leases existing at the date of adoption through a cumulative-effect adjustment of less than $0.1 million to retained deficit. Consequently, financial information is not updated, and the disclosures required under the new standard are not provided for periods prior to January 1, 2019.  As part of the adoption, we elected the package of practical expedients, the short-term lease exemption, and the practical expedient to not separate lease and non-lease components permitted within ASC 842. Accordingly, we accounted for our existing operating leases as operating leases under the new standard, without reassessing (a) whether the contracts contain a lease under ASC 842, (b) whether classification of the operating leases would be different in accordance with ASC 842, or (c) whether any unamortized initial direct costs would have met the definition of initial direct costs in ASC 842 at lease commencement.

We determine whether an arrangement is a lease at inception. Right-of-use (“ROU”) lease assets represent our right to use an underlying asset for the lease term, and lease obligations represent our obligation to make lease payments arising from the lease. ROU lease assets and obligations are recognized at the lease commencement date based on the present value of lease payments over the lease term. When the implicit rate is not readily determinable, we use the estimated incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. The lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Amortization of ROU lease assets is recognized in expense on a straight-line basis over the lease term.

Short-term leases are leases having a term of twelve months or less. We recognize short-term leases on a straight-line basis and do not record a related lease asset or liability for such leases. Finance lease ROU assets consist of equipment used in the manufacturing process with terms between thirteen months and five years. Operating lease ROU assets consist of the following:

• Equipment used in the manufacturing process as well as office equipment with terms between thirteen months and five years.

• Manufacturing plants and office facilities with terms between thirteen months and 25 years.

The following table presents components of lease expense for the three months ended March 31, 2019:

	Financial Statement Line Item	Three Months Ended March 31, 2019
Lease cost:
Finance lease cost
Amortization of right-of-use assets	Depreciation and amortization	$	322
Interest expense	Interest expense	53
Operating lease cost	Cost of sales and selling, general and administrative expense	3,434
Short-term lease cost (1)	Cost of sales and selling, general and administrative expense	107
Total lease cost		$	3,916

_______________________________

(1) Excludes expenses related to leases with a lease term of one month or less.

The following table presents the lease-related assets and liabilities recorded on the balance sheet as of March 31, 2019:

	Financial Statement Line Item	March 31, 2019
Lease assets and liabilities:
Assets
Operating lease assets	Operating lease right-of-use assets	$	68,458
Finance lease asset	Finance lease right-of-use assets	12,886
Total lease assets		$	81,344
Liabilities
Current liabilities
Operating lease liabilities	Current portion of operating lease liability	$	7,630
Finance lease liabilities	Other current liabilities	2,401
Non-current liabilities
Operating lease liabilities	Operating lease liability, net of current portion	66,975
Finance lease liabilities	Other non-current liabilities	6,150
Total lease liabilities		$	83,156

The following table contains supplemental information related to leases for the three months ended March 31, 2019:

Supplemental Cash Flows Information	Three Months Ended March 31, 2019
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from finance leases	$	53
Operating cash flows from operating leases	5,288
Financing cash flows from finance leases	792
Right-of-use assets obtained in exchange for new operating lease liabilities	$	2,836

As of March 31, 2019, the weighted average remaining lease term and weighted-average discount rate for finance and operating leases was as follows:

	Weighted-Average Remaining Lease Term (years)	Weighted-Average Discount Rate
Finance leases	4.1	2.4	%
Operating leases	10.5	8.5	%

The future minimum lease obligations with noncancelable terms in excess of twelve months as of March 31, 2019, is as follows:

	Operating Leases		Finance Leases
2019 (1)	$	10,104	$	2,190
2020	11,979		2,033
2021	11,118		2,020
2022	10,812		1,853
2023	9,264		962
Thereafter	59,946		17
Total future minimum lease payments	113,223		9,075
Less: imputed interest	38,618		524
Total lease liabilities	$	74,605	$	8,551

(1) For the period from April 1, 2019 to December 31, 2019.

As of March 31, 2019, we have an additional operating lease commitment that has not yet commenced that would require us to pay a total of approximately $21.9 million base rent payments over the lease term of 15 years. This lease is expected to commence during the fourth quarter of 2019.

The following table summarizes the future minimum lease payments under operating leases with initial or non-cancelable lease terms in excess of one year prior to adoption of ASC 842 as reported in our Annual Report on Form 10-K for the year ended December 31, 2018.

Year Ending December 31,
2019	$	13,337
2020	11,515
2021	10,557
2022	10,293
2023	8,752
Thereafter	53,945
Total minimum payments	$	108,399

During the three months ended March 31, 2018, we recognized rent expense of $2.1 million.

Leases

Leases

We adopted ASC 842 on January 1, 2019, and elected the modified retrospective approach in which the new standard is applied to all leases existing at the date of adoption through a cumulative-effect adjustment of less than $0.1 million to retained deficit. Consequently, financial information is not updated, and the disclosures required under the new standard are not provided for periods prior to January 1, 2019.  As part of the adoption, we elected the package of practical expedients, the short-term lease exemption, and the practical expedient to not separate lease and non-lease components permitted within ASC 842. Accordingly, we accounted for our existing operating leases as operating leases under the new standard, without reassessing (a) whether the contracts contain a lease under ASC 842, (b) whether classification of the operating leases would be different in accordance with ASC 842, or (c) whether any unamortized initial direct costs would have met the definition of initial direct costs in ASC 842 at lease commencement.

We determine whether an arrangement is a lease at inception. Right-of-use (“ROU”) lease assets represent our right to use an underlying asset for the lease term, and lease obligations represent our obligation to make lease payments arising from the lease. ROU lease assets and obligations are recognized at the lease commencement date based on the present value of lease payments over the lease term. When the implicit rate is not readily determinable, we use the estimated incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. The lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Amortization of ROU lease assets is recognized in expense on a straight-line basis over the lease term.

Short-term leases are leases having a term of twelve months or less. We recognize short-term leases on a straight-line basis and do not record a related lease asset or liability for such leases. Finance lease ROU assets consist of equipment used in the manufacturing process with terms between thirteen months and five years. Operating lease ROU assets consist of the following:

• Equipment used in the manufacturing process as well as office equipment with terms between thirteen months and five years.

• Manufacturing plants and office facilities with terms between thirteen months and 25 years.

The following table presents components of lease expense for the three months ended March 31, 2019:

	Financial Statement Line Item	Three Months Ended March 31, 2019
Lease cost:
Finance lease cost
Amortization of right-of-use assets	Depreciation and amortization	$	322
Interest expense	Interest expense	53
Operating lease cost	Cost of sales and selling, general and administrative expense	3,434
Short-term lease cost (1)	Cost of sales and selling, general and administrative expense	107
Total lease cost		$	3,916

_______________________________

(1) Excludes expenses related to leases with a lease term of one month or less.

The following table presents the lease-related assets and liabilities recorded on the balance sheet as of March 31, 2019:

	Financial Statement Line Item	March 31, 2019
Lease assets and liabilities:
Assets
Operating lease assets	Operating lease right-of-use assets	$	68,458
Finance lease asset	Finance lease right-of-use assets	12,886
Total lease assets		$	81,344
Liabilities
Current liabilities
Operating lease liabilities	Current portion of operating lease liability	$	7,630
Finance lease liabilities	Other current liabilities	2,401
Non-current liabilities
Operating lease liabilities	Operating lease liability, net of current portion	66,975
Finance lease liabilities	Other non-current liabilities	6,150
Total lease liabilities		$	83,156

The following table contains supplemental information related to leases for the three months ended March 31, 2019:

Supplemental Cash Flows Information	Three Months Ended March 31, 2019
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from finance leases	$	53
Operating cash flows from operating leases	5,288
Financing cash flows from finance leases	792
Right-of-use assets obtained in exchange for new operating lease liabilities	$	2,836

As of March 31, 2019, the weighted average remaining lease term and weighted-average discount rate for finance and operating leases was as follows:

	Weighted-Average Remaining Lease Term (years)	Weighted-Average Discount Rate
Finance leases	4.1	2.4	%
Operating leases	10.5	8.5	%

The future minimum lease obligations with noncancelable terms in excess of twelve months as of March 31, 2019, is as follows:

	Operating Leases		Finance Leases
2019 (1)	$	10,104	$	2,190
2020	11,979		2,033
2021	11,118		2,020
2022	10,812		1,853
2023	9,264		962
Thereafter	59,946		17
Total future minimum lease payments	113,223		9,075
Less: imputed interest	38,618		524
Total lease liabilities	$	74,605	$	8,551

(1) For the period from April 1, 2019 to December 31, 2019.

As of March 31, 2019, we have an additional operating lease commitment that has not yet commenced that would require us to pay a total of approximately $21.9 million base rent payments over the lease term of 15 years. This lease is expected to commence during the fourth quarter of 2019.

The following table summarizes the future minimum lease payments under operating leases with initial or non-cancelable lease terms in excess of one year prior to adoption of ASC 842 as reported in our Annual Report on Form 10-K for the year ended December 31, 2018.

Year Ending December 31,
2019	$	13,337
2020	11,515
2021	10,557
2022	10,293
2023	8,752
Thereafter	53,945
Total minimum payments	$	108,399

During the three months ended March 31, 2018, we recognized rent expense of $2.1 million.

XML

Restructuring and Integration

3 Months Ended

Mar. 31, 2019

Restructuring and Related Activities [Abstract]

Restructuring and Integration

Restructuring and Integration

The following table summarizes restructuring and integration charges incurred for the three months ended March 31, 2019 and 2018.

	Three Months Ended March 31, 2019
	Mobile Solutions			Power Solutions		Life Sciences		Corporate and Consolidations		Total
Severance and other employee costs	$	—		$	—	$	—	$	—	$	—
Site closure and other associated costs	(12		)	—		—		—		(12		)
Total	$	(12	)	$	—	$	—	$	—	$	(12	)
	Three Months Ended March 31, 2018
	Mobile Solutions			Power Solutions		Life Sciences		Corporate and Consolidations		Total
Severance and other employee costs	$	—		$	—	$	—	$	728	$	728
Site closure and other associated costs	27			—		—		—		27
Total	$	27		$	—	$	—	$	728	$	755

The following table summarizes restructuring and integration reserve activity for the three months ended March 31, 2019.

	Reserve Balance as of December 31, 2018		Charges			Non-cash Adjustments		Cash Reductions			Reserve Balance as of March 31, 2019
Severance and other employee costs	$	1,122	$	—		$	—	$	(274	)	$	848
Site closure and other associated costs	24		(12		)	—		(12		)	—
Total	$	1,146	$	(12	)	$	—	$	(286	)	$	848

The amount accrued for restructuring and integration costs represents what we expect to pay over the next 1.9 years. We expect to pay $0.5 million within the next twelve months.

XML

Commitments and Contingencies

3 Months Ended

Mar. 31, 2019

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Brazil ICMS Tax Matter

Prior to the acquisition of Autocam Corporation in 2014 (“Autocam”), Autocam’s Brazilian subsidiary (“Autocam Brazil”) received notification from the Brazilian tax authority regarding ICMS (state value added tax or “VAT”) tax credits claimed on intermediary materials (e.g., tooling and perishable items) used in the manufacturing process. The Brazilian tax authority notification disallowed state ICMS tax credits claimed on intermediary materials based on the argument that these items are not intrinsically related to the manufacturing processes. Autocam Brazil filed an administrative defense with the Brazilian tax authority arguing, among other matters, that it should qualify for an ICMS tax credit, contending that the intermediary materials are directly related to the manufacturing process.

We believe that we have substantial legal and factual defenses, and we plan to defend our interests in this matter vigorously. The matter encompasses several lawsuits filed with the Brazilian courts requesting declaratory actions that no tax is due or seeking a stay of execution on the collection of the tax. In 2018, we obtained a favorable decision in one of the declaratory actions for which the period for appeal has expired. We have filed actions in each court requesting dismissal of the matter based on the earlier court action. Although we anticipate a favorable resolution to all matters, we can provide no assurances that we will be successful in achieving dismissal of all pending cases. While we believe a loss is not probable, we estimate the range of possible losses related to this assessment is from $0 to $6.0 million. Noamount was accrued at March 31, 2019, for this matter.

We are entitled to indemnification from the former shareholders of Autocam, subject to the limitations and procedures set forth in the agreement and plan of merger relating to the Autocam acquisition. Management believes the indemnification would include amounts owed for the tax, interest, and penalties related to this matter.

All Other Legal Matters

All other legal proceedings are of an ordinary and routine nature and are incidental to our operations. Management believes that such proceedings should not, individually or in the aggregate, have a material adverse effect on our business, financial condition, results of operations, or cash flows. In making that determination, we analyze the facts and circumstances of each case at least quarterly in consultation with our attorneys and determine a range of reasonably possible outcomes.

XML

Revenue from Contracts with Customers

3 Months Ended

Mar. 31, 2019

Revenue from Contract with Customer [Abstract]

Revenue from Contracts with Customers

Revenue from Contracts with Customers

Revenue is recognized when control of the good or service is transferred to the customer either at a point in time or, in limited circumstances, as our services are rendered over time. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or services. Sales, value add, and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. Incidental items that are immaterial in the context of the contract are recognized as expense.

The following tables summarize sales to external customers by major source.

	Three Months Ended March 31, 2019
	Mobile Solutions		Power Solutions		Life Sciences		Intersegment Sales Eliminations			Total
United States	$	44,457	$	41,115	$	68,343	$	(484	)	$	153,431
China	9,153		1,838		1,692		—			12,683
Mexico	5,378		2,709		127		—			8,214
Brazil	8,382		69		—		—			8,451
Germany	1,406		16		8,885		—			10,307
Switzerland	1,359		16		3,265		—			4,640
Poland	1,913		4		6		—			1,923
Italy	1,856		63		421		—			2,340
Czech Republic	1,509		188		—		—			1,697
France	44		—		1,225		—			1,269
Africa	—		1,156		—		—			1,156
Other	2,618		2,483		2,044		—			7,145
Total net sales	$	78,075	$	49,657	$	86,008	$	(484	)	$	213,256

	Three Months Ended March 31, 2018
	Mobile Solutions		Power Solutions		Life Sciences		Intersegment Sales Eliminations			Total
United States	$	49,655	$	40,128	$	30,553	$	(528	)	$	119,808
China	11,581		1,485		126		—			13,192
Mexico	7,236		3,197		172		—			10,605
Brazil	9,885		50		—		—			9,935
Poland	2,052		14		—		—			2,066
Czech Republic	1,810		—		—		—			1,810
Italy	1,577		98		—		—			1,675
Germany	1,534		7		1		—			1,542
Switzerland	1,406		—		—		—			1,406
Netherlands	—		974		—		—			974
Other	3,058		2,729		348		—			6,135
Total net sales	$	89,794	$	48,682	$	31,200	$	(528	)	$	169,148

Deferred Revenue

The following table provides information about contract liabilities from contracts with customers.

	Deferred Revenue
Balance at January 1, 2019	$	2,974
Balance at March 31, 2019	$	2,890

Revenue recognized during the three months ended March 31, 2019, from amounts included in deferred revenue at the beginning of the period for performance obligations satisfied or partially satisfied during the period, was approximately $0.6 million.

Transaction Price Allocated to Future Performance Obligations

We are required to disclose the aggregate amount of transaction price that is allocated to performance obligations that have not yet been satisfied as of March 31, 2019, unless our contracts meet one of the practical expedients. Our contracts met the following practical expedient provided by the guidance:

• The performance obligation is part of a contract that has an original expected duration of one year or less.

Sales Concentration

During the three months ended March 31, 2019, we recognized sales from a single customer of $23.3 million, or 10.9% of consolidated net sales. Revenues from this customer are in our Life Sciences and Power Solutions groups. No customers represented more than 10% of our net sales during the three months ended March 31, 2018.

XML

Shared-Based Compensation

3 Months Ended

Mar. 31, 2019

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Shared-Based Compensation

Shared-Based Compensation

The following table lists the components of share-based compensation expense by type of award.

	Three Months Ended March 31,
	2019		2018
Stock options	$	192	$	205
Restricted stock	459		460
Performance share units	222		591
Share-based compensation expense	$	873	$	1,256

Stock Options

During the three months ended March 31, 2019, we granted options to purchase 210,400 shares to certain key employees. The weighted average grant date fair value of the options granted during the three months ended March 31, 2019, was $2.77 per share. The fair value of our options cannot be determined by market value because they are not traded in an open market. Accordingly, we utilized the Black Scholes financial pricing model to estimate the fair value. 

The following table shows the weighted average assumptions relevant to determining the fair value of stock options granted in 2019.

	2019
Expected term	6 years
Risk free interest rate	2.47	%
Dividend yield	3.53	%
Expected volatility	49.53	%
Expected forfeiture rate	4.00	%

The expected term is derived from using the simplified method of determining stock option terms as described under the Staff Accounting Bulletin Topic 14, Share-based payment. The simplified method was used because sufficient historical stock option exercise experience was not available, primarily due to the transformation of the management structure over the past several years.

The average risk-free interest rate is derived from United States Department of Treasury published interest rates of daily yield curves for the same time period as the expected term.

The expected dividend yield is derived by a mathematical formula which uses the expected annual dividends over the expected term divided by the fair market value of our common stock at the grant date.

The expected volatility rate is derived from our actual common stock historical volatility over the same time period as the expected term. The volatility rate is derived by mathematical formula utilizing daily closing price data.

The forfeiture rate is determined from examining the historical pre-vesting forfeiture patterns of past option issuances to key employees. While the forfeiture rate is not an input of the Black Scholes model for determining the fair value of the options, it is an important determinant of stock option compensation expense to be recorded.

The following table summarizes stock option activity for the three months ended March 31, 2019.

	Number of Options (in thousands)		Weighted- Average Exercise Price (per share)		Weighted- Average Remaining Contractual Term (years)	Aggregate Intrinsic Value
Outstanding at January 1, 2019	771		$	15.17
Granted	210		7.93
Exercised	—					$	—
Forfeited or expired	(3	)	24.41
Outstanding at March 31, 2019	978		$	13.58	6.3	$	—	(1)
Exercisable at March 31, 2019	701		$	14.27	5.0	$	—	(1)

_______________________________

(1) The aggregate intrinsic value is the sum of intrinsic values for each exercisable individual option grant. The intrinsic value is the amount by which the closing market price of our stock at March 31, 2019, was greater than the exercise price of any individual option grant.

Restricted Stock

During the three months ended March 31, 2019, we granted 281,065 restricted stock awards to non-executive directors, officers and certain other key employees. The shares of restricted stock granted during the three months ended March 31, 2019, vest pro-rata over three years for officers and certain other key employees and over one year for non-executive directors. We determined the fair value of the shares awarded by using the closing price of our common stock as of the date of grant. The weighted average grant date value of restricted stock granted in the three months ended March 31, 2019, was $7.93 per share. Total grant-date fair value of restricted stock that vested in the three months ended March 31, 2019, was $1.5 million.

The following table summarizes the status of unvested restricted stock awards as of March 31, 2019, and changes during the three months then ended.

	Nonvested Restricted Shares (in thousands)		Weighted Average Grant-Date Fair Value (per share)
Nonvested at January 1, 2019	146		$	22.07
Granted	281		$	7.93
Vested	(70	)	$	20.92
Forfeited	(18	)	$	18.98
Nonvested at March 31, 2019	339		$	10.74

Performance Share Units

Performance Share Units (“PSUs”) are a form of long-term incentive compensation awarded to executive officers and certain other key employees designed to directly align the interests of employees to the interests of our stockholders, and to create long-term stockholder value. PSU awards granted in 2019 were made pursuant to the NN, Inc. 2016 Omnibus Incentive Plan and a Performance Share Unit Agreement (the “2016 Omnibus Agreement”). Some PSUs are based on total shareholder return (“TSR Awards”), and other PSUs are based on return on invested capital (“ROIC Awards”).

The TSR Awards vest, if at all, upon our achieving a specified relative total shareholder return, which will be measured against the total shareholder return of the S&P SmallCap 600 Index during specified performance periods as defined in the 2016 Omnibus Agreement. The ROIC Awards vest, if at all, upon our achieving a specified average return on invested capital during the performance periods. Each performance period generally begins on January 1 of the year of grant and ends 36 months later on December 31.

We recognize compensation expense over the performance period in which the performance and market conditions are measured. If the PSUs do not vest at the end of the performance periods, then the PSUs will expire automatically. Upon vesting, the PSUs will be settled by the issuance of shares of our common stock, subject to the executive officer’s continued employment. The actual number of shares of common stock to be issued to each award recipient at the end of the performance periods will be interpolated between a threshold and maximum payout amount based on actual performance results. No dividends will be paid on outstanding PSUs during the performance period; however, dividend equivalents will be paid based on the number of shares of common stock that are ultimately earned at the end of the performance periods.

With respect to the TSR Awards, a participant will earn 50% of the target number of PSUs for “Threshold Performance,” 100% of the target number of PSUs for “Target Performance,” and 150% of the target number of PSUs for “Maximum Performance.” With respect to the ROIC Awards, a participant will earn 35% of the target number of PSUs for “Threshold Performance,” 100% of the target number of PSUs for “Target Performance,” and 150% of the target number of PSUs for “Maximum Performance. For performance levels falling between the values shown below, the percentages will be determined by interpolation.

The following table presents the goals with respect to TSR Awards and ROIC Awards granted in 2019.

TSR Awards:	Threshold Performance (50% of Shares)		Target Performance (100% of Shares)		Maximum Performance (150% of Shares)
2019 grants	35th Percentile		50th Percentile		75th Percentile
ROIC Awards:	Threshold Performance (35% of Shares)		Target Performance (100% of Shares)		Maximum Performance (150% of Shares)
2019 grants (1)	4.7	%	5.8	%	7.0	%

(1) For the ROIC Awards granted in 2019, the denominator of the calculation is different than in prior years, and therefore the target percentages are not comparable to historical target percentages.

We estimate the grant date fair value of TSR Awards using the Monte Carlo simulation model, as the total shareholder return metric is considered a market condition under ASC Topic 718, Compensation – stock compensation. The grant date fair value of ROIC Awards is based on the closing price of a share of our common stock on the date of grant.

The following table presents the number of awards granted and the grant date fair value of each award in the period presented.

	TSR Awards			ROIC Awards
Award Year	Shares (in thousands)	Grant Date Fair Value (per share)		Shares (in thousands)	Grant Date Fair Value (per share)
2019	136	$	9.28	174	$	7.93

We recognize expense for ROIC Awards based on the probable outcome of the associated performance condition. We generally recognize an expense for ROIC Awards based on the Target Performance threshold of 100% because, at the date of grant, the Target Performance is the probable level of performance achievement.

The following table summarizes the status of unvested PSUs as of March 31, 2019, and changes during the three months then ended.

	Nonvested TSR Awards			Nonvested ROIC Awards
	Shares (in thousands)	Weighted Average Grant-Date Fair Value (per share)		Shares (in thousands)	Weighted  Average Grant-Date Fair Value (per share)
Nonvested at January 1, 2019	94	$	26.84	100	$	24.39
Granted	136	$	9.28	174	$	7.93
Forfeited	—	$	—	—	$	—
Nonvested at March 31, 2019	230	$	16.47	274	$	13.93

XML

Net Income (Loss) Per Share

3 Months Ended

Mar. 31, 2019

Earnings Per Share [Abstract]

Net Income (Loss) Per Share

Net Income (Loss) Per Share

	Three Months Ended March 31,
	2019			2018
Numerator:
Net loss	$	(18,600	)	$	(5,983	)
Denominator:
Weighted average shares outstanding	41,972			27,597
Effect of dilutive stock options	—			—
Diluted shares outstanding	41,972			27,597
Per common share net loss:
Basic net loss per share	$	(0.44	)	$	(0.22	)
Diluted net loss per share	$	(0.44	)	$	(0.22	)
Cash dividends declared per share	$	0.07		$	0.07

The calculation of diluted net loss per share for the three months ended March 31, 2019 and 2018, excludes 0.7 million and 0.5 million potentially dilutive stock options, which had the effect of being anti-dilutive. Given the net loss for the three months ended March 31, 2019 and 2018, all options are considered anti-dilutive and were excluded from the calculation of diluted net loss per share.

XML

Fair Value Measurements

3 Months Ended

Mar. 31, 2019

Fair Value Disclosures [Abstract]

Fair Value Measurements

Fair Value Measurements

Fair value is an exit price representing the expected amount that an entity would receive to sell an asset or pay to transfer a liability in an orderly transaction with market participants at the measurement date. We followed consistent methods and assumptions to estimate fair values as more fully described in the 2018 Annual Report.

Our financial instruments that are subject to fair value disclosure consist of cash and cash equivalents, accounts receivable, accounts payable, derivatives, and long-term debt. As of March 31, 2019, the carrying values of these financial instruments approximated fair value. The fair value of floating-rate debt approximates the carrying amount because the interest rates paid are based on short-term maturities. As of March 31, 2019, we had $10.6 million fixed-rate debt outstanding included in the “International lines of credit and other loans” line item within Note 9 to these Notes to Condensed Consolidated Financial Statements. These fair values represent Level 2 under the three-tier hierarchy described above. Due to the nature of these loans, fair value approximates book value.

Recurring Fair Value Measurements

Fair value principles prioritize valuation inputs across three broad levels. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument. Level 3 inputs are unobservable inputs based on the assumptions used to measure assets and liabilities at fair value. An asset or liability’s classification within the various levels is determined based on the lowest level input that is significant to the fair value measurement.

We manage our exposure to fluctuations in interest rates using a mix of fixed and variable rate debt. On February 8, 2019, we entered into a $700.0 million fixed-rate interest rate swap agreement that changed the LIBOR-based portion of the interest rate on a portion of our variable rate debt to a fixed rate of 2.4575% (the “interest rate swap”). The term of the interest rate swap is from the effective date of February 12, 2019, through the termination date of October 19, 2022 (the “interest rate swap term”). The interest rate swap effectively mitigates our exposures to the risks and variability of changes in LIBOR.

The notional amount of the interest rate swap will decrease over the interest rate swap term as follows:

	Notional Amount
February 12, 2019 - December 30, 2020	$	700,000
December 31, 2020 - December 30, 2021	466,667
December 31, 2021 - October 19, 2022	233,333

The objective of the interest rate swap is to eliminate the variability of cash flows in interest payments on the first $700.0 million of variable rate debt attributable to changes in benchmark one-month LIBOR interest rates. The hedged risk is the interest rate risk exposure to changes in interest payments, attributable to changes in benchmark one-month LIBOR interest rates over the interest rate swap term. If one-month LIBOR is greater than the minimum percentage under the Senior Secured Term Loan, the changes in cash flows of the interest rate swap are expected to exactly offset changes in cash flows of the variable rate debt. The interest rate swap is designated as a cash flow hedge.

As of March 31, 2019, we reported $3.9 millionloss , net of tax, in accumulated other comprehensive income related to the interest rate swap.

The following shows the liabilities measured at fair value on a recurring basis for the interest rate swap as of March 31, 2019.

	Fair Value Measurements as of March 31, 2019
Description	Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Derivative liability - other current liabilities	$	—	$	543	$	—
Derivative liability - other non-current liabilities	—		4,417		—
Total	$	—	$	4,960	$	—

The inputs for determining fair value of the interest rate swap are classified as Level 2 inputs. Level 2 fair value is based on estimates using standard pricing models. These standard pricing models use inputs which are derived from or corroborated by observable market data such as interest rate yield curves, index forward curves, discount curves, and volatility surfaces. Counterparty to this derivative contracts is a highly rated financial institution which we believe carries only a minimal risk of nonperformance.

As of December 31, 2018, we had no interest rate swap agreements outstanding.

XML

Subsequent Events

3 Months Ended

Mar. 31, 2019

Subsequent Events [Abstract]

Subsequent Events

Subsequent Event

Tennessee Shared Service Center Closure

On April 18, 2019, we announced the closure of our shared service center in Johnson City, Tennessee, effective at the end of June 2019. Closure of the Tennessee shared service center aligns with our focus on operating excellence and efficiency and is not expected to have a material impact on our financial statements.

XML

Interim Financial Statements (Policies)

3 Months Ended

Mar. 31, 2019

Quarterly Financial Information Disclosure [Abstract]

Nature of Business

Nature of Business

NN, Inc., is a global diversified industrial company that combines advanced engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision components and assemblies for the medical, aerospace and defense, electrical, automotive, and general industrial markets. As used in this Quarterly Report on Form 10-Q, the terms “NN,” the “Company,” “we,” “our,” or “us” refer to NN, Inc., and its subsidiaries. As of March 31, 2019, we had 51 facilities in North America, Europe, South America, and China.

Basis of Presentation

Basis of Presentation

The accompanying condensed consolidated financial statements have not been audited, except that the Condensed Consolidated Balance Sheet as of December 31, 2018, was derived from the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2018 (the “2018 Annual Report”), which we filed with the U.S. Securities and Exchange Commission (the “SEC”), on March 18, 2019. In management’s opinion, the accompanying unaudited condensed consolidated financial statements reflect all adjustments necessary to fairly state our results of operations for the three months ended March 31, 2019 and 2018; financial position as of March 31, 2019, and December 31, 2018; and cash flows for the three months ended March 31, 2019 and 2018, on a basis consistent with our audited consolidated financial statements other than the adoption of new accounting standards, such as the new lease standard (see Note 10). These adjustments are of a normal recurring nature and are, in the opinion of management, necessary to state fairly the Company’s financial position and operating results for the interim periods.

Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) have been condensed or omitted from the interim financial statements presented in this Quarterly Report on Form 10-Q. These unaudited condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and accompanying notes included in the 2018 Annual Report. The results for the three months ended March 31, 2019, are not necessarily indicative of results for the year ending December 31, 2019, or any other future periods.

Except for per share data or as otherwise indicated, all U.S. dollar amounts presented in the tables in these Notes to Condensed Consolidated Financial Statements are in thousands.

Accounting Standards

Accounting Standards Recently Adopted

Leases. On January 1, 2019, we adopted Accounting Standards Codification (“ASC”) 842, Leases, which superseded ASC 840, Leases. We adopted ASC 842 utilizing the modified retrospective transition approach, therefore, historical financial information and disclosures do not reflect the new standard and will continue to be presented under the previous lease accounting guidance. Under the modified retrospective transition method, we recognized the cumulative effect of the initial adoption adjustment to the opening balance of retained deficit as of January 1, 2019. The adoption adjustment to retained deficit was less than $0.1 million. As part of the adoption of ASC 842, we elected the package of practical expedients, the short-term lease exemption, and the practical expedient to not separate lease and non-lease components. We recorded lease-related assets and liabilities to our balance sheet for leases with terms greater than twelve months that were classified as operating leases and not previously recorded on our balance sheet. See Note 10 for the required disclosures related to ASC 842.

Derivatives and Hedging. In August 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities, (“ASU 2017-12”). ASU 2017-12 provides new rules that expand the hedging strategies that qualify for hedge accounting. The new rules also allow additional time to complete hedge effectiveness testing and allow qualitative assessments subsequent to initial quantitative tests if there is supportable expectation that the hedge will remain highly effective. We adopted the guidance on January 1, 2019. We have applied the new rules to 2019 hedging activities as disclosed in Note 16 to these condensed consolidated financial statements. The new guidance has no effect on our historical financial statements.

Effects of Tax Reform in Other Comprehensive Income. In February 2018, the FASB issued guidance related to the impacts of the U.S. Tax Cuts and Jobs Act of 2017 (“Tax Act”). Under existing U.S. GAAP, the effects of changes in tax rates and laws on deferred tax balances are recorded as a component of income tax expense in the period in which the law was enacted. When deferred tax balances related to items originally recorded in accumulated other comprehensive income (“AOCI”) are adjusted, certain tax effects become stranded in AOCI. The FASB issued ASU 2018-2, Income Statement – Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income, that permits reclassification of certain income tax effects of the Tax Act from AOCI to retained earnings. The guidance also requires certain disclosures about stranded tax effects. The new guidance was effective for us on January 1, 2019. We adopted the new guidance at the beginning of the period of adoption. The new guidance had no effect on our financial statements.

Accounting Standards Not Yet Adopted

Fair Value Disclosures. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement, that modifies fair value disclosure requirements. The new guidance could impact us by streamlining disclosures of Level 3 fair value measurements. The modified disclosures are effective for NN beginning in the first quarter of 2020, with early adoption allowed. ASU 2018-13 changes only disclosures and does not impact our financial condition, results of operations, or cash flows. We are in the process of evaluating the effects of this guidance on our fair value disclosures.

Internal-Use Software. In August 2018, the FASB issued ASU 2018-15, Intangibles - Goodwill and Other - Internal-Use Software: Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (a consensus of the FASB Emerging Issues Task Force), that provides guidance on a customer’s accounting for implementation, set-up, and other upfront costs incurred in a cloud computing arrangement that is hosted by the vendor. Under the new guidance, customers will apply the same criteria for capitalizing implementation costs as they would for an arrangement that has a software license. ASU 2018-15 is effective for us on January 1, 2020, using either a prospective or retrospective approach and with early adoption permitted. We are in the process of evaluating the effects of this guidance on our financial statements.

XML

Acquisitions (Tables)

3 Months Ended

Mar. 31, 2019

Business Combinations [Abstract]

Business Acquisition, Pro Forma Information

The provision for income taxes has also been adjusted for all periods, based upon the foregoing adjustments to historical results.

	Three Months Ended March 31, 2018
Pro forma net sales	$	209,830
Pro forma net loss	$	(8,077	)
Basic net loss per share	$	(0.29	)
Diluted net loss per share	$	(0.29	)

XML

Segment Information (Tables)

3 Months Ended

Mar. 31, 2019

Segment Reporting [Abstract]

Segment Information

The following table presents results of operations for each reportable segment.

	Mobile Solutions		Power Solutions		Life Sciences		Corporate and Consolidations				Total
Three Months Ended March 31, 2019
Net sales	$	78,075	$	49,657	$	86,008	$	(484	)	(a)	$	213,256
Income (loss) from operations	$	4,107	$	3,824	$	3,846	$	(11,176	)		$	601
Interest expense											(13,801		)
Other											(3,428		)
Loss before provision for income taxes and share of net income from joint venture											$	(16,628	)
Three Months Ended March 31, 2018
Net sales	$	89,794	$	48,682	$	31,200	$	(528	)	(a)	$	169,148
Income (loss) from operations	$	9,785	$	5,233	$	4,204	$	(15,529	)		$	3,693
Interest expense											(11,996		)
Other											313
Loss before benefit for income taxes and share of net income from joint venture											$	(7,990	)

_______________________________

(a) Includes elimination of intersegment transactions occurring during the ordinary course of business.

	Total Assets as of
	March 31, 2019		December 31, 2018
Mobile Solutions	$	392,100	$	356,387
Power Solutions	311,771		297,947
Life Sciences	824,891		802,770
Corporate and Consolidations	52,231		44,466
Total	$	1,580,993	$	1,501,570

XML

Inventories (Tables)

3 Months Ended

Mar. 31, 2019

Inventory Disclosure [Abstract]

Summary of Inventories

Inventories are comprised of the following amounts:

	March 31, 2019		December 31, 2018
Raw materials	$	55,286	$	52,930
Work in process	47,372		42,578
Finished goods	26,264		27,107
Total inventories	$	128,922	$	122,615

XML

Goodwill (Tables)

3 Months Ended

Mar. 31, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Changes in Carrying Amount of Goodwill

The following table shows changes in the carrying amount of goodwill.

	Mobile Solutions		Power Solutions		Life Sciences		Total
Balance as of December 31, 2018	$	—	$	94,505	$	344,947	$	439,452
Currency impacts	—		198		519		717
Balance as of March 31, 2019	$	—	$	94,703	$	345,466	$	440,169

XML

Intangible Assets, Net (Tables)

3 Months Ended

Mar. 31, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Summary of Carrying Amount of Intangible Assets Net

The following table shows changes in the carrying amount of intangible assets, net.

	Mobile Solutions			Power Solutions			Life Sciences			Total
Balance as of December 31, 2018	$	35,892		$	95,991		$	244,365		$	376,248
Amortization	(885		)	(2,748		)	(9,017		)	(12,650		)
Other	2			—			8			10
Balance as of March 31, 2019	$	35,009		$	93,243		$	235,356		$	363,608

XML

Investment in Joint Venture (Tables)

3 Months Ended

Mar. 31, 2019

Equity Method Investments and Joint Ventures [Abstract]

Summarized Activity Related to Investment in Joint Venture

The following table summarizes activity related to our investment in the JV.

Balance as of December 31, 2018	$	20,364
Share of earnings	269
Foreign currency translation gain	454
Balance as of March 31, 2019	$	21,087

XML

Debt (Tables)

3 Months Ended

Mar. 31, 2019

Debt Disclosure [Abstract]

Summary of Debt

The following table presents debt balances as of March 31, 2019, and December 31, 2018.

	March 31, 2019		December 31, 2018
Senior Secured Term Loan	$	530,625	$	532,063
Incremental Term Loan	276,000		279,000
Senior Secured Revolver	56,184		38,720
International lines of credit and other loans	10,601		9,810
Total principal	873,410		859,593
Less—current maturities of long-term debt	33,444		31,280
Principal, net of current portion	839,966		828,313
Less—unamortized debt issuance costs	13,692		16,842
Long-term debt, net of current portion	$	826,274	$	811,471

XML

Leases (Tables)

3 Months Ended

Mar. 31, 2019

Leases [Abstract]

Lease, Cost

The following table contains supplemental information related to leases for the three months ended March 31, 2019:

Supplemental Cash Flows Information	Three Months Ended March 31, 2019
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from finance leases	$	53
Operating cash flows from operating leases	5,288
Financing cash flows from finance leases	792
Right-of-use assets obtained in exchange for new operating lease liabilities	$	2,836

As of March 31, 2019, the weighted average remaining lease term and weighted-average discount rate for finance and operating leases was as follows:

	Weighted-Average Remaining Lease Term (years)	Weighted-Average Discount Rate
Finance leases	4.1	2.4	%
Operating leases	10.5	8.5	%

The following table presents components of lease expense for the three months ended March 31, 2019:

	Financial Statement Line Item	Three Months Ended March 31, 2019
Lease cost:
Finance lease cost
Amortization of right-of-use assets	Depreciation and amortization	$	322
Interest expense	Interest expense	53
Operating lease cost	Cost of sales and selling, general and administrative expense	3,434
Short-term lease cost (1)	Cost of sales and selling, general and administrative expense	107
Total lease cost		$	3,916

_______________________________

(1) Excludes expenses related to leases with a lease term of one month or less.

Assets and Liabilities, Lessee

The following table presents the lease-related assets and liabilities recorded on the balance sheet as of March 31, 2019:

	Financial Statement Line Item	March 31, 2019
Lease assets and liabilities:
Assets
Operating lease assets	Operating lease right-of-use assets	$	68,458
Finance lease asset	Finance lease right-of-use assets	12,886
Total lease assets		$	81,344
Liabilities
Current liabilities
Operating lease liabilities	Current portion of operating lease liability	$	7,630
Finance lease liabilities	Other current liabilities	2,401
Non-current liabilities
Operating lease liabilities	Operating lease liability, net of current portion	66,975
Finance lease liabilities	Other non-current liabilities	6,150
Total lease liabilities		$	83,156

Lessee, Operating Lease, Liability, Maturity

The future minimum lease obligations with noncancelable terms in excess of twelve months as of March 31, 2019, is as follows:

	Operating Leases		Finance Leases
2019 (1)	$	10,104	$	2,190
2020	11,979		2,033
2021	11,118		2,020
2022	10,812		1,853
2023	9,264		962
Thereafter	59,946		17
Total future minimum lease payments	113,223		9,075
Less: imputed interest	38,618		524
Total lease liabilities	$	74,605	$	8,551

(1) For the period from April 1, 2019 to December 31, 2019.

Finance Lease, Liability, Maturity

The future minimum lease obligations with noncancelable terms in excess of twelve months as of March 31, 2019, is as follows:

	Operating Leases		Finance Leases
2019 (1)	$	10,104	$	2,190
2020	11,979		2,033
2021	11,118		2,020
2022	10,812		1,853
2023	9,264		962
Thereafter	59,946		17
Total future minimum lease payments	113,223		9,075
Less: imputed interest	38,618		524
Total lease liabilities	$	74,605	$	8,551

(1) For the period from April 1, 2019 to December 31, 2019.

Schedule of Future Minimum Rental Payments for Operating Leases

The following table summarizes the future minimum lease payments under operating leases with initial or non-cancelable lease terms in excess of one year prior to adoption of ASC 842 as reported in our Annual Report on Form 10-K for the year ended December 31, 2018.

Year Ending December 31,
2019	$	13,337
2020	11,515
2021	10,557
2022	10,293
2023	8,752
Thereafter	53,945
Total minimum payments	$	108,399

XML

Restructuring and Integration (Tables)

3 Months Ended

Mar. 31, 2019

Restructuring and Related Activities [Abstract]

Summary of Restructuring and Integration Charges and Reserve Activity

The following table summarizes restructuring and integration charges incurred for the three months ended March 31, 2019 and 2018.

	Three Months Ended March 31, 2019
	Mobile Solutions			Power Solutions		Life Sciences		Corporate and Consolidations		Total
Severance and other employee costs	$	—		$	—	$	—	$	—	$	—
Site closure and other associated costs	(12		)	—		—		—		(12		)
Total	$	(12	)	$	—	$	—	$	—	$	(12	)
	Three Months Ended March 31, 2018
	Mobile Solutions			Power Solutions		Life Sciences		Corporate and Consolidations		Total
Severance and other employee costs	$	—		$	—	$	—	$	728	$	728
Site closure and other associated costs	27			—		—		—		27
Total	$	27		$	—	$	—	$	728	$	755

The following table summarizes restructuring and integration reserve activity for the three months ended March 31, 2019.

	Reserve Balance as of December 31, 2018		Charges			Non-cash Adjustments		Cash Reductions			Reserve Balance as of March 31, 2019
Severance and other employee costs	$	1,122	$	—		$	—	$	(274	)	$	848
Site closure and other associated costs	24		(12		)	—		(12		)	—
Total	$	1,146	$	(12	)	$	—	$	(286	)	$	848

XML

Revenue from Contracts with Customers (Tables)

3 Months Ended

Mar. 31, 2019

Revenue from Contract with Customer [Abstract]

Summary of Revenue from Contracts with Customers

The following tables summarize sales to external customers by major source.

	Three Months Ended March 31, 2019
	Mobile Solutions		Power Solutions		Life Sciences		Intersegment Sales Eliminations			Total
United States	$	44,457	$	41,115	$	68,343	$	(484	)	$	153,431
China	9,153		1,838		1,692		—			12,683
Mexico	5,378		2,709		127		—			8,214
Brazil	8,382		69		—		—			8,451
Germany	1,406		16		8,885		—			10,307
Switzerland	1,359		16		3,265		—			4,640
Poland	1,913		4		6		—			1,923
Italy	1,856		63		421		—			2,340
Czech Republic	1,509		188		—		—			1,697
France	44		—		1,225		—			1,269
Africa	—		1,156		—		—			1,156
Other	2,618		2,483		2,044		—			7,145
Total net sales	$	78,075	$	49,657	$	86,008	$	(484	)	$	213,256

	Three Months Ended March 31, 2018
	Mobile Solutions		Power Solutions		Life Sciences		Intersegment Sales Eliminations			Total
United States	$	49,655	$	40,128	$	30,553	$	(528	)	$	119,808
China	11,581		1,485		126		—			13,192
Mexico	7,236		3,197		172		—			10,605
Brazil	9,885		50		—		—			9,935
Poland	2,052		14		—		—			2,066
Czech Republic	1,810		—		—		—			1,810
Italy	1,577		98		—		—			1,675
Germany	1,534		7		1		—			1,542
Switzerland	1,406		—		—		—			1,406
Netherlands	—		974		—		—			974
Other	3,058		2,729		348		—			6,135
Total net sales	$	89,794	$	48,682	$	31,200	$	(528	)	$	169,148

Summary of Contract Liabilities from Contracts with Customers

The following table provides information about contract liabilities from contracts with customers.

	Deferred Revenue
Balance at January 1, 2019	$	2,974
Balance at March 31, 2019	$	2,890

XML

Shared-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2019

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Components of Share-Based Compensation Expense by Type of Award

The following table lists the components of share-based compensation expense by type of award.

	Three Months Ended March 31,
	2019		2018
Stock options	$	192	$	205
Restricted stock	459		460
Performance share units	222		591
Share-based compensation expense	$	873	$	1,256

Weighted Average Assumptions Relevant to Determining the Fair Value at the Dates of Grant and Stock Option Modification

The following table shows the weighted average assumptions relevant to determining the fair value of stock options granted in 2019.

	2019
Expected term	6 years
Risk free interest rate	2.47	%
Dividend yield	3.53	%
Expected volatility	49.53	%
Expected forfeiture rate	4.00	%

Reconciliation of Option Activity

The following table summarizes stock option activity for the three months ended March 31, 2019.

	Number of Options (in thousands)		Weighted- Average Exercise Price (per share)		Weighted- Average Remaining Contractual Term (years)	Aggregate Intrinsic Value
Outstanding at January 1, 2019	771		$	15.17
Granted	210		7.93
Exercised	—					$	—
Forfeited or expired	(3	)	24.41
Outstanding at March 31, 2019	978		$	13.58	6.3	$	—	(1)
Exercisable at March 31, 2019	701		$	14.27	5.0	$	—	(1)

_______________________________

(1) The aggregate intrinsic value is the sum of intrinsic values for each exercisable individual option grant. The intrinsic value is the amount by which the closing market price of our stock at March 31, 2019, was greater than the exercise price of any individual option grant.

Reconciliation of Restricted Stock Option Activity

The following table summarizes the status of unvested restricted stock awards as of March 31, 2019, and changes during the three months then ended.

	Nonvested Restricted Shares (in thousands)		Weighted Average Grant-Date Fair Value (per share)
Nonvested at January 1, 2019	146		$	22.07
Granted	281		$	7.93
Vested	(70	)	$	20.92
Forfeited	(18	)	$	18.98
Nonvested at March 31, 2019	339		$	10.74

Schedule of Performance Based Awards Goals with Respect to TSR and ROIC

The following table presents the goals with respect to TSR Awards and ROIC Awards granted in 2019.

TSR Awards:	Threshold Performance (50% of Shares)		Target Performance (100% of Shares)		Maximum Performance (150% of Shares)
2019 grants	35th Percentile		50th Percentile		75th Percentile
ROIC Awards:	Threshold Performance (35% of Shares)		Target Performance (100% of Shares)		Maximum Performance (150% of Shares)
2019 grants (1)	4.7	%	5.8	%	7.0	%

(1) For the ROIC Awards granted in 2019, the denominator of the calculation is different than in prior years, and therefore the target percentages are not comparable to historical target percentages.

Schedule of Number of Awards Granted and Grant Date Fair Value of Each Award in Periods

The following table presents the number of awards granted and the grant date fair value of each award in the period presented.

	TSR Awards			ROIC Awards
Award Year	Shares (in thousands)	Grant Date Fair Value (per share)		Shares (in thousands)	Grant Date Fair Value (per share)
2019	136	$	9.28	174	$	7.93

Summary of Status of Unvested PSU Awards

The following table summarizes the status of unvested PSUs as of March 31, 2019, and changes during the three months then ended.

	Nonvested TSR Awards			Nonvested ROIC Awards
	Shares (in thousands)	Weighted Average Grant-Date Fair Value (per share)		Shares (in thousands)	Weighted  Average Grant-Date Fair Value (per share)
Nonvested at January 1, 2019	94	$	26.84	100	$	24.39
Granted	136	$	9.28	174	$	7.93
Forfeited	—	$	—	—	$	—
Nonvested at March 31, 2019	230	$	16.47	274	$	13.93

XML

Net Income (Loss) Per Share (Tables)

3 Months Ended

Mar. 31, 2019

Earnings Per Share [Abstract]

Summary of Net Income (Loss) Per Share

	Three Months Ended March 31,
	2019			2018
Numerator:
Net loss	$	(18,600	)	$	(5,983	)
Denominator:
Weighted average shares outstanding	41,972			27,597
Effect of dilutive stock options	—			—
Diluted shares outstanding	41,972			27,597
Per common share net loss:
Basic net loss per share	$	(0.44	)	$	(0.22	)
Diluted net loss per share	$	(0.44	)	$	(0.22	)
Cash dividends declared per share	$	0.07		$	0.07

XML

Fair Value Measurements (Tables)

3 Months Ended

Mar. 31, 2019

Fair Value Disclosures [Abstract]

Schedule of Notional Amounts of Outstanding Derivative Positions

The notional amount of the interest rate swap will decrease over the interest rate swap term as follows:

	Notional Amount
February 12, 2019 - December 30, 2020	$	700,000
December 31, 2020 - December 30, 2021	466,667
December 31, 2021 - October 19, 2022	233,333

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis

The following shows the liabilities measured at fair value on a recurring basis for the interest rate swap as of March 31, 2019.

	Fair Value Measurements as of March 31, 2019
Description	Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Derivative liability - other current liabilities	$	—	$	543	$	—
Derivative liability - other non-current liabilities	—		4,417		—
Total	$	—	$	4,960	$	—

XML

Interim Financial Statements - Additional Information (Detail) $ in Thousands	3 Months Ended
	Mar. 31, 2019 Facility	Jan. 01, 2019 USD ($)	Jan. 01, 2018 USD ($)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Number of manufacturing facilities | Facility	51
Cumulative effect of new accounting principle of adoption		$ 18	$ 17
Accounting Standards Update 2016-02
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect of new accounting principle of adoption		$ 100

XML

Acquisitions - Additional Information (Detail)	Aug. 09, 2018	May 07, 2018	Feb. 22, 2018
Paragon Medical Inc
Business Acquisition [Line Items]
Acquisition percentage		100.00%
Bridgemedica, LLC
Business Acquisition [Line Items]
Acquisition percentage			100.00%
Southern California Technical Arts, Inc.
Business Acquisition [Line Items]
Acquisition percentage	100.00%

XML

Acquisitions Pro Forma Financial Results (Details) - Paragon Medical Inc $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2018 USD ($) $ / shares
Business Acquisition [Line Items]
Pro forma net sales | $	$ 209,830
Pro forma net loss | $	$ (8,077)
Basic net loss per share (in dollars per share) | $ / shares	$ (0.29)
Diluted net loss per share (in dollars per share) | $ / shares	$ (0.29)

XML

Segment Information (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Segment Reporting Information [Line Items]
Net sales	$ 213,256	$ 169,148
Income (loss) from operations	601	3,693
Interest expense	(13,801)	(11,996)
Other	(3,428)	313
Loss before (provision) benefit for income taxes and share of net income from joint venture	(16,628)	(7,990)
Total assets	1,580,993		$ 1,501,570
Mobile Solutions
Segment Reporting Information [Line Items]
Total assets	392,100		356,387
Power Solutions
Segment Reporting Information [Line Items]
Total assets	311,771		297,947
Life Sciences
Segment Reporting Information [Line Items]
Total assets	824,891		802,770
Corporate and Consolidations
Segment Reporting Information [Line Items]
Total assets	52,231		$ 44,466
Operating Segments | Mobile Solutions
Segment Reporting Information [Line Items]
Net sales	78,075	89,794
Income (loss) from operations	4,107	9,785
Operating Segments | Power Solutions
Segment Reporting Information [Line Items]
Net sales	49,657	48,682
Income (loss) from operations	3,824	5,233
Operating Segments | Life Sciences
Segment Reporting Information [Line Items]
Net sales	86,008	31,200
Income (loss) from operations	3,846	4,204
Corporate and Eliminations | Corporate and Consolidations
Segment Reporting Information [Line Items]
Net sales	(484)	(528)
Income (loss) from operations	$ (11,176)	$ (15,529)

XML

Inventories - Summary of Inventories (Detail) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Inventory Disclosure [Abstract]
Raw materials	$ 55,286	$ 52,930
Work in process	47,372	42,578
Finished goods	26,264	27,107
Total inventories	$ 128,922	$ 122,615

XML

Goodwill - Changes in Carrying Amount of Goodwill (Detail) - USD ($)	3 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Goodwill [Roll Forward]
Beginning Balance	$ 439,452,000
Currency impacts	717,000
Ending Balance	440,169,000	$ 439,452,000
Mobile Solutions
Goodwill [Roll Forward]
Beginning Balance	0
Currency impacts	0
Ending Balance	0	0
Power Solutions
Goodwill [Roll Forward]
Beginning Balance	94,505,000
Currency impacts	198,000
Ending Balance	94,703,000	94,505,000
Goodwill, impairment loss	0	109,100,000
Life Sciences
Goodwill [Roll Forward]
Beginning Balance	344,947,000
Currency impacts	519,000
Ending Balance	$ 345,466,000	$ 344,947,000

XML

Goodwill - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Goodwill [Line Items]
Goodwill	$ 440,169,000	$ 439,452,000
Power Solutions
Goodwill [Line Items]
Goodwill, impairment loss	0	109,100,000
Goodwill	$ 94,703,000	$ 94,505,000

XML

Intangible Assets, Net - Summary of Carrying Amount of Intangible Assets by Segment (Detail) $ in Thousands	3 Months Ended
	Mar. 31, 2019 USD ($)
Finite-lived Intangible Assets [Roll Forward]
Beginning Balance	$ 376,248
Amortization	(12,650)
Other	10
Ending balance	363,608
Mobile Solutions
Finite-lived Intangible Assets [Roll Forward]
Beginning Balance	35,892
Amortization	(885)
Other	2
Ending balance	35,009
Power Solutions
Finite-lived Intangible Assets [Roll Forward]
Beginning Balance	95,991
Amortization	(2,748)
Other	0
Ending balance	93,243
Life Sciences
Finite-lived Intangible Assets [Roll Forward]
Beginning Balance	244,365
Amortization	(9,017)
Other	8
Ending balance	$ 235,356

XML

Investment in Joint Venture - Additional Information (Detail) - USD ($)	3 Months Ended
	Mar. 31, 2019	Dec. 31, 2018	Mar. 31, 2018
Joint Venture
Schedule of Equity Method Investments [Line Items]
Impairment charge	$ 0	$ 16,600,000
Net sales			$ 100,000
Joint Venture | Maximum
Schedule of Equity Method Investments [Line Items]
Net sales	$ 100,000
Wuxi Weifu Autocam Precision Machinery Company, Ltd.
Schedule of Equity Method Investments [Line Items]
Investment in joint venture	49.00%

XML

Investment in Joint Venture - Summarized Activity Related to Investment in Joint Venture (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Equity Method Investments [Roll Forward]
Beginning Balance	$ 20,364
Our share of cumulative earnings	269	$ 831
Ending Balance	21,087
Joint Venture
Equity Method Investments [Roll Forward]
Beginning Balance	20,364
Our share of cumulative earnings	269
Foreign currency translation gain	454
Ending Balance	$ 21,087

XML

Income Taxes - Additional Information (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Income Tax Disclosure [Abstract]
Effective tax rate from continuing operations	(13.50%)	14.70%
Change in tax rate, income tax expense (benefit)	$ 6.0

XML

Debt - Summary of Debt (Detail) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Debt Instrument [Line Items]
Total	$ 873,410	$ 859,593
Less current maturities of long-term debt	33,444	31,280
Principal, net of current portion	839,966	828,313
Less unamortized debt issuance costs	13,692	16,842
Long-term debt, net of current portion	826,274	811,471
Chinese
Debt Instrument [Line Items]
International lines of credit and other loans	10,601	9,810
Senior Secured Term Loan B
Debt Instrument [Line Items]
Senior debt	530,625	532,063
Incremental Term Loan
Debt Instrument [Line Items]
Senior debt	276,000	279,000
Senior Secured Revolving Facility
Debt Instrument [Line Items]
Senior debt	$ 56,184	$ 38,720

XML

Debt - Additional Information (Detail) - USD ($)		3 Months Ended
	Mar. 15, 2019	Mar. 31, 2019	Mar. 31, 2018	Feb. 28, 2019	Dec. 31, 2018
Debt Instrument [Line Items]
Capitalized interest costs		$ 600,000	$ 200,000
Payments of debt issuance costs		738,000	$ 0
Senior Secured Term Loan B
Debt Instrument [Line Items]
Borrowings		545,000,000
Interest rate during period			6.24%
Senior debt		$ 530,625,000			$ 532,063,000
Senior Secured Term Loan B | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Applicable margin		3.75%
Senior Secured Term Loan B | London Interbank Offered Rate (LIBOR) | Minimum
Debt Instrument [Line Items]
Interest rate		0.75%
Incremental Term Loan
Debt Instrument [Line Items]
Borrowings		$ 300,000,000
Interest rate during period		5.74%
Senior debt		$ 276,000,000			279,000,000
Incremental Term Loan | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Applicable margin		3.25%
Senior Secured Revolving Facility
Debt Instrument [Line Items]
Borrowings		$ 143,000,000
Interest rate during period		5.99%
Unused capacity, commitment fee percentage		0.50%
Principal available		$ 125,000,000
Senior debt		$ 56,184,000			$ 38,720,000
Payments of debt issuance costs	$ 800,000
Write off of deferred debt issuance cost	$ 2,700,000
Senior Secured Revolving Facility | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Applicable margin		3.50%
Interest Rate Swap
Debt Instrument [Line Items]
Derivative, notional amount				$ 700,000,000
Derivative, fixed interest rate				2.4575%

XML

Leases - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Jan. 01, 2019	Jan. 01, 2018
Lessee, Lease, Description [Line Items]
Cumulative effect of new accounting principle of adoption			$ 18	$ 17
Lessee, operating lease, lease not yet commenced, amount	$ 21,900
Lessee, operating lease, lease not yet commenced, term of contract	15 years
Rent expense		$ 2,100
Equipment | Minimum
Lessee, Lease, Description [Line Items]
Lessee, finance lease, term of contract	13 months
Equipment | Maximum
Lessee, Lease, Description [Line Items]
Lessee, finance lease, term of contract	5 years
Manufacturing Facility | Minimum
Lessee, Lease, Description [Line Items]
Lessee, finance lease, term of contract	13 months
Manufacturing Facility | Maximum
Lessee, Lease, Description [Line Items]
Lessee, finance lease, term of contract	25 years
Accounting Standards Update 2016-02
Lessee, Lease, Description [Line Items]
Cumulative effect of new accounting principle of adoption			100
Retained Earnings
Lessee, Lease, Description [Line Items]
Cumulative effect of new accounting principle of adoption			18	$ 17
Retained Earnings | Accounting Standards Update 2016-02
Lessee, Lease, Description [Line Items]
Cumulative effect of new accounting principle of adoption			$ 100

XML

Leases - Finance and Operating Lease Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Finance lease cost
Amortization of right-of-use assets	$ 322
Interest expense	53
Operating lease cost	3,434
Short-term lease cost	107
Total lease cost	3,916
Assets
Operating lease right-of-use assets	68,458
Finance lease right-of-use assets	12,886
Lease, right-of-use asset	81,344
Current liabilities
Operating lease liabilities	7,630	$ 0
Finance lease liabilities	2,401
Non-current liabilities
Operating lease liabilities	66,975
Finance lease liabilities	6,150
Total lease liabilities	$ 83,156

XML

Leases - Supplemental Cash Flow Information (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2019 USD ($)
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from finance leases	$ 53
Operating cash flows from operating leases	5,288
Financing cash flows from finance leases	792
Right-of-use assets obtained in exchange for new operating lease liabilities	$ 2,836

XML

Leases - Weighted Average Remaining Lease Term and Discount Rate (Details)	3 Months Ended
	Mar. 31, 2019
Weighted-Average Remaining Lease Term (years)
Finance leases	4 years 1 month 6 days
Operating leases	10 years 6 months 18 days
Weighted-Average Discount Rate
Finance leases	2.40%
Operating leases	8.50%

XML

Leases - Future Minimum Lease Obligations After Adoption of 842 (Details) $ in Thousands	Mar. 31, 2019 USD ($)
Operating Leases
2019	$ 10,104
2020	11,979
2021	11,118
2022	10,812
2023	9,264
Thereafter	59,946
Total future minimum lease payments	113,223
Less: imputed interest	38,618
Total lease liabilities	74,605
Finance Leases
2019	2,190
2020	2,033
2021	2,020
2022	1,853
2023	962
Thereafter	17
Total future minimum lease payments	9,075
Less: imputed interest	524
Total lease liabilities	$ 8,551

XML

Leases Leases - Future Minimum Lease Obligations Before Adoption of 842 (Details) $ in Thousands	Dec. 31, 2018 USD ($)
Leases [Abstract]
2019	$ 13,337
2020	11,515
2021	10,557
2022	10,293
2023	8,752
Thereafter	53,945
Total minimum payments	$ 108,399

XML

Restructuring and Integration - Summary of Restructuring and Integration Charges and Reserve Activity (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Restructuring Cost and Reserve [Line Items]
Severance and other employee costs	$ 0	$ 728
Other	(12)	27
Restructuring Reserve [Roll Forward]
Reserve beginning balance	1,146
Charges	(12)	755
Non-cash Adjustments	0
Cash Reductions	(286)
Reserve ending balance	848
Severance and Other Employee Costs
Restructuring Reserve [Roll Forward]
Reserve beginning balance	1,122
Charges	0
Non-cash Adjustments	0
Cash Reductions	(274)
Reserve ending balance	848
Site Closure and Other Associated Costs
Restructuring Reserve [Roll Forward]
Reserve beginning balance	24
Charges	(12)
Non-cash Adjustments	0
Cash Reductions	(12)
Reserve ending balance	0
Operating Segments | Mobile Solutions
Restructuring Cost and Reserve [Line Items]
Severance and other employee costs	0	0
Other	(12)	27
Restructuring Reserve [Roll Forward]
Charges	(12)	27
Operating Segments | Power Solutions
Restructuring Cost and Reserve [Line Items]
Severance and other employee costs	0	0
Other	0	0
Restructuring Reserve [Roll Forward]
Charges	0	0
Operating Segments | Life Sciences
Restructuring Cost and Reserve [Line Items]
Severance and other employee costs	0	0
Other	0	0
Restructuring Reserve [Roll Forward]
Charges	0	0
Corporate and Eliminations | Corporate and Consolidations
Restructuring Cost and Reserve [Line Items]
Severance and other employee costs	0	728
Other	0	0
Restructuring Reserve [Roll Forward]
Charges	$ 0	$ 728

XML

Restructuring and Integration - Additional Information (Detail) $ in Millions	3 Months Ended
	Mar. 31, 2019 USD ($)
Restructuring and Related Activities [Abstract]
Pay period for accrued restructuring and integration costs	1 year 10 months 25 days
Restructuring and related cost, expected cost remaining	$ 0.5

XML

Commitments and Contingencies - Additional Information (Detail)	Mar. 31, 2019 USD ($)
Contingencies And Commitments [Line Items]
Amount accrued for estimation of loss	$ 0
Minimum
Contingencies And Commitments [Line Items]
Possible loss estimated	0
Maximum
Contingencies And Commitments [Line Items]
Possible loss estimated	$ 6,000,000

XML

Revenue from Contracts with Customers - Summary of Revenue from Contracts with Customers (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Revenue, Major Customer [Line Items]
Net sales	$ 213,256	$ 169,148
Intersegment Sales Eliminations
Revenue, Major Customer [Line Items]
Net sales	(484)	(528)
United States
Revenue, Major Customer [Line Items]
Net sales	153,431	119,808
United States | Intersegment Sales Eliminations
Revenue, Major Customer [Line Items]
Net sales	(484)	(528)
Chinese
Revenue, Major Customer [Line Items]
Net sales	12,683	13,192
Chinese | Intersegment Sales Eliminations
Revenue, Major Customer [Line Items]
Net sales	0	0
Mexico
Revenue, Major Customer [Line Items]
Net sales	8,214	10,605
Mexico | Intersegment Sales Eliminations
Revenue, Major Customer [Line Items]
Net sales	0	0
Brazil
Revenue, Major Customer [Line Items]
Net sales	8,451	9,935
Brazil | Intersegment Sales Eliminations
Revenue, Major Customer [Line Items]
Net sales	0	0
Germany
Revenue, Major Customer [Line Items]
Net sales	10,307	1,542
Germany | Intersegment Sales Eliminations
Revenue, Major Customer [Line Items]
Net sales	0	0
Switzerland
Revenue, Major Customer [Line Items]
Net sales	4,640	1,406
Switzerland | Intersegment Sales Eliminations
Revenue, Major Customer [Line Items]
Net sales	0	0
Poland
Revenue, Major Customer [Line Items]
Net sales	1,923	2,066
Poland | Intersegment Sales Eliminations
Revenue, Major Customer [Line Items]
Net sales	0	0
Italy
Revenue, Major Customer [Line Items]
Net sales	2,340	1,675
Italy | Intersegment Sales Eliminations
Revenue, Major Customer [Line Items]
Net sales	0	0
Czech Republic
Revenue, Major Customer [Line Items]
Net sales	1,697	1,810
Czech Republic | Intersegment Sales Eliminations
Revenue, Major Customer [Line Items]
Net sales	0	0
FRANCE
Revenue, Major Customer [Line Items]
Net sales	1,269
FRANCE | Intersegment Sales Eliminations
Revenue, Major Customer [Line Items]
Net sales	0
Africa
Revenue, Major Customer [Line Items]
Net sales	1,156
Africa | Intersegment Sales Eliminations
Revenue, Major Customer [Line Items]
Net sales	0
Netherlands
Revenue, Major Customer [Line Items]
Net sales		974
Netherlands | Intersegment Sales Eliminations
Revenue, Major Customer [Line Items]
Net sales		0
Other Country
Revenue, Major Customer [Line Items]
Net sales	7,145	6,135
Other Country | Intersegment Sales Eliminations
Revenue, Major Customer [Line Items]
Net sales	0	0
Mobile Solutions | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	78,075	89,794
Mobile Solutions | United States | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	44,457	49,655
Mobile Solutions | Chinese | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	9,153	11,581
Mobile Solutions | Mexico | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	5,378	7,236
Mobile Solutions | Brazil | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	8,382	9,885
Mobile Solutions | Germany | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	1,406	1,534
Mobile Solutions | Switzerland | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	1,359	1,406
Mobile Solutions | Poland | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	1,913	2,052
Mobile Solutions | Italy | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	1,856	1,577
Mobile Solutions | Czech Republic | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	1,509	1,810
Mobile Solutions | FRANCE | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	44
Mobile Solutions | Africa | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	0
Mobile Solutions | Netherlands | Operating Segments
Revenue, Major Customer [Line Items]
Net sales		0
Mobile Solutions | Other Country | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	2,618	3,058
Power Solutions | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	49,657	48,682
Power Solutions | United States | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	41,115	40,128
Power Solutions | Chinese | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	1,838	1,485
Power Solutions | Mexico | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	2,709	3,197
Power Solutions | Brazil | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	69	50
Power Solutions | Germany | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	16	7
Power Solutions | Switzerland | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	16	0
Power Solutions | Poland | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	4	14
Power Solutions | Italy | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	63	98
Power Solutions | Czech Republic | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	188	0
Power Solutions | FRANCE | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	0
Power Solutions | Africa | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	1,156
Power Solutions | Netherlands | Operating Segments
Revenue, Major Customer [Line Items]
Net sales		974
Power Solutions | Other Country | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	2,483	2,729
Life Sciences | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	86,008	31,200
Life Sciences | United States | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	68,343	30,553
Life Sciences | Chinese | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	1,692	126
Life Sciences | Mexico | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	127	172
Life Sciences | Brazil | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	0	0
Life Sciences | Germany | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	8,885	1
Life Sciences | Switzerland | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	3,265	0
Life Sciences | Poland | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	6	0
Life Sciences | Italy | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	421	0
Life Sciences | Czech Republic | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	0	0
Life Sciences | FRANCE | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	1,225
Life Sciences | Africa | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	0
Life Sciences | Netherlands | Operating Segments
Revenue, Major Customer [Line Items]
Net sales		0
Life Sciences | Other Country | Operating Segments
Revenue, Major Customer [Line Items]
Net sales	$ 2,044	$ 348

XML

Revenue from Contracts with Customers - Summary of Contract Liabilities from Contracts with Customers (Detail) $ in Thousands	Mar. 31, 2019 USD ($)
Contract with Customer, Liability [Abstract]
Deferred revenue, beginning balance	$ 2,974
Deferred revenue, ending balance	$ 2,890

XML

Revenue from Contracts with Customers Additional Information (Details) $ in Millions	3 Months Ended
	Mar. 31, 2019 USD ($)
Revenue, Major Customer [Line Items]
Amounts included in deferred revenue for performance obligations satisfied or partially satisfied	$ 0.6
Major Customer
Revenue, Major Customer [Line Items]
Revenues	$ 23.3
Major Customer | Customer Concentration Risk | Sales Revenue, Net
Revenue, Major Customer [Line Items]
Concentration risk, percentage	10.90%

XML

Shared-Based Compensation - Components of Share-Based Compensation Expense by Type of Award (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation	$ 873	$ 1,256
Stock Option Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation	192	205
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation	459	460
Performance Based Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation	$ 222	$ 591

XML

Shared-Based Compensation - Additional Information (Detail) $ / shares in Units, $ in Millions	3 Months Ended
	Mar. 31, 2019 USD ($) $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options granted (in shares)	210,400
Weighted average grant date fair value of the options granted (in USD per share) | $ / shares	$ 2.77
Total grant-date fair value of restricted stock | $	$ 1.5
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock units issued (in shares)	281,065
Fair value assumptions, exercise price (in USD per share) | $ / shares	$ 7.93
TSR Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock units issued (in shares)	136,000
Percentage of shares issuable based on threshold performance	50.00%
Percentage of shares issuable based on maximum performance	150.00%
ROIC Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock units issued (in shares)	174,000
Percentage of shares issuable based on threshold performance	35.00%
Percentage of shares issuable based on target performance	100.00%
Percentage of shares issuable based on maximum performance	150.00%
Officers and Key Employees | Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock awards granted vesting period	3 years
Non-executive Directors | Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock awards granted vesting period	1 year

XML

Shared-Based Compensation - Weighted Average Assumptions Relevant to Determining the Fair Value at the Dates of Grant and Stock Option Modification (Detail) - Stock Option Awards	3 Months Ended
	Mar. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term	6 years
Risk free interest rate	2.47%
Dividend yield	3.53%
Expected volatility	49.53%
Expected forfeiture rate	4.00%

XML

Shared-Based Compensation - Reconciliation of Option Activity (Detail) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2019 USD ($) $ / shares shares
Number of Options (in thousands)
Beginning balance (in shares) | shares	771,000
Granted (in shares) | shares	210,400
Exercised (in shares) | shares	0
Forfeitures (in shares) | shares	(3,000)
Ending balance (in shares) | shares	978,000
Options exercisable (in shares) | shares	701,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Beginning balance (in USD per share) | $ / shares	$ 15.17
Granted (in USD per share) | $ / shares	7.93
Exercised (in USD per share) | $ / shares
Forfeitures (in USD per share) | $ / shares	24.41
Ending balance (in USD per share) | $ / shares	13.58
Options exercisable (in USD per share) | $ / shares	$ 14.27
Weighted-average remaining contractual term, outstanding	6 years 3 months 14 days
Weighted- average remaining contractual term, options exercisable	5 years
Aggregate intrinsic value, exercised | $	$ 0
Aggregate intrinsic value, outstanding | $	0
Aggregate intrinsic value, options exercisable | $	$ 0

XML

Shared-Based Compensation - Reconciliation of Restricted Stock Option Activity (Detail)	3 Months Ended
	Mar. 31, 2019 $ / shares shares
Restricted Stock
Nonvested Shares (in thousands)
Nonvested restricted shares, beginning balance (in shares) | shares	146,000
Nonvested restricted shares, granted (in shares) | shares	281,065
Nonvested restricted shares, vested (in shares) | shares	(70,000)
Nonvested restricted shares, forfeited (in shares) | shares	(18,000)
Nonvested restricted shares, ending balance (in shares) | shares	339,000
Weighted average grant-date fair value, beginning balance (in USD per share) | $ / shares	$ 22.07
Weighted average grant-date fair value, granted (in USD per share) | $ / shares	7.93
Weighted average grant-date fair value, vested (in USD per share) | $ / shares	20.92
Weighted average grant-date fair value, forfeited (in USD per share) | $ / shares	18.98
Weighted average grant-date fair value, ending balance (in USD per share) | $ / shares	$ 10.74
TSR Awards
Nonvested Shares (in thousands)
Nonvested restricted shares, beginning balance (in shares) | shares	94,000
Nonvested restricted shares, granted (in shares) | shares	136,000
Nonvested restricted shares, forfeited (in shares) | shares	0
Nonvested restricted shares, ending balance (in shares) | shares	230,000
Weighted average grant-date fair value, beginning balance (in USD per share) | $ / shares	$ 26.84
Weighted average grant-date fair value, granted (in USD per share) | $ / shares	9.28
Weighted average grant-date fair value, forfeited (in USD per share) | $ / shares	0.00
Weighted average grant-date fair value, ending balance (in USD per share) | $ / shares	$ 16.47
ROIC Awards
Nonvested Shares (in thousands)
Nonvested restricted shares, beginning balance (in shares) | shares	100,000
Nonvested restricted shares, granted (in shares) | shares	174,000
Nonvested restricted shares, forfeited (in shares) | shares	0
Nonvested restricted shares, ending balance (in shares) | shares	274,000
Weighted average grant-date fair value, beginning balance (in USD per share) | $ / shares	$ 24.39
Weighted average grant-date fair value, granted (in USD per share) | $ / shares	7.93
Weighted average grant-date fair value, forfeited (in USD per share) | $ / shares	0.00
Weighted average grant-date fair value, ending balance (in USD per share) | $ / shares	$ 13.93

XML

Shared-Based Compensation - Schedule of Performance Based Awards Goals with Respect to TSR and ROIC (Detail)	3 Months Ended
	Mar. 31, 2019
TSR Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Threshold performance, percentage	35.00%
Target performance, percentage	50.00%
Maximum performance, percentage	75.00%
ROIC Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Threshold performance, percentage	4.70%
Target performance, percentage	5.80%
Maximum performance, percentage	7.00%

XML

Shared-Based Compensation - Summary of Number of Awards Granted and Grand Date Fair Value (Detail) shares in Thousands	3 Months Ended
	Mar. 31, 2019 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant Date Fair Value (in USD per share)	$ 7.93
TSR Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of awards granted in fair values (in shares) | shares	136
Grant Date Fair Value (in USD per share)	$ 9.28
ROIC Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of awards granted in fair values (in shares) | shares	174
Grant Date Fair Value (in USD per share)	$ 7.93

XML

Net Income (Loss) Per Share - Summary of Net Income (Loss) Per Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Earnings Per Share [Abstract]
Net loss	$ (18,600)	$ (5,983)
Weighted average shares outstanding (in shares)	41,972	27,597
Effect of dilutive stock options (in shares)	0	0
Diluted shares outstanding (in shares)	41,972	27,597
Basic - net loss per share (in dollars per share)	$ (0.44)	$ (0.22)
Diluted - net loss per share (in dollars per share)	(0.44)	(0.22)
Cash dividends declared per share (in dollars per share)	$ 0.07	$ 0.07

XML

Net Income (Loss) Per Share - Additional Information (Detail) - shares shares in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Stock Option Awards
Net Income Per Share [Line Items]
Anti-dilutive securities excluded from the calculation of diluted earnings per share from continuing operation	0.7	0.5

XML

Fair Value Measurements - Additional Information (Detail) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Feb. 28, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed-rate debt, outstanding	$ 10,600,000
Change in fair value of interest rate swap, net of tax	(3,856,000)	$ 0
Interest Rate Swap
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative, notional amount			$ 700,000,000
Derivative, fixed interest rate			2.4575%
Change in fair value of interest rate swap, net of tax	$ (3,900,000)

XML

Fair Value Measurements - Notional Amounts of the Interest Rate Swap (Details)	Mar. 31, 2019 USD ($)
February 12, 2019 - December 30, 2020
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative, notional amount	$ 700,000
December 31, 2020 - December 30, 2021
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative, notional amount	466,667
December 31, 2021 - October 19, 2022
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative, notional amount	$ 233,333

XML

Fair Value Measurements - Assets and Liabilities Measured on a Recurring Basis (Details) - Fair Value, Measurements, Recurring $ in Thousands	Mar. 31, 2019 USD ($)
Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative liability - other current liabilities	$ 0
Derivative liability - other non-current liabilities	0
Total	0
Significant Other Observable Inputs (Level 2)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative liability - other current liabilities	543
Derivative liability - other non-current liabilities	4,417
Total	4,960
Significant Unobservable Inputs (Level 3)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative liability - other current liabilities	0
Derivative liability - other non-current liabilities	0
Total	$ 0